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ABSTRACT
Synthetic approaches towards various fragments of the marine
natural product calyculin A are described. Attempts at the preparation of
the C1-C9 tetraene making extensive use of Wittig and Horner-Emmons
methodology are discussed in Chapter 1. Chapter 2 is concerned with the
synthesis of the C26-C32 fragment in which the key step involves
condensation of an amide with ethyl bromopyruvate to introduce the
oxazole. Chapter 3 describes the work directed towards completion of the
C33-C37 fragment featuring the hydrolytic opening of an imidate derived
from a lactam followed by elaboration of the dimethylamino group. Final
development of the methodology for the assembly of the C26-C37 fragment
is discussed in Chapter 4, and the use of chiral isoxazolidines as auxiliaries
in asymmetric synthesis as applied to the preparation of the C26-C32 portion
is discussed in Chapter 5. Chapter 6 presents a discussion of our work on
Calyculin A and chiral isoxazolidines as compared to research recently
published by other groups.
Thesis Supervisor: Satoru Masamune
Title: Professor of Chemistry
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0.1 Isolation of the Calyculins
Figure 0.1
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Marine organisms have proven to be important sources of natural
products bearing unique structural and biological properties. Some
9
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examples are shown in Figure 0.1 and are described accordingly.
Tetrodotoxin, 1, is the neurotoxin isolated from the blowfish, Spheroides
rubripes, and is the active component of the so-called Haitian zombification
powder. 1 Bryostatin 7, 2, is a cytotoxin isolated from the sponge, Bugula
neritina..2 Palytoxin, 3, is isolated from the coral, Palythoa toxica, and is
believed to be the most potent non-peptidic, non-alkaloid toxin isolated
from any marine organism.3
Figure 0.2
OH
H
Me'
OHHO /
// 
OH OH
4: Calyculin A: R1 = CN, R2 = R 3 = H
5: Calyculin B: R1 = R 3 = H, R2 = CN
6: Calyculin C: R1 = CN, R2 = H, R3 = Me
7: Calyculin D: R = H, R2 = CN, R 3 = Me
8: Calyculin E: 6,7 Zisomer of A
9: Calyculin F: 6,7 Zisomer of B
10: Calyculin G: 6,7 Zisomer of C
11: Calyculin H: 6,7 Z isomer of D
Between the years of 1986 and 1988, a novel family of four structurally
related compounds was isolated from the biologically active extracts of the
marine sponge, Discodermia calyx, and were characterized by NMR and x-
10
ray crystallographic techniques.4,5,6,7 Furthermore, in 1990 an additional
four members of this family were discovered.8 ,9,10 These compounds were
named calyculins A-H and their structures are shown in Figure 0.2.
Calyculin A, 4, is the most abundant and the most biologically active
member of the calyculin family, however it is present only in
concentrations of about 150 mg/kg of wet sponge (Table 0.1).4,6,9 The
relatively low abundances of these compounds coupled with their diverse
structural features and varied biological properties have made them
desirable targets for many synthetic groups. 11-26
Table 0.14,6,9
Isolated Yields of the Calyculins from Discodermia calyx
Calyculin mg/kg wet sponge yield (%)
A 150 0.15
B 20 0.02
C 30 0.03
D 5 5 X10- 3
E 1.8 1.8 x 10-3
F 1.3 1.3 X 10-3
G 0.9 9 X 10-4
H 0.9 9X10-4
0.2 Biological Properties of the Calyculins
Table 0.2
Minimum Inhibitory Dosages (ID) of Calyculins A-D
Calyculin min ID (g/mL)
A 0.01
B 0.01
C 0.005
D 0.005
Since 1986, the diverse biological properties of the calyculins have
been the subject of intense scientific interest. The calyculins were first found
11
in the extracts of Discodermia calyx which inhibit the growth of fertilized
starfish and sea urchin eggs.5 27 ,28 The inhibitory doses (ID) of calyculins A-
D as measured using methods developed by Ikegami29 are listed in Table 0.2.
Figure 0.3
Okadaic Acid
12
After the initial assays and isolation, other biological properties of
these novel compounds became apparent. One of the earliest of these to be
discovered was the ability of calyculin A to inhibit the activity of various
protein phosphatases.27,30,31,32 This property was discovered when
calyculin A, 4, was found to inhibit the binding of okadaic acid, 5 (Figure
0.3), to protein phosphatases 1 and 2A present in homogenized mouse skin
extracts. Although the binding of calyculin A to protein phosphatase 2A
was found to be comparable to that of okadaic acid, calyculin A was found to
bind 20-300 times more strongly to protein phosphatase 1.27 The inhibitory
concentrations (IC) of okadaic acid and calyculin A to various phosphatases
are shown in Table 0.3.27,30,33,34
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Table 0.327
Inhibitory Concentrations (IC) of Okadaic Acid and
Calyculin A to Various Phosphatases
Okadaic Acid Calyculin A
Phosphatase IC50 (nM) IC5 0 (nM) Substrates
Rabbit skeletal muscle
type PP-1, catalytic 60-200 2 myosin, LC20,
subunit _ ___ phosphorylase a
Rabbit skeletal muscle
type PP-2A, catalytic 0.5-1.0 0.5-1.0 myosin, LC20,
subunit ._ phosphorylase a
Chicken gizzard
endogenous myosin, LC20,
phosphatase of myosin 15-70 0.3-0.7 phosphorylase a
B, crude
Chicken gizzard
endogenous myosin, LC20,
phosphatase of myosin 200 0.7 phosphorylase a
B, partially purified
Bovine aortic bovine heart myosin
polymolecular 100 light chains, labeled
PP-2A by chick gizzard MLCK
bovine heart myosin
Bovine brain PP-2B 10,000 light chains, labeled
(calcineurin) _. by chick gizzard MLCK
bovine heart myosin
Rabbit liver PP-2C no effect at 10 pM light chains, labeled
by chick gizzard MLCK
Bovine semen and
potato acid no effect at 10 gPM no effect at 1 jiM p-nitrophenyl
phosphatases . phosphate
Alkaline phosphatases
from bovine liver/ p-nitrophenyl
intestinalmucosa/ no effect at 10 pM no effect at 1 gM phosphate
kidney and E. coli
Human placental
cytoskeleton PtyP no effect at 10 pM no effect at 1 p.M enolase, poly(Glu-Tyr)
From the studies of calyculin A as a phosphatase inhibitor, much has
been learned about cellular functions and the necessity of the phosphatase-
kinase couple. For example, the 20 kDa myosin light chain prepared from
chicken gizzards was phosphorylated as a result of increased kinase activity
in the presence of calyculin A and in the absence of Ca2 +.35 Furthermore,
calyculin A has been shown to facilitate the opening of Ca2+ channels. This
13
effect is postulated to be regulated by an intracellular phosphorylation
system. 36
When cellular systems were treated with calyculin A a marked
increase in protein phosphorylation within the cytosolic cellular fractions
was observed. Specific species that were phosphorylated include vimetin
and the 20 kDa myosin light chain. Furthermore, as observed by electron
microscopy, addition of calyculin A to 3T3 cells induced a noticeable shape
change in which the cell walls became rounded. This shape change was
reversible on removal of calyculin A. In the shape altered cells, stress fibers,
intermediate filaments, and microtubules were not noticeable. These
observations lend support to the conjecture that cell shape is at least
partially related to the phosphatase-kinase couple.3 7
As a final example of the ability of calyculin A to inhibit intracellular
phosphatase activity, starfish oocytes were treated with calyculin A. The
extract from these oocytes was shown to induce the phosphorylation of
exogenously added H1 histone.3 8 Therefore, from these results, there
appears to be abundant evidence for the interference of calyculin A in
phosphorylation-dephosphorylation systems.
As previously alluded to, calyculin A has also been shown to interact
with Ca2+ levels in cellular systems. Evidence for this property is provided
from the observation that calyculin A causes contractions in the smooth
muscle of guinea pig taenia and rat aorta. The observation that these effects
are independent of the external Ca2 + concentration, and that calyculin A
actually facilitates the opening of voltage dependent Ca2+ channels in
guinea pig taenia coli smooth muscle cells, further supports the above
claim.3 5,3 6
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Although these Ca2+ related effects are evident, they can be inhibited
by protein kinase C inhibitor, H-7, and nifedipine.3 9 Furthermore, the
calyculin A induced muscular contractions can be decreased if the muscle
strips are preincubated with endothelin-1 or phorbol 12-myristate 13-
acetate. 40 These observations seem to lend support to the interrelation of
the phosphatase-kinase couple and Ca2+ channels in cells. Consequently,
with all of these drastic biological effects, it is not surprising that calyculin A
has been shown to be an okadaic acid class tumor promoter when applied
topically to mouse skin. The postulated mode of action of tumor promotion
is initial binding of calyculin A to the okadaic acid receptor followed by
inhibition of protein phosphatases. The result is increased kinase activity
and inhibited protein dephosphorylation -- one of the essential processes
necessary for tumor promotion.2 8 ,3 2 ,41 ,42
Calyculin A has also been shown to possess antitumor and
antileukemic properties. This activity was noted in in vitro tests in which it
was found to be active against L1210 mouse leukemia cells. Additionally, in
in vivo tests, Ehrlich ascites tumor cells and P388 leukemia cells were
implanted into mice and the mice were then treated with doses of calyculin
A. In this in vivo study, the results were expressed as T/C % which is
defined as: (mean survival time of the treated group)/(mean survival time
of the control group) X 100. The results of these tests are shown in Tables 0.4
and 0.5, respectively. 5,7,8,2 8
In light of the variety of biological properties of the calyculins
reviewed here, it is interesting to note that calyculins E and F are being
studied for yet one more function. Initial tests upon the isolation of these
compounds revealed that they posess certain insecticidal attributes against
the German cockroach and mosquito larvae.8 ,l0 With these results to
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complete the list, the biochemical diversity of these Discodermia calyx
isolates seems incontrovertible. Additionally, although the biological effects
of these compounds renders them far too toxic for clinical use, the synthesis
and study of calyculin fragments may reveal the structure/function
requirements necessary to screen out some or all of their harmful effects. In
this respect, synthetic organic chemistry remains unchallenged!
Table 0.4
In Vitro Activities of Calyculins A-D Against:
L1210 (ng/mL) A. pectin (g/mL) H. pulcher (lg/mL)
Calyculin A 0.74 0.02 0.01
Calyculin B 0.88 0.02 0.01
Calyculin C 0.86 0.02 0.005
Calyculin D 1.5 0.05 0.005
Table 0.5
In Vivo Activities of Calyculin A
Dose (mg/kg) Medium Life Span (day) T/C (%)
Erlich 0.0075 17.0 141.7
0.015 29.5 245.8
P388 0.0075 12.5 138.9
0.015 13.0 144.4
0.3 Structural Features of Calyculin A
When examining the structure of calyculin A, we find a diverse
collection of functional groups bearing unique stereogenic relationships.
Among these are an amino sugar fragment bearing the 4-amino-4-deoxy
ribose configuration. The amino sugar is connected, via an amide bond, to a
fragment possessing a 2,4 disubstituted oxazole. This portion is, in turn,
attached to a 5,6 spiroketal unit bearing a phosphate moiety. Continuing
along the skeleton, we find a polypropionate unit which, in turn, is joined
16
to a tetraene capped with a Z oriented nitrile. This illustrates the
tremendous functional diversity of calyculin A contained within the
relatively small space of a 37 carbon backbone, and, when considered
alongside the biological properties, accentuates the appeal of this molecule
to the synthetic organic chemist.
0.4 Retrosynthetic Analysis
Scheme 0.1
N(
V
TBSO O
MeONN 
eNMe OTBS N
Me/N Me 
A
Fragment C
P(CeF
Fragment A
Fragment B
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Our initial retrosynthetic analysis of calyculin A is shown in Scheme
0.1 and involves disconnections of the C8-C9 and the C25-C26 double bonds
to yield fragments A, B, and C. Further disconnection of the amide bond,
shown in Scheme 0.2. further divides fragment C into two distinct
subfragments, C1 and C2.
Scheme 0.2
TBSO O
MeO-~ HN
C HI
me'N Me OTBS N
TBSO o
MeLO.~ .CO 2 Et H2 N \
Me' Me OMPMOMPM
C2 C1
0.5 Chapter Summary
In this thesis, our early synthetic approaches to fragment A will be
discussed in Chapter 1. Chapter 2 will be involved with the synthesis of
fragment C1, and Chapter 3 will discuss the preparation of fragment C2.
Most synthetic projects run into unexpected problems, and the
synthesis of calyculin A was no exception. The troubles referred to became
apparent when two groups independently demonstrated that the absolute
stereochemistry of the calyculins is opposite that shown in Figure 0.2.42a
Therefore, our solutions to the preparation of natural calyculin A and the
final preparation of fragment C will be discussed in Chapter 4.
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Finally, the total synthesis of natural products often provides
opportunities for the development of new chemical methodology. In this
case, chiral isoxazolidines were used as auxiliaries in asymmetric
alkylations. The results obtained from this study as well as a potential
application to the preparation of fragment C1 will be discussed in Chapter 5.
19
Chapter 1:
Approaches to Fragment A
20
1.1 Introduction
The ability to synthesize polyenes with specific substitution patterns
around the double bonds has proven important in the synthesis of many
naturally occurring compounds. The most notable of these syntheses is that
of p-carotene, 1343,44,45 (Figure 1.1). During the evolution of polyene
chemistry, many methods have been developed for the formation of double
bonds in all configurations. Although many elegant olefin syntheses have
subsequently been developed, few have proven as valuable to organic
chemists as the Wittig reaction and the Horner-Emmons modification
thereof. Therefore, we chose this methodology as our first approach to the
synthesis of fragment A.
Figure 1.1
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1.2 Stepwise Approaches to Fragment A
Upon consideration of our initially proposed structure for fragment A
(14, Scheme 1.2), we immediately recognized several problems. Among
these were the possibility that the phosphorane would epimerize the center
adjacent to the aldehyde in fragment B, and also whether we would be able
to selectively introduce the Z-oriented nitrile.
Although it has been demonstrated that phosphoranes can epimerize
a-stereogenic centers,4 6 we decided in favor of taking this calculated risk.
21
However, even if epimerization proved to be of little consequence, the
question of introduction of the Z oriented nitrile had to be addressed.
Upon searching the literature, we found that Still et al., had
developed a phosphonate reagent that preferentially formed Z-oriented
esters when condensed with aldehydes (Scheme 1.1).47 We postulated that if
we could produce the corresponding cyano reagent, we might be able to
obtain some Z selectivity on reaction with an appropriate ketone (Scheme
1.1). Therefore, with these two problems addressed, we proceeded to our
synthetic strategy.
Scheme 1.1
O O
(CF3CH2 )2 PLOMe
K2CO3/1 8-crown-6/Toluene CO2Me
Z/E = 50/1
R R
(CF 3 CH20)2 PCN
R. . .CN
Figure 1.2
:P(CH) 3 5)3
NC ,'-\ /~~
When considering fragment A, 14, as a whole, we considered the
possibility of loss of regiochemical integrity due to the dipolar nature of
22
phosphorus ylides (Figure 1.2). Therefore, we decided to build fragment A
onto the final B-C fragment in the last three steps of the synthesis. Our
retrosynthesis of fragment A, 14, is shown in Scheme 1.2.
Scheme 1.2
NC= -P(C 6H)3
14
NC
\ OCH2CF3
OCH2 CF3
15
+
PO(OC2H5 )2
0 16
1 6
P(C 6H 5)3
17
Scheme 1.3
O.__P(C 6H5)3 +
17
PO(O C 2H 5 )2
0
16
In practice,
carboxaldehyde,
straightforward as
19 NO
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the application of this strategy utilizing cyclohexane
18, as a model for the B-C fragment, was not as
we would have liked. Our initial results are shown in
23
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Scheme 1.3 and are described as follows. The phosphorane, 17,48 was
condensed with cyclohexane carboxaldehyde, 18, to produce a 70% yield of
the enone, 19. Unfortunately, when we attempted to couple the enone, 19,
with the phosphonate, 16,49 we observed no identifiable products.
Scheme 1.4
_.._PO(OC 2H5)2 1. Base
0 2. 0=
16
+
0
S. rv I
Scheme 1.5
Formylolefination
----- ---- ---- AN.
0
0=2 P (C 6H S)3
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In light of our disappointment regarding the reaction of the
phosphonate, 16, with the enone, 19, we decided to test this phosphonate on
24
t
0:
· _ aim, m~
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A. .1
isobutyraldehyde in order to determine the actual utility of this compound.
Surprisingly, we were only able to isolate a 14% yield of the desired product,
20, along with substantially higher yields of compound 21 resulting from an
additional aldol condensation (Scheme 1.4). With this result in hand, we
decided that it would be better to replace the phosphonate, 16, with two
reagents in which the first effects a formylolefination on the enone, 19, to
produce the aldehyde, 22. This aldehyde would then be treated with the
phosphorane, 23, to yield the desired conjugated ketone, 24 (Scheme 1.5).
Scheme 1.6
R R
1. LDA HCV 2 0
' 2. CPO(OC2H5 )2 HC
3. R 2C=O tBuN R R
25 26 27
1. NaH R
2. R 2C=O O HN 3. HCVH20
(C2HO)2 PJ 27
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To date, two methods have been reported for the formyl-olefination
of ketones using phosphonates (Scheme 1.6). The first, developed by Meyers
et al.,50 utilized a one-pot procedure in which ethylidene tert-butylimine, 25,
is condensed with diethylphosphorochloridate. The resulting phosphonate
anion is condensed with a ketone to yield the conjugated imine, 26. The
aldehyde, 27, is freed utilizing an acidic hydrolytic workup. The second
procedure, developed by Nagata et al.,51, 52 utilizes the anion derived from
diethyl 2-(cyclohexylamino)-vinyl-phosphonate, 28. After condensation of
this anion with a ketone, the aldehyde, 27, is liberated during an acidic
25
hydrolytic workup.
Although the Meyers procedure failed to produce any reaction, we
were able to obtain a 79% yield of our desired aldehyde, 22, using Nagata's
procedure. The fact that we obtained a 2.5: 1 ratio of the E and Z isomers as
shown by 1H NMR and nOe studies was without consequence since
treatment of this mixture with the phosphorane, 23, in refluxing toluene
produced a 62% yield of the desired product, 24, as a single geometrical
isomer as shown by 1H NMR and nOe studies (Scheme 1.7). This
presumably occurred as a result of the ability of stabilized ylides to
participate in reversible Michael-type additions to conjugated carbonyls as
shown in Scheme 1.8.53,54,55
Scheme 1.7
r 1
o NaN/K
(C2H5 )2 PJ
28
0
a q
=P(C6H 5) 3
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With the conjugated ketone, 24, in hand, we were now ready to
introduce the Z oriented nitrile. Consequently, we needed to develop an
appropriate reagent to carry out this transformation. The phosphonate we
26
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had designed for this purpose (33, Scheme 1.10) was based on a similar
reagent developed by Still et al.4 7 Although Still reported easily
reproducible results for the preparation of his phosphonate, 30, this
procedure was not readily adapted to the preparation of our desired
phosphonate, 33 (Scheme 1.9). Therefore, we began to explore alternate
strategies to this compound.
Scheme 1.8
R
+ · _P(C6H 5) 3
R
P(C6H)3
It
0- 
R
(C 6H 5)3 P 
0
Scheme 1.9
O O
(MeO)2 P>v'KOMe
29
1. PCI5
2. CF3CH2 0H
0 0
(CF3CH20)2P,vLOMe
30
0II 1. PC5 S
(MeO) 2 P.CN 2. CF3 CH20H
31
- DECOMPOSITION
In another approach to the phosphonate, 33, we felt that we might be
able to condense lithioacetonitrile with bis-trifluoroethyl
27
1r% r1%
phosphorochloridate, 32, (Scheme 1.10) prepared utilizing procedures
described by Sellars et al.56 However, due to the volatility and the
subsequent difficulties involved in the isolation of bis-trifluoroethyl
phosphorochloridate, we decided to search for an alternate but equivalent
electrophile. In the experiments that followed, we were gratified to find that
if we treated tris-trifluoroethylphosphate, 34, with two equivalents of
lithioacetonitrile we could produce a 15% yield of the desired phosphonate,
33 (Scheme 1.11).
Scheme 1.10
O
II
(CF3CH20)2Pci
32
Li CH2CN
------- 
Scheme 1.11
O Li CH2CN
II
(CF3 CH2 0) 3 P
34
O
II(CF3CH20)2 P,.CN
33
0
1(CF3CH20) 2PCN
33
Scheme 1.12
O
II +(CF3CH20)2 P,.CN
33
0
35 36
Z/E= 18/1
With our phosphonate, 33, in hand, we were in a position to
determine if this reagent would indeed perform Z-selective olefinations.
Our initial study of the utility of 33 involved its reaction with benzaldehyde,
28
35, in order to form the anticipated Z-cinnamonitrile, 36. As shown in
Scheme 1.12, this reaction did, in fact, produce the desired product, 36, as an
18: 1 mixture of Z and E isomers as shown by 1H NMR and nOe studies.
Although the initial olefination studies utilizing the phosphonate,
33, were quite promising, we were disappointed to discover that this reagent
would not react with ketones under any conditions. This was apparently
due to the relatively non-nucleophilic nature of the phosphonate anion as a
result of the inductive effect of the electronegative fluorine atoms. With
this unfortunate result in addition to the extended length of the synthesis,
we decided to re-examine our approach to fragment A.
1.3 Fragment A: More Convergent Approaches
Scheme 1.13
NC
4.
Cyano-olefinating
Agent
0
-PO(OR) 2
-I
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In re-evaluating of our strategy to fragment A, we recognized that at
best our initial approach added four linear steps to the end of the synthesis
29
of calyculin A. With this consideration, we felt a more convergent approach
would be in order. Therefore, as shown in Scheme 1.13, we decided to
examine the utility of introducing the bulk of fragment A in the form of the
phosphonate, 37, and end the synthesis with an appropriately designed
cyano-olefinating agent. We chose the second step in this sequence in spite
of our disappointing result with the Z olefination because we felt that there
were still options to be explored in the development of this methodology.
1.3.1 Two-Step Strategies
As illustrated in our retrosynthetic analysis (Scheme 1.13), we initially
decided to continue our study of phosphonate chemistry. The specific
phosphonate (41, Scheme 1.14) was to be prepared by the condensation of
appropriate -ketophosphonates with phosphoranes (Schemes 1.14 and
1.15).
Scheme 1.14
P( C 6H s )3
+ O PO(OC2H5) 2
OMe 38 39
·PO(C 2H5 ) 2 PO(OC2 H5 )2
Tebbe's Reagent
o=(
OMe 40 41
As shown in Scheme 1.14, the phosphorane, 38,57 and the
phosphonate, 39,58 were expected to condense to the phosphonate, 40. Our
30
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expectations that this reaction would proceed arose from the fact that
acetonyl triphenylphosphorane condenses with diethyl formylmethyl
phosphonate to yield a ,y conjugated ketophosphonate. 4 9 The expected
conjugated ester phosphonate, 40, was then to be converted to the desired
conjugated keto phosphonate, 41, on treatment with Tebbe's reagent.59
Unfortunately, we were unable to induce this reaction, presumably due to
proton transfer from the phosphonate to the phosphorane. Therefore, after
attempting the similar but more lengthy approach shown in Scheme 1.15,
we decided to explore the strategy shown in Scheme 1.16.
Scheme 1.15
=P(C6H5 )3 + PO(OC2 H5 )2
OMe 42 39
'PO(OC2 H 5)2
1. DIBAL
=P(C6H 5) 3
O a A
0
As shown in Scheme 1.16, 3-hydroxy-2-butanone, 44, was treated with
triethylchlorosilane and the resulting silyloxy ketone, 45, was converted to
the conjugated aldehyde, 46 (46%, 2 steps), utilizing Nagata's reagent, 28.51,52
Condensation of 46 with the phosphorane, 23, produced a 57% yield of the
desired ketone, 47. Subsequent treatment of 47 with tetrabutylammonium
fluoride produced a 69% yield of the alcohol, 48. Conversion of 48 to the
corresponding chloride, 49, was accomplished utilizing methane
sulfonylchloride as described by Meyers et al.,6 0 The crude chloride, 49, was
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expected to be transformed to the phosphonate, 50, on treatment with
triethylphosphite under Arbuzov conditions.6 1 Unfortunately, as indicated
by our experiments and as alluded to by Font et al.,62 direct conversion of
this type of conjugated ketone to a phosphonate or a phosphorane is not a
promising strategy due to complications involving conjugate additions as
well as enol phosphate formation. 63 With these disturbing revelations, we
felt that the introduction of fragment A in two pieces was not the most
promising approach. Therefore, as our last effort utilizing phosphorus
chemistry in fragment A, we decided to study its introduction as a single
piece.
Scheme 1.16
OH 1. TES-CI OTES
44 O HN - 46
2. (C2H5O)2 j 0 ' 265)3
28 P(C)3
PO(OEt) 2 1. TBAF
P(OEt) 3 2. Ms-CI
50
-OTES
1.3.2 A One-Piece Fragment
In developing fragment A as a single piece, we felt the most direct
approach was to convert the ketone, 47, to the corresponding mixture of
nitriles, separate the isomers, and learn whether we could, in fact, couple
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the conjugated nitrile-phosphonate to an aldehyde. Unfortunately, at this
point, we needed more starting material. Since we found that the
triethylsilyloxy (TES) group was too labile to give high yields in some of our
transformations, we proceeded from the beginning utilizing the more stable
tert-butyldimethylsilyl (TBS) protecting group.
Scheme 1.17
OH 1. TBS-CI OTBS
<4 4 O HNK 5 
2. (C2 HO) 2 P JP(C6H5)3
28 i =* 2
OTBS
O
1. NaH, (MeO) 2 P,,CN
2. Separate Isomers 0
1. TBAF
2. SOC12
3. P(OMe) 3
As shown in Scheme 1.17, 3-hydroxy-2-butanone, 44, was converted to
the TBS ether, 51, in 75% yield on treatment with tert-
butyldimethylchlorosilane. The resulting silyloxy ketone, 51, was then
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converted, in 70% yield, to the aldehyde, 52, utilizing Nagata's reagent,
28.51,52 Treatment of the aldehyde, 52, with the phosphorane, 23, produced a
76% yield of the ketone, 53. Subsequent reaction of the ketone, 53, with
dimethyl cyanomethylphosphonate formed a 1: 3.8 mixture of the Z and E
isomers (54a and 54b) of the fragment A skeleton, respectively. The isomers
were separated on silica gel and the E isomer (54b) was used to model the
final steps to the phosphonate as well as the Horner-Emmons coupling to
the B-C fragment.
Scheme 1.18
-PO(OMe) 2
-I
Four
- Compounds
18
Conversion of the silyl ether, 54b, to the alcohol, 55b, was
accomplished using tetrabutylammonium fluoride. Final conversion to the
E-isomer of fragment A, 57b, was expected to proceed via conversion of the
alcohol to the chloride, 56b, using methanesulfonyl chloride followed by
treatment of the chloride with trimethyl phosphite. However, using 1-
phenyl-l-buten-3-ol as a model system, we determined that conversion of
55b to 56b would best be accomplished using SOC12.6 4 Unfortunately,
although the chloride, 56b, was formed in good yield (75%), we were unable
to form the phosphonate, 57b, in yields greater than 30%. However, in the
hopes of optimizing these results at a later date, we proceeded to attempt its
coupling to a model aldehyde (Scheme 1.18).
When attempting to couple our phosphonate, 57b, to
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cyclohexanecarboxaldehyde, 18, we observed the formation of four isomeric
compounds as shown by 1H NMR and GC analysis. We believed these to
result from isomerization about the C3-4 and C7-8 double bonds. This
postulate was corroborated when the phosphonate, 57b, was treated with
base and quenched with H2 0 thus forming four isomeric compounds as
shown by 1H NMR and GC analysis. In light of these results, the utility of
Wittig and Horner-Emmons methodology in the preparation of fragment A
seemed questionable. Consequently, we have proposed an alternate strategy
involving a Stille coupling as outlined below (Scheme 1.19). This route to
fragment A was investigated by Ms. Sandra A. Filla and has been found to be
successful.
Scheme 1.19
40
PO(OR) 2
+ _ +
58 59 18
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1.4 Experimental Section
0= P ( C 6H$) 30 1
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Ketone, 19
Cyclohexanecarboxaldehyde, 18, (7.28 mL, 60.20 mmoles) and 1-
acylethylidene triphenylphosphorane, 17, (20 g, 60.24 mmoles) were heated
to reflux in toluene (300 mL), under argon, for 65.5 hours. The toluene was
removed under reduced pressure, and the residue was diluted with pentane
(400 mL). The triphenylphosphine oxide was filtered off and the pentane
was removed under reduced pressure. The residue was distilled through a
10 cm Vigreux column (P = 5 mm Hg) and the fraction boiling at 1000C was
collected to yield the desired product as a colorless liquid (6.97 g, 70%).
Physical Properties for 19
Rf = 0.39 (10% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 6.4(m, 1H), 2.3-2.4(m, 1H), 2.26(s, 3H), 1.76(d,
3H, J = 2 Hz), 1.6-1.75(m, 5H), 1.05-1.4(m, 5H).
EI Mass Spec: m/e 166 [M]+, 151,123, 83,43.
IR (neat) cm- l: 2925, 2850, 1665, 1640, 1445, 1363, 1290, 1270, 1257, 1217, 1143,
998, 893.
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Aldehyde, 22
To a suspension of NaH (80%, 0.464 g, 15.33 mmoles) in THF (5mL),
under argon, was slowly added a solution of diethyl 2-(cyclohexylamino)-
vinyl-phosphonate, 28, (4.00 g, 15.33 mmoles) in THF (5 mL). The mixture
was stirred at ambient temperature for 15 minutes after which a solution of
the ketone, 19, (1.27 g, 7.67 mmoles) in THF (5 mL) was added over 15
minutes. The reaction was stirred for an additional 1.5 hours, after which it
was diluted with ether (150 mL) and extracted with citric acid (5% in H2 0, 2
X 30 mL, 1 X 40 mL). The ether layer was then washed with brine (50 mL),
dried over Na2SO4, concentrated, and the residue was purified on silica gel
(10% ethyl acetate/hexane) to yield the desired product as a mixture of
isomers (1.16 g, 79%).
Physical Properties for 22
Rf = 0.30 (10% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): Z isomer: 8 9.62(d, J = 9.89 Hz, 1H), 5.84(m, 1H),
5.3(m, 1H), 2.28-2.42(m, 1H), 2.0(d, J = 2 Hz, 3 H), 1.78 (d, J = 2 Hz, 3H), 1.6-
1.75(m, 5H), 1.05-1.4(m, 5H); E isomer: 8 10.12(d, J = 9.89 Hz, 1H), 6.06(m, 1H),
5.92(m, 1H), 2.28-2.42(m, 1H), 2.27(d, J = 2 Hz, 3H), 1.94(d, J = 2 Hz, 3H), 1.6-
1.75(m, 5H), 1.05-1.4(m, 5H).
El Mass Spec: m/e 192 [M]+, 163, 149, 109, 83.
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Ketone, 24
Acetonyltriphenylphosphorane, 23, (1.91 g, 5.2 mmoles) and the
aldeh-de, 22, (1.00 g, 5.2 mmoles) were heated to reflux in toluene (30 mL)
for 30 hours under argon. The toluene was distilled off and the residue was
diluted with pentane (100 mL). The triphenylphosphine oxide was filtered
off and the pentane was removed under reduced pressure. The residue was
purified on silica gel (3% ethyl acetate/hexane) to yield the desired product
as a yellow solid (0.75 g, 62%).
Physical Properties for 24
Rf - 0.22 (10% ethyl acetate/hexane).
mp=50-51°C.
Xmax = 328 nm (measured)
Xmax = 329 nm (calculated).
1H NMR (300 Hz, CDC13): 6 7.53-7.63(m, 1 H), 6.27(d, J = 15.3 Hz, 1H), 6.16(d, J
= 18.4 Hz, 1H), 5.77(d, I = 12.2 Hz, 1H), 2.28-2.38(m, 1H), 2.27(s, 3H), 2.02(d, 3H,
J = 2Hz), 1.83(d, J = 2 Hz, 3H), 1.6-1.75(m, 5H), 1.05-1.4(m, 5H).
El Mass Spec: m/e 232 [M]+, 217,189, 109, 83.
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Bis-Trifluoroethyl Cyanomethylphosphonate, 33
A 500 mL round bottomed flask was charged with THF (200 mL) and
cooled to -78°C under a nitrogen atmosphere. n-BuLi (2.5 M in hexane, 58
mL, 0.145 mole) was added followed by CH3CN (10 mL, 0.193 mole). The
mixture was stirred at -78°C for 1 hour after which, a solution of tris-
trifluoroethylphosphate, 34, (24.1 g, 70.0 mmoles) in THF (100 mL) was
added at a rate of 0.99 mL/minute. The addition was stopped when
complete consumption f the precipitate was observed, and the reaction was
quenched with 50% saturated NH4CI solution (80 mL). The mixture was
warmed to room temperature and extracted with ether (300 mL). The ether
layer was dried over Na2SO4, concentrated, and the residue was distilled (0.2
mm Hg, 100-1030 C) to yield the product as a milky liquid (2.17 g, 15%).
Physical Properties for 33
1H NMR (300 MHz, CDCl3 ): 8 4.50(m, 4H), 3.18(d, 2H).
13C NMR (300 MHz, CDC13): 8 16.72(d), 63.3(m), 110.6(d), 122.03(dq).
El Mass Spec: m/e 285 [M]+, 266, 245, 83, 69.
IR (neat) cm-1: 2980, 2925, 2260, 1460, 1420, 1395, 1300, 1175, 1095, 960, 890,
840.
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Silyloxyketone, 45
Freshly distilled 3-hydroxy-2-butanone, 44, (8.8 g, 0.1 mole) was
dissolved in ether (200 mL). Imidazole (13.6 g, 0.2 mole) was added and the
mixture was cooled to 0°C under argon. Triethychlorolsilane (25.0 mL, 0.15
mole) was added over 45 minutes after which the reaction was allowed to
warm to room temperature. Stirring was continued for an additional 45
minutes after which the solids were filtered off and washed with ether. The
combined ether phases were washed with 5% citric acid solution (3 X 100
mL), saturated NaHCO 3 solution (100 mL) and brine (100 mL). The ether
phase was then dried over Na2SO4, filtered, and concentrated to a colorless
liquid. Distillation of the liquid (920C, 14 mm Hg) yielded the product as a
colorless liquid (15.5 g, 77%).
Physical Properties for 45
Rf = 0.67 (20% ethyl acetate/hexane).
1 H NMR (CDC13, 300 MHz): 8 4.1(q, 1H), 2.15(s, 3H), 1.25(d, 3H), 0.95(t, 9H),
0.6(q, 6H).
EI Mass Spec: m/e 199 [M - 2]+ , 173, 159, 131, 115, 43.
IR (neat) cm-l: 2920, 1725, 1460, 1415, 1350, 1235, 1120, 1055, 1000, 920, 780,
720.
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Aldehyde, 46
To a suspension of NaH (80%, 0.225 g, 7.50 mmoles) in THF (4 mL)
under nitrogen was added a solution of diethyl 2-(cyclohexylamino)-vinyl-
phosphonate, 28, (1.88g, 7.22 mmoles) in THF (3 mL). The mixture was
stirred at room temperature for 30 minutes after which a solution of the
silyloxyketone, 45, (0.999 g, 4.95 mmoles) in THF (3 mL) was added. The
reaction was stirred for 20 minutes after which it was diluted with ether (50
mL) and washed with 5% citric acid (3 X 10 mL). The ether phase was dried
over Na 2SO4, filtered, and concentrated to a yellow residue. Elution of the
residue down silica gel (5% ethyl acetate/hexane) yielded the product as a
light yellow oil (0.675 g, 60%).
Physical Properties for 46
Rf = 0.53 (20% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl3): 10.04(d, J = 7.72 Hz, 1H), 6.1(m, 1H), 4.26(q, J =
6.40, 1H), 2.12(d, I = 1. A Hz, 3H), 1.28(d, = 6.57 Hz, 3H), 0.9(t, J = 7.86 Hz, 9H),
0.6(q, I = 7.67 Hz, 6H).
EI Mass Spec: m/e 226 [M - 1]+, 199, 131, 115, 97, 43.
IR (neat) cm-l: 2920, 1680, 1460, 1410, 1380, 1235, 1190, 1085, 815.
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Ketone, 49
Acetonyltriphenylphosphorane, 23, (2.08 g, 6.5 mmoles) and the
aldehyde, 46, (1.49 g, 6.5 mmoles) were heated to reflux in benzene (20 mL)
for 48 hours under argon. The reaction was concentrated under reduced
pressure and the residue was diluted with hexane (25 mL). The
triphenylphosphine oxide was filtered off and the hexane was removed
under reduced pressure. The residue was purified on silica gel (4% ethyl
acetate/hexane) to yield the desired product as a yellow oil (0.99 g, 57%).
Physical Properties for 47
Rf = 0.49 (20% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 7.43(m, 1H), 6.23(d, J = 11.65 Hz, 1H), 6.14(d, J =
15.43 Hz, 1H), 4.25(q, J = 6.5 Hz, 1H), 1.87(s, 3H), 2.28(s, 3H), 1.25(d, J - 6.43 Hz,
3H), 0.9(t, J = 7.86 Hz, 9H), 0.6(q, I = 7.67 Hz, 6H).
EI Mass Spec: m/e 268 [M]+, 253, 115.
42
OH
TBAF
0 0
47
Hydroxyketone, 48
The ketone, 47, (0.996 g, 3.72 mmoles) was dissolved in THF (20 mL)
and cooled to 0°C under argon. Tetrabutylammonium fluoride (1M in THF,
7.44 mmoles) was slowly added to the mixture. The reaction was stirred at
0°C for 5 minutes after which, the reaction mixture was partitioned between
ether (50 mL) and saturated NaHCO 3 solution (50 mL). The ether was
washed with saturated NaHCO3 solution (2 X 25 mL) and brine (25 mL), after
which it was dried over Na2SO4, filtered and concentrated. The residue was
purified on silica gel (25% ethyl acetate/hexane) to yield the product as a
light yellow oil (0.393 g, 69%).
Physical Properties for 48
Rf = 0.34 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 7.44(dd, 2H), 6.26(d, 1H), 6.17(d, 1H), 4.33(q,
1H), 2.30(s, 3H), 1.90(d, 3H), 1.33(d, 3H).
EI Mass Spec: m/e 154 [M]+, 136, 111, 43.
IR (neat) cm-n: 3340, 2960, 1660, 1350, 1225, 1075.
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Silyloxyketone, 51
Freshly distilled 3-hydroxy-2-butanone, 44, (17.80g, 0.202 mole) and
imidazole (16.85g, 0.248 mole) were dissolved in ether (350 mL) and cooled
to 0°C under nitrogen. A solution of tert-butyldimethylchlorosilane (37.36 g,
0.248 mole) in ether (150 mL) was added over 45 minutes. The reaction was
warmed to room temperature and stirred for 16 hours, after which the solids
were filtered off and the filtrate was concentrated. Distillation of the residue
(14 mm Hg, 70-73C) yielded the product as a cloudy liquid (30.4 g, 75%).
Physical Properties for 51
Rf = 0.74 (20% ethyl acetate/hexane).
1H NMR (250 MHz, CDCl3): 6 4.10(q, 1H), 2.18(s, 3H), 1.28(d, 3H), 0.90(s, 9H),
0.06(s, 6H).
IR (neat) cm-1: 2900, 1725, 1470, 1360, 1255, 1120, 1060, 1000, 920, 830, 770, 660.
oNa N
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Aldehyde, 52
NaH (80%, 4.60 g, .153 mole) was suspended in THF (50 mL) at room
temperature under argon. A solution of diethyl 2-(cyclohexylamino)-vinyl-
phosphonate, 28, (40 g, 0.153 mole) in THF (50 mL) was added over 30
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minutes. The resulting mixture was stirred for an additional hour after
which, the silyloxyketone, 51, (25.0 g, 0.123 mole) in THF (50 mL) was added
over 1 hour. The reaction was stirred for an additional 40 minutes after
which, it was quenched with saturated NH4CI solution (150 mL). Ether (500
mL) was added and the layers were separated. The ether layer was washed
with 5% citric acid solution (3 X 150 mL) and brine (2 X 100 mL). The organic
phase was dried over Na2SO4, filetered and concentrated, and the residue
was distilled (0.1 mm Hg, 82-830C) to yield the product as a colorless liquid
(19.48 g, 70%).
Physical Properties for 52
Rf = 0.55 (20% ethyl acetate/hexane).
1H NMR (250 MHz, CDC13): 10.03(d, 1H), 6.08(d, 1H), 4.25(q, 1H), 2.11(d,
3H), 1.27(d, 3H), 0.90(s, 9H), 0.03(d, 6H).
'OTBSOTBS o=P(C6 H) 3
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Ketone, 53
Acetonyltriphenylphosphorane, 28, (11.65 g, 37.0 mmoles) and the
aldehyde, 52, (8.35 g, 37.0 mmoles) and were heated to reflux in benzene (100
mL) under argon for 24 hours. The solvent was removed and the residue
was washed with hexane. The solids were filtered off and the filtrate was
concentrated. The residue was purified on silica gel (4% ethyl
acetate/hexane) to yield the product as a yellow liquid (7.57 g, 76%).
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Physical Properties for 53
Rf = 0.52 (20% ethyl acetate/hexane).
1 H NMR (250 MHz, CDC13 ): 7.41(dd, H), 6.20(d, 1H), 6.12(d, 1H), 4.23(q,
1H), 2.27(s, 3H), 1.86(d, 3H), 1.22(d, 3H), 0.87(s, 9H), 0.03(d, 6H).
O
(MeO)2 PvCN
0:
54b: E isomer
ZIE Nitrile, 54a/54b
NaH (80%, 0.935 g, 31.2 mmoles) was suspended in THF (20 mL) at
room temperature under argon. A solution of dimethyl
cyanomethylphosphonate (4.63 g, 31.1 mmoles) in THF (20 mL) was added
over 20 minutes. The mixture was stirred for an additional 20 minutes after
which, a solution of the ketone, 53, (7.57 g, 28.25 mmoles) was added over 45
minutes. The reaction was stirred for 3 hours after which a solution of the
anion of dimethyl cyanomethylphosphonate (prepared from dimethyl
cyanomethylphosphonate (3 g), NaH (80%, 0.608 g), and THF (20 mL)) was
added over 10 minutes. The reaction was stirred for an additional 10
minutes after which, it was quenched with saturated NH4Cl solution (50
mL). Ether (100 mL) was added and the layers were separated. The organic
phase was washed with saturated NH4Cl solution (50 mL) and brine (2 X 25
mL). The organic layer was dried over Na2S04, filtered and concentrated,
and the residue was separated into its two components by repetitive flash
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chromatography (silica gel, 9% ethyl acetate/hexane) to yield the Z-isomer
(1.352 g, 16%), 54a, and the E-isomer (5.099 g, 62%), 54b.
Physical Properties for 54a
Rf = 0.62 (20% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13): 6.82(dd, 1H), 6.74(d, J = 15.14 Hz, 1H), 6.19(d, J =
10.29 Hz, 1H), 5.07(s, 1H), 4.24(q, J = 6.43 Hz, 1H), 2.04(s, 3H), 1.81(s, 3H),
1.21(d, J = 6.43 Hz, 3H), 0.87(s, 9H), 0.06(d, J = 8.78 Hz, 6H).
IR (neat) cmn-1: 3040, 2940, 2850, 2700, 1720, 1635, 1600, 1567, 1460, 1440, 1360,
1308, 1250, 1217, 1150, 1075, 980, 960, 825, 770, 657.
Physical Properties for 54b
Rf = 0.64 (20% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13 ): 8 6.80(dd, 1H), 6.24(d, J = 15.14 Hz, 1H), 6.15(d, J =
11.07 Hz, 1H), 5.18(s, 1H), 4.23(q, J = 6.43, 1H), 2.20(s, 3H), 1.82(s, 3H), 1.23(d, J =
6.43 Hz, 3H), 0.89(s, 9H), 0.03(d, J = 8.83 Hz, 6H).
IR (neat) cm-l: 3040, 2930, 2850, 2700, 1720, 1635, 1600, 1570, 1460, 1440, 1385,
1358, 1250, 1150, 1080, 955, 825, 770, 658.
TBAF
-- b
Hydroxynitrile, 55b
The nitrile, 54b, (1.0 g, 3.44 mmoles) was dissolved in THF (20 mL)
and cooled to 0°C under argon. Tetrabutylammonium fluoride (1M in THF,
47
-
7 mL) was slowly added and the mixture was stirred at 0°C for 3 hours, after
which the reaction was quenched with saturated NaHCO3 solution (50 mL).
The aqueous mixture was extracted with ether (3 X 50 mL), and the
combined ether layers were dried over Na2SO4, filtered and concentrated.
The residue was purified on silica gel (35% ethyl acetate/hexane) to yield the
product as a light brown oil (0.612 g, 99%).
Physical Properties for 55b
Rf = 0.48 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13 ): 6.78(dd, 1H), 6.26(d, 1H), 6.17(d, 1H), 5.18(s,
1H), 4.30(q, 1H), 2.19(s, 3H), 1.84(s, 3H), 1.30(d, 3H).
EI Mass Spec: m/e 177 [M]+, 162, 134, 43.
N,
-OH
SOCI2
NI
Chloride, 56b
The hydroxynitrile, 55b, (53.2 mg, 0.30 mmoles) was dissolved in THF
(0.5 mL) and cooled to 0°C under argon. 2,6-Lutidine (80 mL, 0.688 mmoles)
was added followed by SOC12 (50 mL, .685 mmoles). The reaction was stirred
at 0°C for 3 hours, after which it was quenched with saturated NH4 Cl
solution (2 mL). The aqueous mixture was washed with ethyl acetate (5
mL), and the ethyl acetate was washed with saturated CuSO4 solution (2 mL)
and brine (2 X 2 mL). The organic phase was dried over Na2SO4, filtered and
concentrated to yield the pure product (44.6 mg, 76%).
48
Physical Properties for 56b
Rf = 0.54 (20% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 6.73(dd, 1H), 6.29(d, I = 15.14 Hz, 1H), 6.16(d, I =
10.85 Hz, 1H), 5.20(s, 1H), 4.61(q, = 6.69 Hz, 1H), 2.18(s, 3H), 1.93(s, 3H),
1.61(d, J = 7.00 Hz, 3H).
PO(OMe)2
P(OMe) 3
NC ' 56b NC 57b
Phosphonate, 57b
The chloride, 56b, (44.6 mg, 0.23 mmoles) was heated to reflux in
trimethyl phosphite (0.5 mL) under argon for 24 hours. The excess
phosphite was removed under vacuum and the residue was purified on
silica gel (ethyl acetate) to yield the product as a yellow oil (25.9 mg, 42%).
Physical Properties for 57t
Rf = 0.35 (ethyl acetate).
1H NMR (300 MHz, CDC13): 6.80(m, 1H), 6.25(dd, 1H), 6.10(dd, 1H), 5.18(s,
1H), 3.75(dd, 6H), 2.73(dq, 1H), 2.18(s, 3H), 1.96(dd, 3H), 1.37(dd, 3H).
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1.5 NMR Spectra
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Chapter 2:
Fragment C1
61
2.1 Introduction
Figure 2.1
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Pimprinine
61
Ostreogrycin A
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The presence of oxazoles in many biologically active naturally
occurring compounds has generated much interest among synthetic organic
chemists. Consequently, oxazole bearing synthetic targets have included
annuloline, 60,65,66 pimprinine, 61,67 and ostreogrycin A, 6268,69,70 (Figure
2.1). Unfortunately, the harshness of conditions required for the
preparation of oxazoles has generally provided low to good yields.71,72
Additionally, relatively few examples exist in which stereogenic centers are
present a to the ring. Synthetically speaking, it is for these reasons that
oxazoles have been attractive targets to organic chemists and have enticed
us to develop a new protocol for their preparation. Since, at the time of this
research, the absolute stereochemistry of calyculin A was unknown, this
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protocol was applied to the preparation of fragment C1 with stereochemistry
subsequently shown to be enantiomeric to that of the natural product.
2.2 Retrosynthetic Analysis
Our retrosynthetic analysis of fragment C1, 63, is shown in Scheme
2.1. We originally envisioned the oxazole, 63, arising from the
corresponding oxazoline, 64.73,74 We then imagined deriving the oxazoline,
64, from the imidate of the corresponding amide, 65, on treatment with
serine methyl ester.75 Since little is known about the application of this
methodology to amides bearing a stereogenic centers, we felt we would
have the added advantage of being able to determine the enantiomeric
purity of the a center, through NMR analysis of the diastereomers, if we
trapped the imidate with enantiomerically pure serine methyl ester.
Scheme 2.1 I
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2.3 Preparation of the Amide, 65
The first phase of our amide synthesis brought us to the 1,2-diol, 72,
shown in Scheme 2.2. Treatment of 3-buten-l-ol, 66, with tert-butyl
diphenylchlorosilane produced a quantitative yield of the protected alcohol,
63
67. The olefin was then ozonolyzed and the resulting aldehyde was
homologated, on treatment with triethyl phosphonoacetate, 68, to the a,3-
unsaturated ester, 69, utilizing the Masamune conditions for the Horner-
Emmons modification of the Wittig reaction76 (75%, two steps). The ester,
69, was then reduced to the allylic alcohol, 70, in quantitative yield on
treatment with DIBAL, and the allylic alcohol, 70, was converted to the
epoxy alcohol, 71, in 86% yield utilizing the Sharpless asymmetric
epoxidation. 77
Scheme 2.2
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At this stage, we were unable to determine the enantiomeric purity of
our intermediate due to a lack of resolution of the peaks in the 1H and 19F
NMR spectra of the corresponding Mosher ester. However, when we
introduced the methyl group with regioselective opening of the epoxide to
the diol, 72 (91% yield), 78 ,79 we found a > 40: 1 mixture of 1,2 to 1,3 diols as
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well as an enantiomeric purity of > 20: 1 as shown by 19F NMR analysis of
the corresponding bis-Mosher ester.
Scheme 2.3
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At this point we were ready to convert the diol, 72, to the amide, 65, as
shown in Scheme 2.3. The diol, 72, was treated with NaIO4 79 and the
resulting aldehyde was oxidized to the acid, 73, with KMnO480 (95%, two
steps). Unfortunately, on reduction of the acid, 73, to the corresponding
alcohol with BH3-Me2S8 1 and analysis of the corresponding Mosher ester by
1H NMR we found that significant epimerization of the stereogenic center
had occurred. Fortunately, we were able to avoid this problem by running
the two step procedure buffered at pH = 5. With the epimerization problem
solved, we converted the acid, 73, to the corresponding acid chloride on
treatment with oxalyl chloride. In situ treatment of the crude acid chloride
with liquid ammonia yielded the amide, 65, in quantitative yield over two
steps. Additionally, we were able to show, via HPLC analysis, that the
enantiomeric purity of the amide remained > 20: 1.82 Furthermore,
through recrystallization from hexane, we were able to enhance the optical
purity of the amide, 65, to > 99: 1. With the amide in hand, we were ready
to explore the preparation of the oxazole.
65
2.4 Preparation of the Oxazole
Our original approach to the oxazole (Scheme 2.4) involved
treatment of the amide, 65, with methyl triflate and reaction of the resulting
imidate with serine methyl ester, 74, to yield the oxazoline, 64, in 90%
yield. 75 The oxazoline was then oxidized to the oxazole, 75, in 42% yield on
heating to reflux in benzene in the presence of NiO2 or MnO2.73,74 Due to
(1) the relatively low yields from the oxidation, (2) our observed
epimerization when optically pure serine methyl ester was used, and (3) the
fact that oxazolines bearing 0a-stereogenic centers are completely racemized
when heated to 400C for 16 hours,8 3,84 we elected to explore alternate
strategies for the preparation of oxazoles.
Scheme 2.4
1 1. MeOTf B 
tBuPh2SiO CONH 2 HO tCO21e NAC
65 2. NH2 64 CO2Me
74
NiO2 or MnO2
O'Me
It has been well documented that when heated with a-bromoketones
to 1400C in the absence of solvent, amides yield 2,4-disubstituted oxazoles in
relatively low yields.8 5,86 The proposed mechanism, shown in Scheme 2.5,
involves initial displacement of the bromide by the amide oxygen forming
the imidate-type species, 77. Cyclization then forms the 4-hydroxyoxazoline,
78, which dehydrates under acidic conditions to the oxazole, 79.
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In order to apply this type of methodology to our synthesis, we had to
address two points -- (1) the previously mentioned fact that oxazolines
bearing ac-stereogenic centers are completely racemized on heating to 40°C
for 16 hours, and (2) the fact that our amide bears an acid unstable silyl ether.
We felt, however, that both of these problems could be overcome if we
utilized a polar aprotic solvent in the presence of an acid scavenger.
Scheme 2.5
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Initially, we set out to determine if we could form the intermediate 4-
hydroxyoxazoline, 81, by treating our amide, 65, with ethyl bromopyruvate,
80, as shown in Scheme 2.6. Our study involved a variety of solvents and
acid scavengers, the results of which are shown in Table 2.1. Consequently,
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we found that heating our amide and ethyl bromopyruvate to reflux in
acetonitrile in the presence of cyclopentene oxide as an acid scavenger, we
were able to produce an 81% yield of the desired 4-hydroxyoxazoline, 81,
with an 18% yield of recovered amide, 65. What was now required was a
means of dehydrating our oxazoline to the desired oxazole, 82.
Table 2.1
Conditions for Hydroxyoxazoline Formation
Solvent Acid Scavenger Temp Pyruvate 81 65
Toluene K2 C03 (3eq) Reflux 1.1 eq- 
EtOH K2C03 (3eq) Reflux 1.1 eq - -
CH 3CN K2 C03 (3eq) Reflux 1.1 eq 61% 14%
CH 3 CN K2 C03 (10eq) Reflux 3 eq 57% -
CH3CN NaHCO3 (10eq) Reflux 2 eq 28% -
CH 3 CN K2 C03 (10eq) 500C 2 eq 24% -
CH3CN/EtOH 1/1 K2C03 (1Oeq) Reflux 2 eq_-
CH 3CN K2 CO3 (1eq) Reflux 6 eq 29% --
CH3CN °> (2.5eq) Reflux 2 eq 81% 18%
Scheme 2.7
Dehydrating
Reagent
81 82
Table 2.2
Conditions for Dehydration of the Hydroxyoxazoline to the Oxazole
Reagent Solvent Temp Yield
AcOH AcOH Reflux
AcOH AcOH RT
POC13 POC13 RT to 500 C
PPE CHCl3 Reflux --
P2 05 /Ac20 CHCl3 RT
TFAA/Pyridine THF RT 76%
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Our search for suitable conditions to effect the dehydration of the 4-
hydroxyoxazoline, 81, to the desired oxazole, 82, shown in Scheme 2.7, led us
through a variety of conditions shown in Table 2.2. As it turned out, the
only conditions which did not cause complete decomposition of the 4-
hydroxyoxazoline were trifluoroacetic anhydride (TFAA) in the presence of
pyridine. These conditions afforded a 76% yield of the desired oxazole, 82.
With this result, we were ready to combine these two steps into a one-pot
process.
Scheme 2.8
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While optimizing the one-pot oxazole preparation shown in Scheme
2.8, we tried a variety of conditions, all of which included running the first
phase of the reaction at reflux temperatures and using, in the second phase,
four equivalents of TFAA and eight equivalents of pyridine. The results of
our study, shown in Table 2.3, demonstrated that little change in the yield
occurred when we switched from the more strained cyclopentene oxide to
the less strained epoxy butane. This result was advantageous in that the
latter epoxide is much less expensive. Unfortunately, as we learned by
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removal of the silyl group and subsequent formation of the Mosher ester,
this reaction sequence was causing significant epimerization. This came as
no surprise as we were running these reactions at elevated
temperatures. 83 ,84 Therefore, we set out in search of more mild conditions.
Table 2.3
Scheme 2.9
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In varying the conditions for our oxazole synthesis, we found that, in
addition to running the reaction at room temperature, the choice of acid
scavenger was critical for the success of this reaction - specifically, the more
reactive the epoxide, the less the degree of epimerization. Additionally,
after embarking on this study, we found two significant side products, the
quantities of which were also controlled by the choice of epoxide. These
products were the 2,5-disubstituted oxazole, 83, and the nitrile, 84 (Scheme
2.9). The 2,5-disubstituted oxazole, 83, is believed to arise from initial attack
of ethyl bromopyruvate by the amide nitrogen. The nitrile, 84, is believed to
arise from dehydration of the amide. This study, the results of which are
shown in Table 2.4, eventually led to a 63% yield of the desired oxazole, 82,
in enantiomerically pure form when epoxy cyclopentene 87 was used as the
acid scavenger. Additionally, although the undesired 2,5-oxazole, 83, was
not formed, we were unable to suppress a 35% yield of the nitrile, 84.
Table 2.4
Final Conditions for the One-Pot Oxazole Formation (Scheme 2.9)
Scavenger Pyruvate Time 82 83 84 Ratio
C (7eq) e 18 Hours 56% 0.5% --- 6: 1
o (7e) 5e 14 Hours 71% 1% --- 10: 1
(76) 5eq . 7 Hours 20% - 55% > 40: 1
c (7e) 5eg 16 Hours 43% - 49% > 40: 1
~[~° (1Oeq) 5eq 16 Hours 30% --- 50%
(7eq) eq 32 Hours ---- --- 95% 
(16eq) 5eq 17 Hours 63% 35% > 40: 1
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2.5 Completion of the C1 Fragment
With the yield of the oxazole formation optimized with the exclusion
of epimerization, we were ready to complete the synthesis of the Cl
fragment. Beginning with the intermediate, 82, reduction of the ester
functionality with LAH afforded a 96% yield of the alcohol, 85. Subsequent
protection of the alcohol with MPM-Br produced a 95% yield of the desired
MPM ether, 86, as shown in Scheme 2.10.
Scheme 2.10
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At this stage, we felt it prudent to see if the MPM group could be
cleaved and if the alcohol could be oxidized to the corresponding aldehyde
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in preparation for the Julia-Lythgoe coupling88 8 9, 90 to be used in the
coupling of the B and C fragments. As shown in Scheme 2.11, treatment of
the MPM ether with DDQ91,92 produced a 92% yield of the alcohol, 85. The
alcohol was then converted, in 99% yield, to the desired aldehyde, 87,
utilizing Swern conditions. 93
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Continuing on with the MPM ether, 86, treatment with TBAF
produced the alcohol, 88, in quantitative yield. The alcohol, 88, was then
treated with methanesulfonyl chloride to yield the mesylate which was
converted, in situ, to the azide, 89, on reaction with sodium azide (98%
yield, two steps). Reduction of the azide, 89, with triphenylphosphine/H20
produced an 83% yield of the amine, 63 (Scheme 2.12).94 Although the yield
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of the amine was quite good, we were able to show that the reduction
actually proceeded in much greater yield by converting the azide, 89, to the
acetamide, 90, in 97% over the two step process (Scheme 2.13). With these
results, we have postulated that the 83% yield of the amine, 63, was due to
loss of product during chromatography as well as possible air oxidation of
the amine itself. In any event, we had now completed the synthesis of
fragment C1 and could now proceed to the preparation of fragment C2.
2.6 Experimental Section
BuPh2Si-CI BuPh2SiO'
66 67
Silyl Ether, 67
At room temperature under argon, tert-butyldiphenylchlorosilane
(41.0 mL, 157.01 mmoles) was slowly added to a solution of 3-butene-l-ol, 66,
(11.1 g, 153.93 mmoles) and imidazole (23.1 g, 338.65 mmoles) in methylene
chloride (120 mL). After stirring for 15 hours, the reaction was quenched
with pH = 7 buffer. The products were extracted three times with ethyl
acetate, and the combined extracts were washed with brine and dried over
MgSO4. The solvent was removed and the product was purified on silica
gel (2% ethyl acetate/hexane) to yield the product (47.8 g, 100%) as a colorless
oil.
Physical Properties for 67
Rf = 0.83 (30% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 7.66-7.69(m, 4H), 7.34-7.45(m, 6H), 5.83(ddd, J =
17.1, 10.2, 6.8 Hz, 1H), 5.05(ddd, J = 17.1, 3.4, 1.4 Hz, 1H), 5.02(dd, J = 10.2, 1.4
Hz, 1H), 3.71(t, J = 6.7 Hz, 2H), 2.32(qt, I = 6.7 and 1.1 Hz, 2H), 1.05(s, 9H).
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13 C NMR (300 MHz, CDC13): 135.63, 135.46, 134.03, 129.58, 127.62, 116.37,
63.55, 37.25, 26.90, 19.26.
FAB Mass Spec: m/e 311 [M + 1]+,253, 135, 105.
Exact Mass: [M + 11+ = 311.18312 (calculated)
[M + 1]+ = 311.1829 (measured).
IR (CHC13 ) cm- 1: 2975-3020 (m, br), 2900-2960 (s, br), 2870 (s), 2830 (s), 1950
(w), 1456 (m), 1449 (m), 1410 (m), 1375 (m), 1348 (m), 1165-1200 (s, br), 1052-
1105 (s, br), 980 (m), 970 (m), 895 (s).
tBu PhSiO ./,,,.uPhSi
67
0 0
(Et)2)OtL %BPh2 SiO C 0 2Et68 tBuPhSjO 69
a,3-Unsaturated Ester, 69
A solution of the olefin, 67, (11.20 g, 33.09 mmoles) in methylene
chloride-methanol (10 : 1, 200 mL) was cooled to -780C and ozone was
bubbled into the solution until saturated (solution turned blue). Me2S (3.65
mL, 49.64 mmoles) and (iPr)2NEt (8.65 mL, 49.64 mmoles) were then added.
The resulting solution was slowly warmed to room temperature and
quenched with pH = 7 buffer. The products were extracted three times with
CH2C12, and the combined extracts were washed with brine and dried over
MgSO4. The solvent was removed and the residual oil was diluted with
acetonitrile (60 mL). The resulting solution was added dropwise to a
solution of triethyl phosphonoacetate, 68, (8.54 mL, 43.02 mmoles), LiCI (2.0
g, 43.02 mmoles), and DBU (5.44 mL, 36.40 mmoles) in acetonitrile (40 mL) at
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0°C under argon. The resulting solution was stirred for 15 minutes at room
temperature and quenched with pH = 7 buffer. The products were extracted
three times with ethyl acetate, and the combined extracts were washed with
brine and dried over MgSO4. The solvent was removed and the product
was purified on silica gel (2% ethyl acetate/hexane) to yield the desired
product (9.53 g, 75% yield) as a colorless oil.
Physical Properties for 69
Rf = 0.53 (13% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 7.64-7.67(m, 4H), 7.35-7.46(m, 6H), 6.98(dt, j =
15.7, 7.1 Hz, 1H), 5.83(dt, J = 15.7, 1.5 Hz, 1H), 4.17(q, = 7.1 Hz, 2H), 3.74(t, J =
6.4 Hz, 2H), 2.41(qd, J = 6.5,1.4 Hz, 2H), 1.27(t, J = 7.1 Hz, 3H), 1.02(s, 9H).
13C NMR (300 MHz, CDCl 3 ): 166.45, 145.78, 135.57, 133.63, 129.71, 127.69,
123.07, 62.34, 60.16, 35.47, 26.85, 19.21, 14.29.
FAB Mass Spec: m/e 383 [M + 1]+, 325, 327, 135.
Exact Mass: [M + 1+ = 383.20425 (calculated)
[M + 1]+ = 383.2038 (measured).
IR (CHC13 ) cm-1: 3005 (s), 2960 (s), 2940 (s), 2860 (s), 1720 (s), 1655 (s), 1585 (w),
1510 (m), 1480 (m), 1470 (m), 1430 (m), 1390 (m), 1380 (m), 1160-1250 (s, br),
1040 (s), 984 (m), 930 (m).
tBuPhSiO-CO 2Et DIBAL tBuPh2SiO CH20H
69 70
Allylic Alcohol, 70
A solution of the ester, 69, (12.13 g, 31.71 mmoles) in ether (240 mL)
was cooled to -780C under argon and a solution of DIBAL (46.5 mL, 69.76
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mmoles, 1.5M in toluene) was added dropwise over 30 minutes. After an
additional hour at -78C, the reaction was added, via cannula, to an ether
(100 mL)-saturated Rochelle's salt (100 mL) solution maintained at 0C.
After the addition the resulting mixture was stirred for 1 hour at room
temperature, after which two layers formed. The products were extracted
three times with ether, and the combined extracts were washed with 10%
HCI, saturated NaHCO3 solution, and brine. The resulting solution was
dried over MgSO4 and concentrated to dryness yielding the pure allylic
alcohol (10.69 g, 99%) as a colorless oil.
Physical Properties for 70
Rf = 0.41 (33% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 7.65-7.69(m, 4H), 7.35-7.45(m, 6H), 5.67(m, 2H),
4.06(m, 2H), 3.71(t, J = 6.5 Hz, 2H), 1.30(m, 2H), 1.16(m, 1H), 1.05(s, 9H).
13C NMR (300 MHz, CDCl 3): 6 135.60, 133.96, 131.01, 129.62, 129.54, 127.64,
63.75, 63.50, 35.61, 26.89, 19.25.
FAB Mass Spec: m/e 323 [M - 17]+, 199, 135.
Exact Mass: [M - OH] + = 323.18312 (calculated)
[M - OH] + = 323.1828 (measured).
IR (CHCl 3 ) cm-1: 3695 (m), 3610 (m), 3010 (s), 2960 (s), 2917 (s), 2860 (s), 2397
(m), 2325 (m), 2315 (m), 1715-1750 (w, br), 1690 (w), 1605 (w), 1595 (w), 1514 (s),
1480 (m), 1425 (s), 1380-1390 (m, br), 1180-1240 (s, br), 1075-1120 (s, br), 995 (m),
970 (s), 920 (s).
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Epoxide, 71
4A molecular sieves (22 g) were suspended in methylene chloride
(190 mL) and cooled to -300C under argon. (+)-DET (0.651 mL, 3.81 mmoles),
and Ti(OiPr)4 (0.944 mL, 3.17 mmoles) were added and the mixture was
stirred for 5 minutes. TBHP (6.4M solution in toluene, 9.91 mL, 63.42
mmoles) was added dropwise and the resulting mixture was stirred at -30°C
for 30 minutes. A solution of the allylic alcohol, 70, (10.78 g, 31.71 mmoles)
in CH2C12 (50 mL) was added dropwise and the resulting mixture was stirred
at -30°C for 20 hours, after which it was warmed to 0°C. Water (20 mL) was
then added followed by a 30% aqueous solution of NaOH-NaCl (3.8 mL).
The resulting suspension was stirred at room temperature for 1 hour and
the organic layer was separated. The aqueous layer was washed three times
with CH2C12, and the combined extracts were washed with brine and dried
over MgSO4. The solvent was removed and the residue was purified on
silica gel (14% ethyl acetate/hexane) to furnish the epoxide, 71, as a colorless
oil (9.93g, 88%).
Physical Properties for 71
Rf = 0.30 (33% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13): 7.62-7.69(m, 4H), 7.34-7.45(m, 6H), 3.90(ddd, J =
12.4, 5.4, 2.4 Hz, 1H), 3.80(m, 2H), 3.60(ddd, J = 12.4, 6.9, 4.3 Hz, 1H), 3.13(td, J =
5.8, 2.5 Hz, 1H), 2.97(ddd, J = 4.4, 2.5, 2.5 Hz, 1H), 1.92(dd, J = 6.8, 6.3 Hz, 1H),
1.81(dd, J = 11.8, 6.2 Hz, 2H), 1.04(s, 9H).
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13C NMR (300 MHz, CDC13): 6135.56, 133.61, 129.72, 127.73, 61.69, 60.78, 58.61,
53.73, 34.82, 26.86, 19.19.
FAB Mass Spec: m/e 357 [M + 1]+, 269, 199,135.
Exact Mass: [M + 1]+ = 357.188599 (calculated)
[M + 11+ = 357.1887 (measured).
IR (CHC13) cm- 1: 3680 (w), 3600 (m), 3010 (s), 2960 (s), 2917 (s), 2860 (s), 2397
(m), 2325 (m), 2315 (m), 1715-1750 (w, br), 1690 (w), 1605 (w), 1595 (w), 1514 (s),
1505 (s), 1480 (m), 1425 (s), 1380-1390 (m, br), 1180-1240 (s, br), 1075-1120 (s, br),
995 (m), 970 (s), 920 (s).
0,O Me 3AI CH2 HtBulph25iO~CHH - CH2OH 
71 72 OH
Diol, 72
A solution of the epoxide, 71, (9.81 g, 27.51 mmoles) in pentane (200
mL) was cooled to 0°C and Me3Al (2.0M in hexane, 41.3 mL, 82.53 mmoles)
was added dropwise over 15 minutes. After 2 hours at 0°C, the reaction was
carefully quenched with 10% HCl. The resulting mixture was stirred at
room temperature for 15 minutes. The products were extracted three times
with ethyl acetate and the combined extracts were washed with saturated
NaHCO3 solution and brine. After drying over MgSO4, the solvent was
removed and the product was purified on silica gel (20% ethyl
acetate/hexane) to give the diol, 72, (9.30g 91%) as a colorless oil. The
products comprised a diastereomeric mixture of > 20 : 1, as determined by
300-MHz 1H NMR of the corresponding bis-MTPA ester and a > 40 : 1
mixture of 1,2 and 1,3 diols, as determined by GLC analysis.
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Physical Properties for 72
Rf = 0.20 (40% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl 3): 8 7.68-7.71(m, 4H), 7.39-7.49(m, 6H), 3.64(s, 1H),
3.52-3.82(m, 5H), 2.41(s, 1H), 1.57-1.85(m, 3H), 1.07(s, 9H), 0.90(d, = 6.9 Hz,
3H).
13C NMR (300 MHz, CDC13 ): 8 135.59, 133.19, 129.83, 127.79, 76.10, 64.97, 62.27,
35.79, 34.06, 26.84, 19.11, 16.54.
FAB Mass Spec: m/e 373 [M + 1]+, 297, 199, 135, 117, 99.
Exact Mass: [M + 1]+ = 373.219899 (calculated)
[M + 1]+ = 373.2196 (measured).
IR (CHC13) cn-l: 3560, 3350, 2900, 1450, 1410, 1375, 1075.
tBuPhSO O CH20H NaIO4 [IL
-- " tBuPh2 L uPh2SiO CHO
72 OH
KMn04 
tBuPh2SiO C0 2H
Acid, 73
The diol, 72, (2.01 g, 5.395 mmoles) was dissolved in tBuOH (30 mL)
and pH = 5 buffer (30 mL). NaIO4 (1.73 g, 8.093 mmoles) was added and the
mixture was stirred at room temperature for 40 minutes. KMnO4 (1.OM
aqueous solution, 14 mL) was then added and the reaction was stirred for an
additional 10 minutes, after which the reaction was titrated with saturated
Na2SO3 solution until the purple color was gone. The resulting brown
precipitate was dissolved by titration with 10% HCI. The products were then
extracted three times with ethyl acetate and the combined extracts were
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washed with brine and dried over MgSO4. The solvent was removed and
the residue was purified on silica gel (9% ethyl acetate/hexane) to yield the
acid (1.84 g, 95%) as a colorless solid. Upon reduction of the acid (Me2S-BH3,
ether) and formation of the corresponding MTPA ester, the enantiomeric
purity of the acid was found to be > 20: 1.
Physical Properties for 73
Rf = 0.29 (33% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 7.65-7.68(m, 4H), 7.37-7.46(m, 6H), 3.71(m, 2H),
2.74(ddd, 1 = 13.8, 7.1, 7.1 Hz, 1H), 2.02(m, 1H), 1.65(ddd, J = 13.8, 7.8, 6.0 Hz,
1H), 1.19(d, J = 7.1 Hz, 3H), 1.04(s, 9H).
13C NMR (300 MHz, CDC13): 8 182.38, 135.54, 133.69, 129.58, 127.62, 61.56,
36.09, 35.87, 26.81, 19.14, 16.82.
FAB Mass Spec: m/e 357 [M + 1]+, 339, 299, 221, 199, 135.
Exact Mass: [M + 1]+ = 357.188599 (calculated)
[M + 11+ = 357.1889 (measured).
IR (CHC13) cm- 1: 3530 (w), 2900-3330 (m, br), 3030 (w), 2960 (s), 2935 (s), 2890
(s), 2860 (s), 1710 (s), 1590 (w), 1475 (m), 1430 (m), 1390 (m), 1375 (w), 1240-1305
(m, br), 1090-1230 (m, br), 995 (m), 900 (m).
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Amide, 65
Oxalyl chloride (0.31 mL, 3.54 mmoles) was added dropwise to a
solution of the acid, 73, (840 mg, 2.36 mmoles) in dry benzene (10 mL) at 0°C
under argon. The reaction was stirred for 1 hour at room temperature after
which, N,N-dimethylformamide (1 drop) was added. After an additional 1
hour, the solution was diluted with THF (15 mL) and transferred, via
cannula, to a solution of NH3(1) (5 mL) in THF (10 mL) at -780C under argon.
The mixture was warmed to room temperature and the excess NH3 was
allowed to evaporate over 4 hours. After dilution with ethyl acetate,
saturated NH4CI solution was added and the products were extracted twice
with ethyl acetate. The combined extracts were washed with brine, dried
over MgSO4, filtered and concentrated to dryness to yield the pure amide
(840 mg, 100%) as a colorless solid. The products comprised a > 20 : 1
mixture enantiomers, as determined by HPLC.8 2 After three
recrystallizations from hexane, the optical purity was > 99: 1.
Physical Properties for 65
Rf = 0.25 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 7.64-7.67(m, 4H), 7.35-7.46(m, 6H), 5.49(s, 1H),
5.42(s, 1H), 3.71(m, 2H), 2.58(m, 1H), 1.87(ddd, J = 13.5, 8.2, 5.3 Hz, 1H),
1.64(ddd, J = 13.5, 6.5, 6.5 Hz, 1H), 1.14(d, J = 7.1 Hz, 3H), 1.06(s, 9H).
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13C NMR (300 MHz, CDCl 3): 6 179.15, 135.50, 133.67, 129.70, 127.70, 61.66,
36.85, 36.67, 26.92, 19.21, 17.51.
EI Mass Spec: m/e 340 [M - 15]+, 298, 220, 198.
Exact Mass: [M - CH3]+ = 340.17328 (calculated)
[M - CH3]+ = 340.1732 (measured).
IR (CHC13 ) cm-l1 : 3540 (m), 3420 (m), 2980 (s), 2940 (s), 2890 (s), 2860 (s), 1685
(s, br), 1595 (s), 1475 (m), 1445 (w), 1395 (m), 1370 (w), 1280 (m, br), 1070-1125
(s, br), 995 (m), 975 (m), 895 (m).
s1~u MeOT
tBuPSiO 5 CONH 265
HO4NC2Me
NH 2
74
Oxazoline, 64
A solution of the amide, 65, (73.9 mg, 0.208 mmole) in CH 2 C12 (3 mL)
was cooled to 0°C under argon and methyl triflate (1.02M in CH2C12, 0.4 mL,
0.416 mmole) was added. After 48 hours at room temperature, the solution
was cooled to 0°C and l-serine methyl ester hydrochloride, 74, (47.7 mg, 0.250
mmole) was added followed by triethylamine (53 mL, 0.312 mmole). The
mixture was stirred at room temperature for 20 hours, after which
triethylamine (53 mL, 0.312 mmole) was added. The reaction was stirred an
additional 10 hours and quenched with water. The products were extracted
three times with ethyl acetate and the combined extracts were washed with
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brine and dried over MgSO4. The solvent was removed and the residue was
purified on silica gel (25% ethyl acetate/hexane) to give the oxazoline (82.5
mg, 90%) as a colorless oil.
Physical Properties for 64
Rf = 0.60 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC 3): 8 7.62-7.65(m, 4H), 7.33-7.44(m, 6H), 4.64(ddd, J
= 10.8, 7.7, 3.0 Hz, 1 H), 4.40(td, J = 8.2, 3.0 Hz, 1 H), 4.29(dd, J = 10.8, 8.2 Hz, 1
H), 3.72(s, 3H), 3.68(m, 2H), 2.78(sept, J = 7.0 Hz, 1H), 1.98(sept of d, I = 6.6, 2.2
Hz, 1H), 1.67(sept of d, I = 6.6, 1.6 Hz, 1H), 1.16(d, J = 7.0 Hz, 3H), 1.01(s, 9H).
13C NMR (300 MHz, CDC13): 6174.4, 172.1, 135.8, 134.0, 129.7, 127.8, 77.2, 69.1,
67.9, 61.3, 52.4, 36.4, 36.3, 29.9, 29.7, 26.6, 19.0, 17.3.
tBu Ph2S NiO2
Oxazole, 75
NiO2 (421 mg, 200 wt%) was suspended in a solution of the oxazoline,
64, (231.3 mg, 0.526 mmole) in dry benzene (20 mL), and the mixture was
heated to reflux for 2 hours. NiO2 (460 mg) was then added and heating was
continued until no oxazoline was detected by TLC (about 6 hours). After
cooling to room temperature, the mixture was filtered through a Celite pad,
the solids were washed with ethyl acetate, and the combined organic phases
were concentrated to dryness. Purification of the residue on silica gel (9%
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ethyl acetate/hexane) gave the oxazole, 75, (97.2 mg, 42%) as a colorless oil,
and the amide, 65, (15.1 mg, 8%) as a colorless solid.
Physical Properties for 75
Rf - 0.52 (33% ethyl acetate/hexane).
1 H NMR (300 MHz, CDCl3 ): 8.09(s, 1H), 7.57-7.66(m, 4H), 7.29-7.40(m, 6H),
3.89(s, 3H), 3.66(dd, J = 6.4, 5.9 Hz, 2H), 3.31(sext, I = 7.0 Hz, 1H), 2.11(sext, J =
6.6 Hz, 1H), 1.83(sext, J = 6.6 Hz, 1H), 1.31(d, I = 7.0 Hz, 3H), 1.00(s, 9H).
O
CO02Et
BuPhS iO CONH2 865
4-Hydroxyoxazoline, 81
The amide, 65, (0.502 g, 1.410 mmole) was dissolved in acetonitrile (10
mL) at room temperature under argon. Cyclopentene oxide (0.308 mL, 3.526
mmoles) was added followed by ethyl bromopyruvate, 80, (0.354 mL, 2.821
mmoles). The resulting solution was heated to reflux for 3 hours, after
which the reaction was concentrated to dryness. Purification of the residue
on silica gel (25% acetone/hexane) gave the 4-hydroxyoxazoline, 81, (0.536 g,
81%) as a colorless oil and the amide, 65, (90.3 mg, 18%) as a colorless solid.
Physical Properties for 81
Rf = 0.36 (20% acetone/hexane).
1H NMR (300 MHz, CDC13): 6 7.64-7.67(m, 4H), 7.34-7.45(m, 6H), 4.54(d, J =
9.9 Hz, 1H), 4.22(qd, J = 7.2, 1.5 Hz, 2H), 4.15(dd, J = 9.9, 1.0 Hz, 1H), 4.04(m,
85
1H), 3.70(m, 2H), 2.83(sext, I = 7.1 Hz, 1H), 2.02(m, 1H), 1.70(ddd, J = 13.4, 6.2,
6.2 Hz, 1 H), 1.22(td, J = 7.2, 1.5 Hz, 3H), 1.22(d, J = 7.1 Hz, 3H), 1.04(s, 9H).
IR (CHC13 ) cm-l: 3475, 2930, 1725,1625, 1450, 1415, 1355, 1200, 1075, 855.
TFAA , tBuPh2SO iON
OH
),Et 82 COEt
Oxazole, 82
A solution of the 4-hydroxyoxazoline, 81, (70.8 mg, 0.151 mmole) in
THF (2 mL) was cooled to 0°C under argon. Pyridine (98 mL, 1.208 mmole)
was added followed by trifluoroacetic anhydride (85 mL, 0.604 mmole) and
the reaction was stirred at 0°C for 15 minutes. The reaction was then
quenched with pH = 7 buffer and the products were extracted three times
with ethyl acetate. The combined organic extracts were with washed
saturated CuSO4 solution (2 X 1 mL), saturated NaHCO3 solution (1 mL),
and brine (1 mL). After drying over MgSO4, The solvent was removed and
the residue was purified on silica gel (7% ethyl acetate/hexane) to give the
oxazole (57.7 mg, 85%) as a colorless oil.
Physical Properties for 82
Rf = 0.46 (20% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 8.09(s, 1H), 7.60-7.66(m, 4H), 7.32-7.44(m, 6H),
4.38(q, J = 6.9 Hz, 2H), 3.67(m, 2H), 3.34(m, 1H), 2.15(m, 1H), 1.83(m, 1H),
1.37(t, I = 6.9 Hz, 3H), 1.33(d, I = 6.9 Hz, 3H), 1.03(s, 9H).
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13C NMR (300 MHz, CDC13): 8 169.19, 161.41, 143.30, 135.51, 133.74, 133.67,
129.55, 127.60, 61.27, 60.96, 37.31, 30.45, 26.82, 19.14, 18.29, 14.29.
EI Mass Spec: m/e 436 [M - 15]+, 394, 288,179.
Exact Mass: [M - CH3 ]+ = 436.19441 (calculated)
[M - CH3]+ = 436.1941 (measured).
IR (neat) cm-1: 3160,3060,2930, 1780, 1740, 1580, 1470, 1425, 1370, 1310.
0(kCoEt
1. Br 80 tBuPh2SiO
tBu Ph2Si C ONH2 2. TFAA
65 82 CC2Et
Oxazole, 82
The amide, 65, (500 mg, 1.4061 mmole) was dissolved in THF at room
temperature under argon. Epoxycyclopentene (0.80 mL, 10.00 mmoles) was
added followed by ethyl bromopyruvate, 80, (0.882 mL, 7.030 mmoles). The
resulting solution was stirred at room temperature for 5 hours, after which
epoxycyclopentene (0.33 mL, 4.12 mmoles) was added. Stirring was
continued for an additional 5 hours, after which epoxycyclopentene (0.33
mL, 4.12 mmoles) was added. After 5 more hours, a final addition of
epoxycyclopentene (0.33 mL, 4.12 mmoles) was made. The reaction was
stirred for 8 hours, after which it was cooled to 0°C. Pyridine (0.910 mL,
11.249 mmoles) was added followed by TFAA (0.794 mL, 5.624 mmoles) and
the resulting solution was stirred at 0°C for 10 minutes. The reaction was
quenched with pH = 7 buffer and washed three times with ethyl acetate. The
combined extracts were washed twice with saturated CuSO4 solution,
saturated NaHCO3 solution, and brine. After drying over MgSO4, the
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solvent was removed and the residue was purified on silica gel (6% ethyl
acetate/hexane) to give the oxazole, 82, (0.400 g, 63%) and the nitrile, 84,
(0.166 g 35%) as colorless oils.
Physical Properties for 82
Rf = 0.46 (20% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13) 8 8.09(s, 1H), 7.60-7.66(m, 4H), 7.32-7.44(comp m,
6H), 4.38(q, J = 6.9 Hz, 2H), 3.67(m, 2H), 3.34(m, 1H), 2.15(m, 1H), 1.83(m, 1H),
1.37(t, J = 6.9 Hz, 3H), 1.33(d, J = 6.9 Hz, 3H), 1.03(s, 9H).
13C NMR (300 MHz, CDCI!: 8 169.19, 161.41, 143.30, 135.51, 133.74, 133.67,
129.55, 127.60, 61.27, 60.96, 37.31, 30.45, 26.82, 19.14, 18.29, 14.29.
EI Mass Spec: m/e 436 [M - 15]+, 394, 288, 179.
Exact Mass: [M - CH 3]+ = 436.19441 (calculated)
[M - CH 3]+ = 436.1941 (measured).
IR (neat) cm-l: 3160, 3060, 2930, 1780, 1740, 1580, 1470, 1425, 1370, 1310.
Physical Properties for 84
Rf = 0.46 (10% acetone/hexane).
1 H NMR (300 MHz, CDCl3 ) 8 7.62-7.70(m, 4H), 7.36-7.47(m, 6H), 3.79(m, 2H),
2.96(m, 1H), 1.69-1.91(m, 2H), 1.32(d, I = 7.1 Hz, 3H), 1.06(s, 9 H).
EI Mass Spec: m/e 280 [M - 57]+, 208, 181, 91.
IR (neat) cm-1: 3080, 2945, 2850, 2225, 1585, 1460, 1425, 1385, 1100.
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LAH
82 85
Alcohol, 85
LiAlH4 (81.1 mg, 2.106 mmoles) was suspended in ether (10 mL) and
cooled to 0°C under argon. The oxazole, 82, (460.9 mg, 1.053 mmole) was
dissolved in ether (25 mL) and added, via cannula, to the LiAlH4. The
mixture was stirred at 0°C for 20 minutes, after which it was quenched with
Na2SO4-10H20. The resulting mixture was stirred at room temperature for 1
hour, after which it was filtered through a Celite pad. Concentration of the
filtrate produced the pure alcohol (412.3 mg, 96%) as a colorless oil.
Physical Properties for 85
Rf = 0.30 (60% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13): 7.61-7.67(m, 4H), 7.45(s, 1H), 7.33-7.45(m, 6H),
4.55(d, = 5.5 Hz, 2H), 3.69(m, 2H), 1.O0(s, 9H), 3.25(sext, J = 6.9 Hz, 1H),
2.11(m, 2H), 1.81(m, 1H), 1.30(d, I = 6.9 Hz, 3H).
13C NMR (300 MHz, CDCl 3): 8 168.91, 139.75, 135.52, 134.30, 133.76, 129.54,
127.59, 61.36, 56.84, 37.49, 30.33, 26.83, 19.16, 18.32.
EI Mass Spec: m/e 409 M+ , 394, 352, 274, 199, 136.
Exact Mass: M+ = 409.20732 (calculated)
M+ = 409.2069 (measured).
IR (neat) cm-1 : 3350, 3060, 2920, 1560, 1470, 1425, 1100.
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N.
85
IPM
MPM-Ether, 86
KH (35%, 230 mg, 2.064 mmoles) was suspended in THF (10 mL) and
18-Crown-6 (cat. amount) was added. The mixture was cooled to 0°C under
argon, and a solution of the alcohol, 85, (600.7 mg, 1.474 mmole) in THF (20
mL) was added. After 15 minutes at 0°C, p-methoxybenzyl bromide (0.31
mL, 2.064 mmoles) was added. The reaction was stirred at room
temperature for 4 hours, cooled to 0°C, and carefully quenched with water.
The products were extracted three times with ethyl acetate, and the
combined extracts were washed with brine and dried over MgSO4. The
solvent was removed and the residue was purified on silica gel (6% ethyl
acetate/hexane) to give the desired product (744 mg, 95%) as a colorless oil.
Physical Properties for 86
Rf = 0.24 (15% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl 3 ): 8 7.60-7.66(m, 4H), 7.45(t, J = 0.98 Hz, 1H), 7.30-
7.43(m, 6H), 1.02(s, 9H), 7.27(dm, J = 8.8 Hz, 2H), 6.87(dm, I = 8.8 Hz, 2H),
4.53(s, 2H), 4.39(d, J = 0.98 Hz, 2H), 3.80(s, 3H), 3.69(d, J = 6.3 Hz, 2H), 3.24(m,
1H), 2.12(m, 1H), 1.80(m, 1H), 1.30(d, J = 7.0 Hz, 3H).
90
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13C NMR (300 MHz, CDC13): 6 168.59, 159.24, 137.41, 135.47, 133.72, 133.65,
129.96, 129.50, 127.53, 113.76, 72.29, 63.71, 61.28, 55.19, 37.39, 30.23, 26.78, 19.12,
18.31.
EI Mass Spec: m/e 514 [M - 15]+, 472, 393, 259, 121.
Exact Mass: [M - CH3] + = 514.24136 (calculated)
[M - CH3 ]+ = 514.2409 (measured).
IR (neat) cm-l: 3060, 2910, 2850, 1610, 1565, 1510, 1460, 1425, 1245, 1170, 1100,
815, 730,690.
tBuPh2SiO DDQ 'BuPh2Si1
8 6 CH2 OMPM
Alcohol, 85
The MPM-ether, 86, (61.9 mg, 0.117 mmole) was dissolved in
CH 2C12/water (20/1, 1 mL) at room temperature under argon. DDQ (29.1
mg, 0.129 mmole) was added and the reaction was stirred for 15 hours. After
quenching with saturated NaHCO3 solution, the products were extracted
four times with CH2C12. The combined extracts were washed with brine and
dried over MgSO4. The solvent was removed and the residue was purified
on silica gel (33% ethyl acetate/hexane) to yield the alcohol (43.2 mg, 92%) as
a colorless oil.
Physical Properties for 85
Rf = 0.30 (60% ethyl acetate/hexane).
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1
1H NMR (300 MHz, CDC13 ): 8 7.61-7.67(m, 4H), 7.45(s, 1H), 7.33-7.45(m, 6H),
4.55(d, J = 5.5 Hz, 2H), 3.69(m, 2H), 3.25(sext, I = 6.9 Hz, 1H), 2.11(m, 2H),
1.81(m, 1H), 1.30(d, J = 6.9 Hz, 3H), 1.03(s, 9H).
EI Mass Spec: m/e 409 M+, 394, 352, 274, 199, 136.
Exact Mass: M+ = 409.20732 (calculated)
M + = 409.2069 (measured).
IR (neat) cm-1: 3350, 3060, 2920, 1560, 1470, 1425, 1100.
(COC)2
DMSO ' tBuPh2SiO
8 7 CHO
Aldehyde, 87
Oxalyl chloride (18.4 mL, 0.212 mmole) was dissolved in CH2C12 (1
mL) and cooled to -780C under argon. DMSO (30 mL, 0.424 mmole) was
added, dropwise, and the reaction was stirred for at -780C for 5 minutes. A
solution of the alcohol, 85, (43.2 mg, 0.106 mmole) in CH2C12 (2 mL) was
added, via cannula, and the resulting milky solution was stirred for 20
minutes at -78C. Triethylamine (0.132 mL, 0.954 mmole) was added, and
the reaction was stirred for 10 minutes at -780C. After warming to room
temperature, the reaction was quenched with water and the products were
extracted three times with ethyl acetate. The combined extracts were washed
with brine, dried over MgSO4, and concentrated to dryness. The residue was
purified on silica gel (14% ethyl acetate/hexane) to give the aldehyde (42.4
mg, 99%) as a colorless oil.
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Physical Properties for 87
Rf = 0.50 (50% ethyl acetate/hexane).
1H NMR (250 MHz, CDC13 ): 8 9.88(s, 1H), 8.12(s, IH), 7.60-7.65(m, 4H), 7.32-
7.45(m, 6H), 3.70(m, 2H), 3.34(sext, J = 7.1 Hz, 1H), 2.14(ddt, J = 13.7, 6.2, 6.2 Hz,
IH), 1.85(ddt, J = 12.7, 6.3, 6.3 Hz, 1H), 1.35(d, J = 7.1 Hz, 3H), 1.03(s, 9H).
tBuPh2SiO TBAF HO
8 6 CH2OMPM 8 8 CH2OMPM
Alcohol, 88
The silyl ether, 86, (744 mg, 1.404 mmol) was dissolved in THF (8 mL)
at room temperature under argon. Tetrabutylammonium fluoride (1.OM in
THF, 2.8 mL, 2.808 mmole) was added and the reaction was stirred for 6
hours. The solvent was removed and the product purified on silica gel (75%
ethyl acetate/hexane) to give the alcohol (418.9 mg, 100%) as a colorless oil.
Physical Properties for 88
Rf = 0.24 (80% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13 ): 7.50(t, J = 0.95 Hz, 1H), 7.29(dm, J = 8.7 Hz, 2H),
6.88(dm, J = 8.7 Hz, 2H), 4.52(s, 2H), 4.40(d, I = 0.95 Hz, 2H), 3.80(s, 3H), 3.68(t, I
= 5.9 Hz, 2H), 3.19(m, 1H), 2.74(s, 1H), 1.84-2.08(m, 2H), 1.36(d, I = 7.1 Hz, 3H).
13C NMR (300 MHz, CDC13): 8 168.49, 159.30, 137.26, 135.81, 129.88, 129.51,
113.81, 72.38, 63.55, 60.25, 55.24, 37.54, 31.09, 18.46.
FAB Mass Spec: m/e 292 [M + 1]+, 155, 121.
Exact Mass: [M + 1]+ = 292.15488 (calculated)
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[M + 1]+ = 292.1547 (measured).
IR (neat) cm-1: 3400, 2940, 1613, 1570, 1510, 1460, 1300, 1245, 1170, 1075, 813.
Msl
IPM
NaN3 N 3N
8 9 CH2OMPM
Azide, 89
The alcohol, 88, (136.2 mg, 0.467 mmole) was dissolved in CH2 C12 (1.6
mL), cooled to 0°C under argon, and triethylamine (0.19 mL, 1.401 mmole)
was added. Methanesulfonyl chloride (54.4 L, 0.700 mmole) was then
added and the reaction was stirred at 0°C for 30 minutes. The solvent was
removed under reduced pressure and the residue was dissolved in DMF (4.7
mL). NaN3 was added and the reaction was stirred at room temperature
under argon for 30 hours. The reaction was quenched with water (10 mL)
and extracted with ethyl acetate (3 X 10 mL). The combined organics were
washed with brine (5 mL) and dried over Na2SO4. Concentration of the
organics and purification of the residue on silica gel (25% ethyl
acetate/hexane) gave the azide, 89, (128.1 mg, 87%) as a colorless oil.
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Physical Properties for 89
Rf = 0.50 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 6 7.51(t, = 0.94 Hz, 1H), 7.29(dm, J = 8.3 Hz, 2H),
6.88(dm, J = 8.3 Hz, 2H), 4.55(s, 2H), 4.41(d, J = 0.94 Hz, 2H), 3.80(s, 3H), 3.33(td,
J = 7.0, 2.9 Hz, 2H), 3.11(m, 1H), 2.10(ddd, I = 13.4, 8.1, 6.7 Hz, 1H), 1.86(ddd, J =
13.4, 7.4, 5.9 Hz, 1H), 1.36(d, I = 7.5 Hz, 3H).
13C NMR (300 MHz, CDC13 ): 166.97, 159.04, 137.51, 135.61, 129.69, 129.24,
113.53, 72.07, 63.44, 54.92, 48.87, 33.66, 30.85, 18.12.
FAB Mass Spec: m/e 317 [M +1]+, 274, 180.
Exact Mass: [M + 1]+ = 317.16137 (calculated)
[M + 1]+ = 317.1610 (measured).
IR (neat) cm-1 : 2940, 2040, 1610, 1570, 1510,1455, 1360, 1300, 1245, 1170, 1075,
1030,810.
PPh 3 .H2 N
H20N
8 9 CH2OMPM 63 CH2OMPM
Amine, 63
The azide, 89, (120.1 mg, 0.405 mmole) was dissolved in THF (8 mL)
and PPh3 (127.8 mg, 0.486 mmole) was added. The mixture was stirred at
room temperature under argon for 10 hours, after which water (72.9 IL, 4.05
mmoles) was added. After stirring for an additional 12 hours, the reaction
was concentrated to dryness and the residue was purified on silica gel
(CH2CI 2/Et3N 100/1 then CH2C 2 /MeOH/Et3N 9/1/0.1 then
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CH2 CI2/MeOH/H 20/Et 3N 75/22/3/1) to yield the amine (98.0 mg, 83%) as a
colorless oil.
Physical Properties for 63
1H NMR (250 MHz, C6D 6): 7.24(s, 1H), 7.20(d, J = 6.67 Hz, 2H), 6.77(d, ] =
6.74 Hz, 2H), 4.41(s, 2H), 4.40(s, 2H), 3.28(s, 3H), 2.94(sext, ] = 7.47 Hz, 1H),
2.44(dd, = 6.97 Hz, 2H), 1.79(sext, = 8.07 Hz, 1H), 1.44(sext, = 6.40 Hz, 1H),
1.17(d, = 7.12 Hz, 3H), 0.88(s, 2H).
1. PPh3/H20 0+\N3892. Ac2O/Py ' AcNH
8 9 CH2OMPM 90 CH2OMPM
Acetamide, 90
The azide, 89, (125.0 mg, 0.396 mmole) was dissolved in THF (8 mL)
and PPh 3 (124.5 mg, 0.475 mmole) was added. The mixture was stirred at
room temperature under argon for 10 hours after which, water (71.2 JIL,
3.956 mmoles) was added. After stirring for an additional 12 hours, pyridine
(500 gL) was added followed by Ac20 (100 gL). Stirring was continued for an
additional 30 minutes, after which the reaction was concentrated to dryness
and the residue was purified on silica gel (ethyl acetate) to yield the
acetamide (125.3 mg, 97%) as a colorless oil.
Physical Properties for 9_0
Rf = .15 (ethyl acetate).
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1 H NMR (300 MHz, CDC13): 7.51(s, 1H), 7.25(m, 2H), 6.85(m, 2H), 6.00(s,
1H), 4.52(s, 2H), 4.39(d, ] = .98 Hz, 2H), 3.78(s, 3H), 3.35(m, 1H), 3.18(m, 1H),
3.09(m, 1H), 1.91(m, 2H), 1.90(s, 3H), 1.33(d, J = 7.01 Hz, 3H).
FAB Mass Spec: m/e 333 [M +1]+, 153, 121.
Exact Mass: [M + 1]+ = 333.18143 (calculated)
[M + 1]+ = 333.1812 (measured).
IR (neat) an-1: 3300, 3040 2925, 1650, 1620, 1550,1520, 1450, 1360, 1240, 1170,
1070, 1025, 810.
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2.7 NMR Spectra
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Chapter 3:
Fragment C2
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3.1 Introduction
Figure 3.1
OH
HOoOH
NH2
2-Amino-2-Deoxyglucose
Glucosamine
91
HONH2
3-Amino-3-Deoxyrhammose
Mycosamine
92
HO
OH
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Amino sugars have presented themselves in the chemistry of natural
products through a variety of ways. They appear as components of
biopolymers such as glucosamine, 91, in chitin, 93,95,96,97 and as side groups
such as mycosamine, 92, in amphotericin B, 94,98,99,100 (Figure 3.1).
Consequently, both amino sugars and natural products containing
subfragments of similar structure have gained much attention from
synthetic organic chemists. In the case of calyculin A, this similarity is
apparent when comparing fragment C2 to 4-amino-4-deoxyribonic acid.
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Strategies used to synthesize carbohydrates and their derivatives
include the utilization of chiral pool starting materials such as amino acids,
as well as the derivitization of readily available carbohydrates. In our search
for an efficient method for the preparation of fragment C2, we have
explored three major strategies. These strategies will be discussed in this
chapter.
3.2 Strategy 1: D-Serine as the Starting Material
Upon examining the structure of fragment C2, D-serine can
immediately be identified as a viable starting material for its preparation.
This section will describe our study of this strategy.
3.2.1 Retrosynthetic Analysis
In our initial retrosynthetic analysis for fragment C2, 95 (Scheme 3.1),
we envisioned the target arising from the epoxy alcohol, 96, via a Payne
rearrangementlOl followed by standard protecting group methodology. The
epoxy alcohol, 96, was envisioned to arise from a Wittig homologation of
the aldehyde derived from reduction of d-serine, 97, followed by a Sharpless
asymmetric epoxidation. 77
Although the use of D-serine, 97, had the advantage of possessing the
amine functionality with its necessary stereochemistry there were some
problems inherent to this strategy. Among these problems were finding a
protecting group for the amine which was fully compatible with the reaction
sequence, and also performing a Sharpless asymmetric epoxidation in the
presence of this functional group. In spite of these potential drawbacks, we
initially approached the preparation of fragment C2, 95, utilizing this
strategy.
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3.2.2 D-Serine Results
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Using D-serine, 97, as the starting material for fragment C2, 95, our
first task was to see that the amine was suitably protected. Although similar
chemistry was known with N-tBOC-serine, we decided to begin our study
with the CBZ protecting group.
Formation of N-CBZ-D-serine, 98, was easily achieved in 55% yield.
Unfortunately, we were unable to methylate the oxygen using conditions
developed by Benoiton for N-tBOC-serine, 102 possibly due to formation of
the oxazolidone, 99 (Scheme 3.2). Therefore, still desiring a protecting group
containing a chromophore, we turned to the 9-phenylfluorenyl protecting
group. 103
Scheme 3.4
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As shown in Scheme 3.3, treatment of D-serine, 97, with 9-
phenylfluorenylbromide 1 0 3 afforded the protected amino acid (63% yield).
Treatment of the resulting 9-phenyl fluorenyl-D-serine, 100, with sodium
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methoxide and methyl iodide,102 followed by diazomethane yielded 101
(45% yield, two steps). The ester was then reduced to the alcohol, 102, on
treatment with DIBAL (50% yield). Ireland's Swern-Wittig combination 104
was then applied to produce the desired a,3-unsaturated ester, 104 (79%
yield). Reduction to the allylic alcohol, 105, was then accomplished on
treatment with DIBAL (97% yield). Unfortunately, at this stage, all attempts
to form 106 failed. This was presumably due to the size of the 9-
phenylfluorenyl protecting group. The construction of space filling
molecular models demonstrated that this protecting group completely
covered the double bond thus blocking the approach of any reactive agents.
In lieu of extending the length of this relatively inefficient strategy by
adding deprotection and reprotection steps, we opted to utilize D-serine, 97,
with one more protecting group as shown in Scheme 3.4. tBOC-D-serine,
107, was converted, in 48% yield, to the methyl ether, 108. The ether was
then converted to the methyl ester, 109, in 79% yield on treatment with
diazomethane. Reduction to the alcohol, 110, was accomplished in 95% on
reaction with DIBAL, and the subsequent Swern-Wittig combination1 04
produced a 49% yield of the 0a,-unsaturated ester, 111. Unfortunately, at
this stage, we were unable to reduce the ester to the allylic alcohol, 112, in
any yield greater than 20%. The major product was consistently the fully
reduced alcohol, 113. Therefore, due to the relatively low yields and
protecting group problems, we chose to abandon this strategy in favor of one
in which the amine is introduced at a later stage in the synthesis.
3.3 Strategy 2: (S)-Isopropylidine Glyceraldehyde as the Starting Material
When re-evaluating our strategy towards fragment C2, we realized
that instead of building from left to right using D-serine, 97, we could build
136
from right to left utilizing (S)-isopropylidine glyceraldehyde, 114. This
section will describe our exploration of this strategy.
3.3.1 Retrosynthetic Analysis
Scheme 3.5
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As shown in Scheme 3.5. We had envisioned obtaining fragment C2
in the form of the acid, 115, or the methyl ester, 116, from the carbamate, 117.
The carbamate, 117, was to be derived from the epoxy alcohol, 118, which is
readily available from (S)-isopropylidine glyceraldehyde, 114. The main
advantage inherent in this route is a well documented strategy for the
incorporation of the amine functionality at a late stage in the synthesis.10 6
The main disadvantage involves problems associated with performing
oxidations in the presence of amines. Fortunately, such oxidations had been
ducumented utilizing platinum catalysts108 and we decided to procede with
this strategy.
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3.3.2 The Carbamate, 117
Scheme 3.6
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En route to the carbamate, 117, we first needed to obtain the epoxide,
118. As shown in Scheme 3.6, this was accomplished beginning with (S)-
isopropylidine glyceraldehyc!e, 114.105 Treatment of 114 with
triethylphosphonoacetate, 68, produced the a,3-unsaturated ester, 119, in
73% yield. Reduction of the ester with DIBAL produced a 96% yield of the
allylic alcohol, 120. Finally, conversion of the allylic alcohol, 120, to the
epoxide, 118, was accomplished in 87% yield utilizing the Sharpless
asymmetric epoxidation.7 7
Scheme 3.7
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As shown in Scheme 3.7, preparation of the carbamate, 117, was
accomplished by conversion of the epoxy alcohol, 118, to the open chain
138
methyl carbamate, 121 (87% yield), on treatment with methyl isocyanate. 106
Treatment of 121 with potassium tert-butoxide 107 effected cyclization with
ring opening of the epoxide to form the cyclic carbamate, 117, in 78% yield.
3.3.3 Attempts at the Completion of Fragment C2
Scheime 3.8
OH OH
0 1. ACOH/H20 OOOTBS
Me 2. TBS-CI NMe OH
O 117 122
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Me2N 
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As shown in Scheme 3.8, the acetonide, 117, was hydrolyzed with
aqueous acetic acid, and the crude triol was selectively silylated at the
primary position with tert-butyldimethylchlorosilane. This two step
sequence produced the diol, 122, in 93% overall yield.
Conversion of the diol, 122, to the acetonide, 123, was accomplished
in 97% yield on treatment with 2,2-dimethoxypropane in the presence of
139
catalytic camphorsulphonic acid. The dimethyl amine, 124, was then
formed in 90% yield on reduction of the carbamate with LAH. The resulting
primary alcohol was then converted to the methyl ether, 125, in 72% yield
on treatment with MeI and NaH. Finally, the silyl group was removed in
94% yield on treatment with tetrabutylammonium fluoride, thus forming
the primary alcohol, 126.
Scheme 3.9
MeO OH -------
MeN o
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Figure 3.2
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At this stage, the completion of fragment C2 rested on our ability to
convert the amino alcohol, 126, to the corresponding amino acid, 115, or
amino ester, 116, as shown in Scheme 3.9. One method used for the
oxidation of amino sugars to amino uronic acids involves the use of
molecular oxygen in the presence of a platinum catalyst. 108 Unfortunately,
140
when we applied this method to our dimethylamino alcohol, we found that
the reaction conditions demethylated the amine. 10 9, 110 With this
disappointing result, we set out to try a variety of other oxidation methods.
When we attempted the Swern oxidation, 93 our initial results seemed
promising in that the crude product mixture could be converted back to
starting material on treatment with NaBH4. However, the reaction never
proceeded beyond 50% completion and the highly polar nature of the
product made purification by chromatography impossible even in the most
polar solvent systems. Consequently, we saw an even greater need for an
oxidation that would give a clean reaction in near quantitative yields.
Therefore, we studied the recently reviewed TPAP o: idation, 111 the use of
PDC,1 12 the S0 3 /pyridine/DMSO oxidation, 1 13 and the use of the Dess-
Martin periodinane reagent. l l4 Unfortunately, none of these methods
produced the desired product as observed by the crude H NMR spectra.
Furthermore, no reaction was observed when AgCO3/Celite 115 was used.
However, when DCC/DMS01 16 was used, we observed a set of completely
new peaks in the 1H NMR. Unfortunately, the reaction was not clean
enough to allow any definitive conclusions. Therefore, we attempted the
use of acetic anhydride/DMS0 117 and the use of TFAA/DMSO. 118 Where
the former only acylated the alcohol, the latter produced a compound which
could be purified by maintaining the crude reaction mixture under vacuum
for long periods of time. The yields were approximately 50% and no
aldehyde peaks were apparent in the 1H NMR. However, the spectrum was
consistent with 127 (Figure 3.2) in which the amine had added to the
aldehyde to produce an ammonium salt. 119 This is also consistent with our
ability to reduce the product back to the alcohol, 126. Unfortunately, we
were unable to oxidize this product to the acid, 115. Furthermore, treatment
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of 127 with N-iodosuccinimide in methanol 120 failed to give the methyl
ester, 116. Therefore, we felt it was time to reevaluate our synthetic strategy.
3.4 Strategy 3: D-Gulonolactone as the Starting Material
Our first strategy to fragment C2 demonstrated that the introduction
of the amine at a late stage was necessary, and the second strategy showed
that a late stage oxidation would not work. With these results, we chose to
incorporate a starting material that was already in the proper oxidation state
for fragment C2. This starting material was D-gulonolactone, 131, and had
the added advantage of possessing two of the three necessary stereocenters.
With the understanding that the third stereocenter required inversion, we
began an exploration of this strategy. This section will describe our results.
3.4.1 Retrosynthetic Analysis
Scheme 3.10
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As shown in Scheme 3.10, we envisioned the completion of fragment
C, 128, by inverting the alcohol on 129 with a nitrogen nucleophile and
elaborating the nitrogen to the dimethylamino group. The alcohol, 129, was
to come from ring opening of the lactone, 130, with fragment C1, 63. The
lactone, 130, was available in five steps from D-gulonolactone, 131.121,122
3.4.2 The Lactone
Our preparation of the lactone, 130, shown in Scheme 3.11, began
with the convertion of D-gulonolactone, 131, to its bis-acetonide, 132 (80%
yield), on treatment with dimethoxypropane and camphorsulphonic acid.
The bis-acetonide, 132, was then hydrolyzed to the diol, 133, in 87% yield as
described by Jones.121 The diol, 133, was then converted to the aldehyde, 134,
on treatment with NaIO4, and the aldehyde was reduced to the alcohol, 135,
with NaHB(OAc)3 (79%, two steps). Methylation to 130 was accomplished
on treatment with methyl iodide nd silver oxide (83% yield). 122
Scheme 3.11
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3.4.3 The Hydroxyamide
At this stage, we were ready to study the coupling of fragment C1 with
the lactone, 130. In the interest of optimizing the coupling conditions before
using fragment C1, 63, we decided to study the final stages with
benzylamine, 136, as a model. As shown in Scheme 3.12, heating the
lactone, 130, benzylamine, 136, and a catalytic amount of Hinig's base to
reflux in methanol 123 produced a 96% yield of the model hydroxyamide,
137. With substantial quantities of this compound in hand, we were ready
to study the completion of fragment C.
Scheme 3.12
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3.4.4 Attempted Completion of Fragment C
Scheme 3.13
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Completion of the synthesis was expected to proceed either through
the direct displacement of the hydroxyl group with a nitrogen nucleophile
such as phthalimide or by initial conversion of the alcohol to the
corresponding mesylate followed by displacement with azide. However,
when we treated the alcohol with phthalimide or zinc azide under
Mitsunobu conditions, 12 4 ,12 5 we were disappointed to find an 83%
combined yield of the hydroxyamide, 138, and the lactone, 139, in a 3: 1
ratio, respectively (Scheme 3.13). It is important to note that the
hydroxyamide, 138, and the lactone, 139, possess the inverted configuration
at C4 when compared to the starting hydroxyamide, 137, and the lactone,
131, respectively. Furthermore, although we were able to convert the
hydroxyamide, 137, into the mesylate, 140, we observed the same mixture of
products obtained under Mitsunobu conditions when we attempted to
displace the mesylate with azide. These results can be explained by the
imidate, 141 (Figure 3.3), which forms when the amide oxygen displaces the
leaving group to form a 5,5 cis-fused system with inversion of the center at
C4. Hydrolysis then affords the observed products. This effect, believed to
result from the acetonide holding the ends of the molecule in close
proximity, caused us to re-evaluate the utility of this group.
145
3.4.5 The Acetonide: Turning Problems to Advantages
Scheme 3.14
1. Ms-Ci
~N ~ 2. BuOK
HUJ
137 142
When considering the ability of the acetonide to hold the side groups
of the hydroxyamide, 137, in close proximity thus making intramolecular
reactions with inversion of stereochemistry inevitable, we considered the
possibility of inducing the nitrogen of the amide to displace a leaving group.
This would provide two advantages. The first is that the nitrogen would be
introduced at the correct site with the correct stereochemistry, and the
second is that all of the stereocenters included in fragment C2 would be
established. As shown in Scheme 3.14, when exploring this possibility, we
found that converting the hydroxyamide, 137, to the corresponding
mesylate, 140, followed by treatment of the crude mesylate with potassium
tert-butoxide cleanly produced an 87% yield of the desired lactam, 142.126
At this stage, all that remained for the completion of fragment C, 143,
was to open the lactam, 142, to the benzylamino amide, 144, remove the
benzyl group to form the amino amide, 145, and methylate the amine
(Scheme 3.15). Unfortunately, all attempts to open the lactam failed. We
felt, however, that if we could remove some electron density from the
nitrogen thus stabilizing the anion, we would be able to avoid this problem.
146
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In developing a strategy utilizing electron withdrawing protecting
groups on the lactam nitrogen, we went back and opened the lactone, 130, to
the p-methoxy benzylamide, 146,127,128,129 in 99% yield (Scheme 3.16). This
hydroxyamide was then carried through to the MPM-protected lactam, 147,
in 87% yield over two steps. The MPM group was then removed with ceric
ammonium nitrate (CAN) 130 to form the lactam, 148, which was then
treated with tBOC anhydride 1 3l to provide the tBOC-protected lactam, 149.
This lactam was easily opened with the Weinreb reagent derived from
heptylaminel 27 ,128,129 to form the tBOC protected amino amide, 150.
147
.lmm! - J P
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Successful completion of our strategy now relied on the removal of
the tBOC protecting group followed by methylation of the amine. As shown
in Scheme 3.17, the tBOC group was removed in 81% yield on treatment
with TBSOTf followed by tetrabutylammonium fluoride (TBAF).132 To our
disappointment, all attempts to convert the primary amine, 151, to the
dimethylamine, 152, resulted in cyclization to the lactam, 153.
148
At this stage, we realized our synthesis was becoming far too elaborate
considering the size of the fragment. Therefore, we began to re-evaluate our
options and needs with respect to protecting groups. Additionally, we
decided to search for alternative methods used to open lactams.
Scheme 3.17
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3.4.6 Protecting Groups and the Lactam
When considering how to shorten our synthetic strategy while
enhancing its efficiency, we felt it would be advantageous to introduce one
of the methyl groups to the nitrogen at a relatively early stage. Therefore, as
shown in Scheme 3.18, we converted the lactone, 130, to the hydroxy amide,
154, in 99% yield utilizing the Weinreb reagent derived from methylamine
hydrochloride. 12 9 Cyclization of the resulting hydroxy amide, 154, to the
methyl lactam, 155, was effected on treatment with methanesulfonyl
chloride followed by potassium tert-butoxide (84%, two steps) as previously
described.
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Scheme 3.18
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Realizing that the presence of the acetonide was preventing us from
efficiently opening the lactam, we decided to explore alternative protecting
150
MeO
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Me
MeO,
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groups for the diol. Therefore, as shown in Scheme 3.19, we removed the
acetonide under acidic hydrolytic conditions and reprotected the diol, 156, as
the bis-benzyloxy lactam, 157, (83% yield, 2 steps) and the bis-tert-
butyldimethylsilyloxy lactam, 158, (95% yield, 2 steps).
3.4.7 Ring Opening of the Lactam
Scheme 3.20
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Exploring the ring opening reactions of lactams, we began our study
with the bis-benzyloxy lactam, 157. We felt that if we could form an imidate
from this lactam, mild basic hydrolysis of this imidate would yield an amino
ester 13 2a which could be trapped with various electrophiles.1 33 As shown in
Scheme 3.20, treatment of the bis benzyloxy lactam, 157, with the Meerwein
reagentl 3 4 cleanly formed the imidate in the presence of 2,6-di-tert-
butylpyridine. Furthermore, basic hydrolysis of the imidate in the presence
of CBZ-Cl or tBOC anhydride provided the CBZ protected amino ester, 159,
(75% yield, 2 steps) or the tBOC protected amino ester, 160, (72% yield, 2
steps) respectively.
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Scheme 3.21
Me
1. Et3OBF4 tnu u
2. NaHCO 3, H2 0,
H2C=O MeO i OEI
3. NaCNBH 3, ZnCI2 MN Me2N OBn
157 161
MeO'
1
1. Et3OBF 4 TBSO O
2. NaHCO 3, H20, '
H2C=O MeO I OE1
3. NaCNBH3, ZnC2 MeN OTBS
158 162
Although it is well known that carbamates can be reduced to methyl
groups using strong reducing agents, the likelihood of being able to perform
this reaction on the protected amino esters, 159 or 160, seemed quite low.
However, we felt that if the amino ester was trapped in the form of an
imine, reduction of the imine to the amine could be accomplished with no
consequence to the ester functionality. Therefore, as shown in Scheme 3.21,
we converted the bis-benzyloxy lactam, 157, to the imidate on treatment
with the Meerwein reagent,13 4 and hydrolyzed the crude imidate under
basic conditions in the presence of formaldehyde to form the imine. The
imine was then reduced, in situ, to the bis-benzyloxy dimethylaminoester,
161, in 79% yield over three steps with the zinc chloride modification of the
NaCNBH3 reduction.l3 5 Additionally, this reaction sequence was easily
adapted to the bis-tert-butyldimethylsilyloxy lactam, 158, thus providing, in
69% yield over three steps, the bis-tert-butyldimethylsilyloxy aminoester,
162. With these results, we had completed fragment C2 and were now ready
to study its coupling with fragment C1.
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3.5 Experimental Section
HO co 2H PhF-Br . HOC H
.' r g
H2 N HNPhF97 100
N-(9-Phenylfluorenyl)-D-Serine, 100
D-Serine (2.10 g, 20 mmoles) was suspended in CH2Cl 2 (35 mL) at
room temperature under argon. Trimethylchlorosilane (8.8 mL, 70
mmoles) was added and the mixture was heated to reflux for 20 minutes.
The reaction was allowed to cool, after which a solution of triethylamine
(9.76 mL) in CH2Cl2 (20 mL) was added. The reaction was stirred for an
additional 45 minutes, cooled to 0°C, and a solution of methanol (1.22 mL,
30 mmoles) in CH2C12 (5 mL) was added. The mixture was allowed to warm
to room temperature, after which triethylamine (2.79 mL) was added
followed by 9-phenylfluorenyl bromide (6.42 g, 20 mmoles) and Pb(NO3)2
(6.42 g, 20 mmoles). The reaction was stirred under argon for 2 days, after
which methanol (5 mL) was added. The mixture was stirred for 15 minutes
and the solvent was removed under reduced pressure. The residue was
partitioned between THF (100 mL), 5% citric acid solution (100 mL), and
ether (100 mL). The layers were separated and the organic phase was washed
with 1M NaOH solution (2 X 50 mL) and water (2 X 50 mL). The combined
aqueous layers were neutralized with glacial acetic acid and washed with
50% THF/ethyl acetate (2 X 100 mL). The organic phases were washed with
brine (100 mL), dried over Na2SO4, filtered, and concentrated under reduced
pressure to yield the pure product (4.35 g, 63%) as a light brown solid.
Physical Properties for 100
Rf = 0.17 (ethyl acetate).
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1H NMR (250 MHz, CDC13): 7.60-7.70(m, 2H), 7.15-7.40(m, 11H), 3.10-
3.55(m, 2H), 2.60(t, IH).
EI Mass Spec: m/e 345 [M]+, 314, 300, 268, 241.
HO".02 1. MNaOMe/MeMeO,
Hh 2. CH 2 N 2 I-
HNPhF HNPhF
100 101
N-(9-Phenylfluorenyl)-O-Methyl-D-Serine Methyl Ester, 101
NaH (80%, 1.20 g, 40 mmoles) was suspended in THF (74 mL) under
argon and methanol (6 mL) was added. The mixture was stirred at room
temperature for 10 minutes, after which 40 mL of the solution was
transferred to a solution of N-(9-phenylfluorenyl)-D-serine (3.45 g, 10
mmoles) in THF (100 mL). The mixture was stirred at room temperature
under argon for 1 hour, after which a solution of methyl iodide (1 mL, 16
mmoles) in THF (10 mL) was added. The reaction was stirred for 1 hour,
after which the remainder of the NaOMe solution was added followed by a
solution of methyl iodide (2 mL, 32 mmoles) in THF (10 mL). The reaction
was stirred for 18 hours, after which the solvent was removed under
reduced pressure. The residue was dissolved in water '/o mL) and the
aqueous mixture was washed with ether (25 mL) and acidified with solid
citric acid. The aqueous phase was then washed with ethyl acetate (3 X 25
mL). The ethyl acetate was washed with 10% Na2S203 solution (3 X 25 mL).
The combined aqueous phases were washed with ethyl acetate (25 mL) and
the combined ethyl acetate phases were washed with 10% Na2S203 solution
(25 mL) and brine (2 X 25 mL). The ethyl acetate was dried over Na2S04 and
concentrated to a light brown foam which was immediately taken up in
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ether (100 mL). An ethereal solution of diazomethane was then added until
no more gas evolved. The reaction was quenched with glacial acetic acid
and the ether was washed with saturated NaHCO3 solution (2 X 50 mL) and
brine (2 X 50 mL). The organic phase was then dried over Na2SO4, filtered,
and concentrated under reduced pressure. The residue was purified on
silica gel (25% ethyl acetate/hexane) to yield the desired product (1.67 g, 45%)
as a light yellow crystalline solid.
Physical Properties for 101
Rf = 0.45 (25% ethyl acetate/hexane).
1 H NMR (300 MHz, CDCl 3): 7.65-7.7(m, 2H), 7.2-7.45(m, 11H), 3.42(dd, 1H),
3.30(s, 3H), 3.28(dd, 1H), 3.20(s, 3H), 3.07(m, 1H), 2.88(m, 1H).
El Mass Spec: m/e 373 [M]+, 328, 314, 241.
MeOC O 2M e DIBAL . MeO CHOH2
HNPhF HNPhF
101 102
Alcohol, 102
N-(9-Phenyfluorenyl)-O-methyl-D-serine methyl ester (0.95 g, 2.55
mmoles) was dissolved in ether (10 mL) and cooled to -78°C under argon.
DIBAL (1M in hexane, 5 mL, 5 mmoles) was added dropwise and the
reaction was warmed from -78°C to room temperature over 3.5 hours. The
reaction was quenched with methanol (10 mL) and combined with ethyl
acetate (50 mL). The ethyl acetate was washed with 1N HCl (3 X 20 mL) and
saturated NaHCO3 solution (20 mL), after which it was dried over Na2SO4,
filtered, and concentrated to yield the product (0.445 g, 50%) as a yellow oil.
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Physical Properties for 102
Rf = 0.21 (25% ethyl acetate/hexane).
1H NMR (250 MHz, CDC13): 8 7.65-7.75(m, 2H), 7.15-7.45(m, 11H), 3.20(dd,
1H), 3.10(s, 3H), 3.06(dd, 1H), 2.96(dd, 1H), 2.84(dd, 1H), 2.69(broad s, 1H),
2.34(m, 1H), 1.55(broad s, 1H).
MeOCH20 H 1. (COCI)2/DMSO MeO c O 2Et
HNPhF =PPh HNPhF
102 2. OEt 103 104
Ester, 104
To a solution of (COC1)2 (0.135 mL, 1.54 mmoles) in CH2 C12 (13 mL) at
-78°C under argon was added DMSO (0.222 mL, 3.13 mmoles). The resulting
mixture was stirred at -780C for 10 minutes, after which a solution of the
alcohol, 102, (0.45 g, 1.30 mmoles) in CH2Cl2 (10 mL) was added. The
mixture was stirred at -78°C for 2 hours, after which triethylamine (0.90 mL,
6.46 mmoles) was added. Stirring was continued at -78C for 1 hour, after
which a solution of (carbethoxymethylene)triphenylphosphorane, 103, (1.30
g, 3.73 mmoles) in CH2C12 (5 mL) was added. The mixture was allowed to
warm to room temperature over 20 hours, after which it was poured onto
brine (100 mL) and washed with CH2C12 (2 X 100 mL). The organic phase
was dried over Na2SO4, filtered, and concentrated under reduced pressure.
Purification of the residue on silica gel (15% ethyl acetate/hexane) yielded
the product (0.425 g, 79%) as a colorless oil.
Physical Properties for 104
Rf = 0.45 (25% ethyl acetate/hexane).
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1H NMR (250 MHz, CDCl3): 1.23(t, 3H), 2.80(broad s, 1H), 2.95(m, 2H),
3.15(s, 3H), 3.23(m, 1H), 4.05(q, 2H), 5.27(d, 1H), 6.38(dd, 1H), 7.1-7.5(m, 11H),
7.55-7.7(m, 2H).
MeO.-CO 2E DIBAL M eo CHO H
HNPhF HNPhF
104 105
Alcohol, 105
The ester, 104, (0.42 g, 1.02 mmoles) was dissolved in ether (10 mL)
and cooled to -780°C under argon. DIBAL (1M in hexane, 3 mL, 3 mmoles)
was added dropwise and the mixture was warmed from -78°C to room
temperature over 2.5 hours. The reaction was then transferred, via cannula,
to saturated Rochelle's salt solution (50 mL) and stirred at room temperature
for 15 minutes. The mixture was washed with CH2C12 (3 X 50 mL) and the
combined organic layers were dried over Na2SO4, filtered, and concentrated
under reduced pressure to yield the pure product (0.37 g, 97%) as a light
yellow oil.
Physical Properties for 105
Rf = 0.10 (25% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl 3 ): 7.7(d, 1H), 7.6(d, 1H), 7.15-7.45(m, 11H), 4.8-
5.1(m, 2H), 3.52(m, 2H), 3.27(t, 1H), 3.25(s, 3H), 1.55(broad s, 1H), 3.00(m, 2H),
2.85(broad s, 1H).
EI Mass Spec: m/e 326 [M - 33]+, 241.
IR (neat) cm- 1: 3400, 3060, 2900, 1600, 1450, 1200.
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HO'" C02 H 1. NaOMe/MeI lMeO , 2Me
: 2. CH2N2 '
HNtBOC HNtBOC
107 109
N-tBOC-O-Methyl-D-Serine Methyl Ester, 109
NaH (80%, 6 g, 0.2 mole) was suspended in THF (370 mL) under argon
and methanol (30 mL) was added. The mixture was stirred at room
temperature for 30 minutes, after which 200 mL of the solution was
transferred to a solution of N-tBOC-D-serine (10.25 g, 50 mmoles) in THF
(500 mL). The mixture was stirred at room temperature under argon for 1
hour, after which a solution of methyl iodide (5 mL, 80 mmoles) in THF (50
mL) was added. The reaction was stirred for 1 hour, after which the
remainder of the NaOMe solution was added followed by a solution of
methyl iodide (10 mL, 0.16 mole) in THF (50 mL). The reaction was stirred
for 18 hours, after which the solvent was removed under reduced pressure.
The residue was dissolved in water (250 mL), and the aqueous layer was
washed with ether (125 mL) and acidified, at 0°C, with solid citric acid. The
aqueous phase was then washed with ethyl acetate (3 X 125 mL) and the
combined ethyl acetate phases were washed with 20% Na2S203 solution (3 X
125 mL). The combined aqueous phases were washed with ethyl acetate (125
mL) and the combined organic phases were washed with 20% Na2S203
solution (125 mL) and concentrated. The residue was then dissolved in
water (150 mL) and washed with CH2C12 (150 mL). The CH2C12 was dried
over Na2SO4 and concentrated to a viscous oil. The oil was dissolved in
ethyl acetate (100 mL) and an ethereal solution of diazomethane was added
until no more gas evolved. The reaction was quenched with glacial acetic
acid, after which it was washed with saturated NaHCO3 solution (2 X 50 mL)
and brine (50 mL). The organic phase was dried over Na2SO4, filtered, and
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concentrated under reduced pressure. The residue was purified on silica gel
(25% ethyl acetate/hexane) to yield the product (4.40 g, 38%) as a colorless oil.
Physical Properties for 109
Rf = 0.36 (25% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 5.36(broad m, 1H), 4.42(broad m, 1H), 3.79(dd,
1H), 3.75(s, 3H), 3.59(dd, 1H), 3.35(s, 3H), 1.45(s, 9H).
MeO c C0 2M e DIBAL MeO" H 20 H
HNtBOC HNtBOC
109 110
Alcohol, 110
N-tBOC-O-methyl-D-serine methyl ester (0.244 g, 1.05 mmoles) was
dissolved in ether (2 mL) and cooled to -78°C under argon. DIBAL (1M in
toluene, 2.6 mL, 2.6 mmoles) was added dropwise and the reaction was
warmed from -780C to room temperature over 18 hours. The reaction was
then transferred, via cannula, to saturated Rochelle's salt solution (10 mL).
The resulting mixture was stirred at room temperature for 40 minutes, after
which the layers were separated and the aqueous phase was washed with
ethyl acetate (10 mL). The combined organic phases were dried over
Na2 SO4, filtered, and concentrated under reduced pressure to yield the pure
product (0.203 g, 95%) as a yellow oil.
Physical Properties for 110
Rf = 0.29 (50% ethyl acetate/ether).
1 H NMR (250 MHz, CDC13): 8 5.15(broad s, 1H), 3.76(broad m, 2H), 3.55(m,
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2H), 3.35(s, 3H), 2.65(broad m, 1H), 1.60(s, 1H), 1.45(s, 9H).
EI Mass Spec: m/e 205 [M]+, 174, 160, 132, 118, 104, 74,57.
IR (neat) cm-l: 3400, 2950, 1680, 1500, 1330.
1. DIBAL
~CO2Me O=PPh 3MeO-~ 2. OEt 10 3HNtBOC
10° 9 MeO c O2 Et
HNtBOC
MeO 1. (COC)2/DMSO 111
HNtBOC p
2. OEt 1 0 3
Ester, 11l
From 109:
N-tBOC-O-methyl-D-serine methyl ester (0.91 g, 3.90 mmoles) was
dissolved in ether (10 mL) and cooled to -78°C under argon. DIBAL (1M in
toluene, 10 mL, 10 mmoles) was added to the mixture over 10 minutes and
the reaction was stirred at -78C for 3 hours. The reaction was transferred,
via cannula, to saturated Rochelle's salt solution (50 mL) pre-cooled to 0°C,
and the mixture was stirred at room temperature for 1 hour. Ethyl acetate
(20 mL) was then added and the layers were separated. The organic layer
was dried over Na2SO4, filtered, and concentrated under reduced pressure.
The residue was dissolved in CH2 C 1 2 (10 mL) and
(carbethoxymethylene)triphenylphosphorane, 103, (1.35 g, 3.90 mmoles) was
added. The reaction was stirred at room temperature under argon for 36
hours and concentrated to dryness. Purification of the residue on silica gel
(20% ethyl acetate/hexane) gave the product (0.58 g, 55%) as a colorless oil.
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From 110:
To a solution of (COC1)2 (0.51 mL, 5.76 mmoles) in CH2C12 (50 mL) at
-78C under argon was added DMSO (0.86 mL, 12.13 mmoles). The resulting
mixture was stirred at -780C for 10 minutes, after which a solution of the
alcohol, 110, (0.995 g, 4.85 mmoles) in CH2Cl 2 (36 mL) was added. The
mixture was stirred at -780C for 2 hours, after which triethylamine (3.54 mL,
25.38 mmoles) was added. Stirring was continued at -780C for 1 hour, after
which a solution of (carbethoxymethylene)triphenylphosphorane, 103, (5 g,
14.35 mmoles) in CH2C12 (25 mL) was added. The mixture was allowed to
warm to room temperature over 21 hours, after which it was poured onto
brine (200 mL) and extracted with CH2C12 (2 X 200 mL). The CH2C12 was
dried over Na2SO4 , filtered, and concentrated under reduced pressure.
Purification of the residue on silica gel (20% ethyl acetate/hexane) yielded
the product (0.58 g, 44%) as a colorless oil.
Physical Properties for 111
Rf = 0.31 (25% ethyl acetate/hexane).
1H NMR (250 MHz, CDC13): 6.90(dd, 1H), 5.95(dd, 1H), 4.97(broad s, 1H),
4.44(broad s, 1H), 4.15(q, 2H), 3.48(d, 2H), 3.31(s, 3H), 1.42(s, 9H), 1.25(t, 3H).
EI Mass Spec: m/e 200 [Ml+, 172,157, 128, 57.
IR (neat) cm- 1: 2980, 2940, 1720, 1660, 1520, 1365.
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0 0 0
(Et0)2kAOE 
EtO0- 68 +
114 119
Ester, 119
Triethyl phosphonoacetate (2.013 g, 7.684 mmoles) was dissolved in
THF (20 mnL). The resulting solution was added to a suspension of NaH
(80%, 0.279 g, 9.313 mmoles) in THF (20 mL) at room temperature under
argon. After stirring for 20 minutes, the phosphonate solution was added to
a solution of (S)-isopropylidine glyceraldehyde (0.896 g, 6.892 mmoles) in
THF (60 mL) over 10 minutes. The mixture was stirred at room
temperature under argon for 20 minutes, after which the reaction was
diluted with ether (150 mL) and washed with saturated NH4Cl solution (50
mL), NaHCO3 solution (50 mL), and brine (50 mL). The organic phase was
dried over Na2SO4 and concentrated to dryness. Purification on silica gel
(15% ethyl acetate/hexane) gave the product as a colorless oil (1.1202 g, 73%).
Physical Properties for 119
Rf = 0.55 (25% ethyl acetate/hexane).
[a]D = -39.4 c = 3.39 (CHC13, observed)
= -41.8 c = 3.28 (CHCl 3, literature).
1H NMR (250 MHz, CDC13 ): 8 6.87(m, 1H), 6.08(m, 1H), 4.65(m, 1H), 4.18(m,
3H), 3.66(dd, 1H), 1.43(s, 3H), 1.38(s, 3H), 1.28(t, 3H).
IR (neat) cm- 1: 2980, 2940, 2870, 1720, 1660, 1450, 1370, 1300.
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OEt O DIB-L')iw'A
19 120119 120
Allylic Alcohol, 120
The ester, 119, (2.318 g, 11.60 mmoles) was dissolved in CH2C12 (45
mL) and cooled to 0°C under argon. DIBAL (M in toluene, 25 mL, 25
mmoles) was added and the reaction was stirred at 0°C for 20 minutes, after
which it was transferred to saturated Rochelle's salt solution (50 mL) at 0°C.
The resulting mixture was stirred at room temperature for 1.5 hours, after
which the layers were separated and the aqueous phase was washed with
ethyl acetate (2 X 20 mL). The combined organics were dried over Na2SO4
and concentrated to dryness. The residue was passed through a 1 inch plug
of silica gel (50% ethyl acetate/hexane). Concentration of the filtrate yielded
the product as a colorless oil (1.761 g, 96%).
Physical Properties for 120
Rf = 0.28 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDCI 3): 5.95(m, 1H), 5.71(m, 1H), 4.53(m, 1H), 4.16(m,
2H), 4.08(dd, 1H), 3.59(dd, H), 1.42(s, 3H), 1.38(s, 3H).
IR (CDC13) cm-l: 3620, 2995, 2940, 2880, 1450, 1370, 1215, 1150, 1050.
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OH ON .N O'N (.)-DET, Ti(OPr)46 'BuOOH :--
120 118
Epoxide, 118
Activated 4A powdered molecular sieves (0.155 g) were suspended in
CH2Cl 2 (11 mL) and cooled to -200C. (+)-Diethyl tartrate (32.2 mL, 0.189
mmole) was added followed by (iPrO)4Ti (46.7 mL, 0.157 mmole). tert-Butyl
hydroperoxide (3M in isooctane, 2.1 mL, 6.287 mmoles) was added dropwise
and the resulting mixture was stirred at -200C for 30 minutes. A solution of
the alcohol, 120, (0.497 g, 3.144 mmoles) in CH2CI2 (2 mL) was added
dropwise and the mixture was stirred at -20°C under argon for 23 hours,
after which the reaction was warmed to 0°C and water (0.89 mL) was added.
The mixture was then warmed to room temperature over 30 minutes and a
solution of NaOH (30% in saturated NaCI, 0.18 mL) was added. The mixture
was stirred for 25 minutes, the layers were separated, and the aqueous layer
was washed with CH2 C12 (2 X 25 mL). The combined organics were dried
over Na2SO4, concentrated, and the residue was purified on silica gel (70%
ethyl acetate/hexane) to yield the product as a colorless oil (0.471 g, 86%).
Physical Properties for 118
Rf = 0.37 (70% ethyl acetate/hexane).
[a]D = +36.0 c = 0.145 (CHCl 3 , observed)
= +38.6 c = 0.145 (CHCl 3, literature).
1H NMR (300 MHz, CDC13): 8 4.16(dd, 1H), 3.97(m, 3H), 3.72(m, 1H), 3.13(m,
2H), 1.70(t, 1H), 1.47(s, 3H), 1.40(s, 3H).
IR (CDCl3) cm-l: 3580, 2900, 1440, 1360,1235, 1200, 1140, 1045.
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HO O CH3NCO 0
~~~O NHMe
118 121
Epoxycarbamate, 121
The epoxide, 118, (0.471 g, 2.708 mmoles) was dissolved in benzene (10
mL) and methyl isocyanate (0.18 mL, 3.054 mmoles) was added. The
reaction was warmed to 500C for 3 days, after which methanol (2 mL) was
added. Stirring was continued at 500C for 1 hour, after which the reaction
was concentrated and the residue was purified on silica gel (50% ethyl
acetate/hexane) to yield the product as a colorless oil (0.545 g, 87%).
Physical Properties for 121
Rf = 0.47 (70% ethyl acetate/hexane).
[a]D = +35.4 c = 0.04247 (CHC13).
1H NMR (300 MHz, CDC13): 6 4.67(broad s, 1H), 4.41(dd, 1H), 4.80(dd, 1H),
3.90(m, 3H), 3.19(m, 1H), 2.95(m, 1H), 2.78(d, 3H), 1.43(s, 3H), 1.34(s, 3H).
EI Mass Spec: m/e 216 [M - 15]+, 99, 71, 58, 43.
IR (CHCl3) cm-1: 3440, 2960, 1715, 1500, 1360, 1180.
OH
O KOtBu O
O NHMe NMe 0
121 0 117
Oxazolidinone, 117
The epoxycarbamate, 121, (3.316 g, 14.354 mmoles) was dissolved in
THF (66 mL) and cooled to -100C under argon, after which potassium tert-
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butoxide (0.58M in THF, 27.20 mL, 15.79 mmoles) was added. The reaction
was stirred at -100C for 30 minutes, after which it was quenched with
saturated NH4CI solution (50 mL). The reaction was partitioned with ethyl
acetate (150 mL) and the aqueous layer was washed with ethyl acetate (150
mL). The combined organic phases were dried over Na2SO4 and
concentrated. The residue was purified by recrystallization from ethyl
acetate/hexane to yield the product as colorless needles (2.578 g, 78%).
Physical Properties for 117
Rf = 0.24 (70% ethyl acetate/hexane).
[a]D = -6.17 c = 0.02041 (CHC13).
1H NMR (300 MHz, CDC13): 4.48(dd, 1H), 4.33(dd, 1H), 4.17(dd, 1H), 4.03(m,
2H), 3.90(m, 2H), 3.83(m, 1H), 2.90(s, 3H), 1.41(s, 3H), 1.33(s, 3H).
EI Mass Spec: m/e 216 [M - 15]+, 131,100, 73, 56.
IR (CHCl 3) cm-1: 3350, 2960, 1735, 1420, 1050.
OH OH
° 1. AcOH/H20 OOTBS
NMe ° WNMe OH
117 122
Diol, 122
The oxazolidinone, 117, (0.100 g, 0.434 mmole) was dissolved in acetic
acid (0.63 mL) and water (0.89 mL) was added. The reaction was heated to
50°C for 6 hours, after which it was concentrated to dryness. After 24 hours
under vacuum, the residue was taken up in DMF (4 mL). Imidazole (118
mg, 1.735 mmoles) was added and the mixture was cooled to -100C under
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argon. A solution of tert-butyldimethylchlorosilane (82.7 mg, 0.548 mmole)
in DMF (2 mL) was added and the reaction was warmed from -10°C to room
temperature over 2.5 hours. The reaction was then partitioned between
water (20 mL) and ethyl acetate (40 mL). The aqueous phase was washed
with ethyl acetate (40 mL) and the combined organic extracts were dried over
Na2SO4 and concentrated to dryness. The residue was purified on silica gel
(ethyl acetate) to yield the product as a white crystalline solid (0.122 g, 93%).
Physical Properties for 122
Rf = 0.53 (ethyl acetate).
1H NMR (300 MHz, CDC13 ): 4.43(dd, 1H), 4.30(dd, 1H), 4.07(m, 1H), 3.84(m,
2H), 3.71(m, 2H), 3.49(m, 1H), 2.85(s, 3H), 2.61(d, 1H), 0.88(s, 9H), 0.07(s, 6H).
IR (CDC13) cm-1: 3550, 3350, 2910, 1730, 1450, 1240.
OH
. : OTBS Me2C(OMe)2CSA
NMe OH
o 122
Acetonide, 123
The diol, 122, (0.122 g, 0.399 mmole) was dissolved in CH2C12 (5 mL).
2,2-dimethoxypropane (0.24 mL, 1.993 mmoles) was added followed by
camphorsulfonic acid (10 mg). The mixture was stirred at room
temperature under argon for 1 hour, after which it was diluted to 10 mL
with CH2C12. The reaction was then washed with saturated NaHCO3
solution (10 mL). The organics were dried over Na2SO4 and concentrated to
dryness. The residue was purified by filtration through a 1 inch plug of
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silica gel (70% ethyl acetate/hexane) to yield the product as a colorless
crystalline solid (0.133 g, 97%).
Physical Properties for 123
Rf = 0.62 (70% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 4.43(m, 2H), 4.31(m, 2H), 4.04(m, IH), 3.78(dd,
1H), 3.50(dd, 1H), 2.93(s, 3H), 1.48(s, 3H), 1.39(s, 3H), 0.91(s, 9H), 0.10(s, 6H).
IR (CDCI 3) cm-1: 2900, 1740, 1420,1245, 1030.
1' A
Amino Alcohol, 124
The acetonide, 123, (11.947 g, 34.628 mmoles) was dissolved in ether
(200 mL). LiAlH4 (4.342 g, 114.274 mmoles) was suspended in ether (150
mL). Both solutions were cooled to -100C under argon, after which the
acetonide was added, dropwise, to the LiAlH4. The reaction was allowed to
warm from -10°C to room temperature over 4 hours after which, it was
quenched by slowly adding Na2SO410H20 until no more gas evolution was
observed. After 1 hour, the solids were filtered off and washed with ether.
The combined filtrates were concentrated to dryness to yield the product
requiring no further purification (10.947 g, 95%).
Physical Properties for 124
Rf = 0.29 (70% ethyl acetate/hexane).
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1H NMR (300 MHz, CDC13): 4.33(dd, 1H), 4.18(dd, 1H), 3.74(m, 3H), 3.60(dd,
1H), 2.94(m, 1H), 2.75(broad s, 1H), 2.29(s, 6H), 1.40(s, 3H), 1.32(s, 3H), 0.88(s,
911), 0.06(s, 6H).
IR (CDC13 ) cm-1: 3520, 2910, 1445, 1360, 1240.
124 125
Methyl Ether, 125
NaH (35%, 27.8 mg, 0.405 mmole) was suspended in THF (1.5 mL) and
a solution of the amino alcohol, 124, (67.5 mg, 0.203 mmole) in THF (2 mL)
was added. The mixture was stirred at room temperature under argon for 10
minutes, after which methyl iodide (13.8 mL, 0.222 mmole) was added.
Stirring was continued for 1.5 hours, after which the reaction was quenched
with methanol (0.10 mL) and partitioned between ethyl acetate (15 mL) and
brine (5 mL). The layers were separated and the organic phase was dried
over Na2SO4 and concentrated. The residue was purified on silica gel (25%
ethyl acetate/hexane) to yield the product as a colorless oil (50.5 mg, 72%).
Physical Properties for 125
Rf = 0.31 (25% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl 3): 4.17(m, 2H), 3.89(dd, 1H), 3.72(dd, 1H), 3.61(dd,
1H), 3.52(dd, 1H), 3.33(s, 3H), 2.95(m, 1H), 2.34(s, 6H), 1.43(s, 3H), 1.32(s, 3H),
0.90(s, 9H), 0.06(s, 6H).
IR (CDCl3 ) cm-1: 2900, 1450, 1360, 1240.
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Amino Alcohol, 126
The methyl ether, 125, (0.146 g, 0.419 mmole) was dissolved in THF (5
mL) and tetrabutylammonium fluoride (1M in THF, 0.46 mL, 0.46 mmole)
was added. The reaction was stirred for 15 minutes at room temperature
under argon, after which it was filtered through silica gel (ethyl acetate) and
concentrated to dryness. The resulting oil was purified on silica gel (70%
ethyl acetate/hexane) to yield the desired product (91.7 mg, 94%).
Physical Properties for 126
Rf = 0.26 (70% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13 ): 8 6.36(broad s, 1H), 4.29(m, 2H), 3.65(m, 4H),
3.33(s, 3H), 2.97(m, 1H), 2.39(s, 6H), 1.37(s, 3H), 1.32(s, 3H).
IR (CDC13) cm-1: 3150, 2910, 1445, 1235, 1210, 1040.
HO-
HO-
0 Me2C(OMe)2 0
CSA 'O
131 132
2,3-5,6-Di-O-Isopropylidine-D-Gulono-1,4-Lactone, 132
D-Gulono-1,4-lactone (1.001 g, 5.623 mmoles) was suspended in
CH2C12 (50 ml) and camphorsulfonic acid (0.101 g, 0.435 mmole) was added
followed by 2,2-dimethoxy propane (7 mL, 57 mmoles). The mixture was
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stirred at room temperature under argon for 24 hours, after which it was
washed with saturated NaHCO3 solution (50 mL). The aqueous phase was
washed with CH2Cl2 (50 mL) and the combined organic layers were dried
over Na2SO4 and concentrated. The resulting residue was purified on silica
gel (40% ethyl acetate/hexane) to yield the desired product (1.162 g, 80%).
Physical Properties for 132
Rf = 0.60 (50% ethyl acetate/hexane).
[a]D = -57.8 c = 2.8 (acetone).
m. p. = 151-152 0C.
1H NMR (300 MHz, CDCl 3 ): 4.81(d, 1H), 4.71(m, 1H), 4.40(m, 2H), 4.20(m,
1H), 3.80(m, 1H), 1.52(s, 6H), 1.37(s, 3H), 1.35(s, 3H).
EI Mass Spec: m/e 243 [M - 15]+, 185, 157, 125, 101, 59, 43.
Exact Mass: [M - CH3]+ = 243.08686 (calculated)
[M - CH 3] + = 243.0867 (measured).
O
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Diol, 133
2,3-5,6-Di-O-isopropylidine-D-gulono-1,4-lactone (49.4 mg, 0.192
mmole) was dissolved in acetic acid (0.30 mL) and water (44 mL) was added.
The mixture was warmed to 45C for 5.5 hours, after which it was
concentrated to dryness under vacuum. The residue was purified on silica
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gel (ethyl acetate) to yield the desired product (36.3 mg, 87%).
Physical Properties for 133
Rf = 0.39 (ethyl acetate).
[a]D = -76.1 c = 2.79 (acetone).
m. p. = 140-1410C.
1H NMR (300 MHz, acetone): 4.95(m, 2H), 4.59(dd, 1H), 4.20(m, 1H),
3.93(m, 1H), 3.77(m, 1H), 3.70(m, 2H), 1.37(s, 3H), 1.35(s, 3H).
EI Mass Spec: m/e 203 [M - 15]+, 187, 159, 143, 125, 116, 83.
Exact Mass: [M - CH3 ]+ = 203.05556 (calculated)
[M - CH3] + = 203.0555 (measured).
IR (nujol mull) cm- 1: 3250, 1775, 1455, 1370, 1080.
1. NaIO 4
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Alcohol, 135
The diol, 133, (1.017 g, 4.665 mmoles) was dissolved in water (40 mL)
and NaIO4 (1.002 g, 4.704 mmoles) was added. The mixture was stirred at
room temperature for 30 minutes, after which it was saturated with NaCl.
The resulting mixture was washed with ethyl acetate (15 X 40 mL). The
combined organic layers were dried over Na2SO4 and concentrated to
dryness under vacuum. To the residue was added benzene (40 mL), acetic
acid (4 mL), and NaHB(OAc)3 (1.003 g, 4.730 mmoles). The mixture was
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stirred at room temperature under argon for 45 minutes, after which it was
concentrated to dryness. The residue was dried, azeotropically, with toluene
(2 X 50 mL) and methanol (3 X 50 mL), and finally purified on silica gel (70%
ethyl acetate/hexane) to yield the desired product (0.697 g, 79%).
Physical Properties for 135
Rf = 0.63 (ethyl acetate).
[a]D = -90 c = 1.00 (acetone).
m. p. = 97-98°C.
1 H NMR (250 MHz, CDC13): 4.88(m, 2H), 4.59(m, 1H), 4.00(m, 2H), 2.00(dd,
1H), 1.49(s, 3H), 1.40(s, 3H).
13C NMR (300 MHz, CDC13): 8 173.44, 114.54, 79.18, 76.22, 76.15, 60.90, 26.67,
25.76.
EI Mass Spec: m/e 173 [M - 15]+, 149, 129, 83, 59,43.
Exact Mass: [M - CH3 ]+ = 173.0450 (calculated)
[M - CH3 ]+ = 173.0452 (measured).
IR (CHCl 3) cm-l: 3600, 1795, 1375, 1175, 1110.
HO
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Methyl Ether, 130
The alcohol, 135, (0.010 g, 0.531 mmole) was dissolved in methyl
iodide (2 mL) and Ag20 (0.399 g) was added followed by anhydrous CaSO4
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(0.147 g). The resulting suspension was stirred at room temperature under
argon for 7.5 hours, after which it was filtered through Celite and
concentrated to dryness. The residue was purified on recrystallization
desired product (0.089 g, 83%).
Physical Properties for 130
Rf = 0.47 (50% ethyl acetate/hexane).
[(]D = -80 c = 0.50 (acetone).
m. p. = 83-850C.
1H NMR (300 MHz, CDCl3): 6 4.84(s, 2H), 4.63(m, 1H), 3.77(m, 2H), 3.46(s,
3H), 1.49(s, 3H), 1.41(s, 3H).
13C NMR (300 MHz, CDC13): 6 173.34, 114.30, 77.98, 76.02, 75.95, 70.16, 59.45,
26.73, 25.89.
EI Mass Spec: m/e 187 [M - 15]+, 143, 85, 71, 45.
Exact Mass: [M - CH3]+ = 187.06065 (calculated)
[M - CH3]+ = 187.0607 (measured).
IR (CDCl3) cm- 1: 1795, 1455, 1375, 1085, 870.
MeO
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Benzyl Amide, 137
The lactone, 130, (0.103 g, 0.510 mmole) was dissolved in methanol (10
mL) and benzylamine (60 L, 0.550 mmole) was added, followed by Hiinig's
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base (57 I.L, 0.328 mmole). The reaction was heated to reflux under argon for
14 hours, after which the mixture was concentrated to dryness and the
residue was purified on silica gel (70% ethyl acetate/hexane) to yield the
product as a colorless oil (0.149 g, 94%).
Physical Properties for 137
Rf = 0.33 (70% ethyl acetate/hexane).
[]D = +45.79 c = 1.865 (acetone).
1H NMR (300 MHz, CDC13): 8 7.29(m, 5H), 6.90(broad m, 1H), 4.59(d, 1H),
4.45(m, 3H), 4.13(m, 1H), 3.45(m, 2H), 3.45(s, 3H), 2.34(d, 1H), 1.50(s, 3H),
1.35(s, 3H).
13C NMR (300 MHz, CDC13 ): 8 170.06, 138.04, 128.88, 127.90, 127.68, 109.88,
77.05, 75.79, 73.97, 67.20, 59.03, 42.88, 26.36, 24.23.
EI Mass Spec: m/e 309 [M]+, 294, 277, 264, 235, 205, 177, 91.
Exact Mass: [M]+ = 309.15762 (calculated)
[M]+ = 309.1574 (measured).
IR (neat) cm-1: 3440, 3020, 2980, 2940, 1675, 1530, 1455, 1375.
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Lactam, 142
The hydroxyamide, 137, (158.5 mg, 0.512 mmole) and triethylamine
(0.215 mL, 1.536 mmoles) were dissolved in CH2CL2 (2 mL) and cooled to 0°C
under argon. Methanesulfonyl chloride (60 pL, 0.768 mmole) was added and
the reaction was stirred at 0°C for 30 minutes. The solvent was then
removed under reduced pressure and the residue was diluted with THF (13
mL) and filtered through Celite under argon. The resulting solution was
cooled to -400C and potassium tert-butoxide (0.6M ion THF, 1.8 mL, 1.075
mmoles) was added. After warming to room temperature over of 1 hour,
the reaction was quenched with pH = 7 buffer. The products were extracted
with ethyl acetate (3 X 10 mL) and the combined extracts were washed with
brine and dried over MgSO4. The solvent was removed and the residue was
purified on silica gel (60% ethyl acetate/hexane) to give the product (129.8
mg, 87%) as a colorless oil.
Physical Properties for 142
Rf = 0.23 (30% acetone/hexane).
1H NMR (300 MHz, CDC13): 7.25-7.33(m, 5H), 4.86(1/2 ABq, JAB = 15.2 Hz,
1H), 4.76(1/2 ABq, JAB = 5.6 Hz, 1H), 4.55(1/2 ABq, JAB = 5.6 Hz, 1H), 4.16(1/2
ABq, JAB = 15.2 Hz, 1H), 3.57(dd, J = 2.6 Hz, 1H), 3.38(d, I = 2.6 Hz, 2H), 3.23(s,
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3H), 1.44(s, 3H), 1.38(s, 3H).
13C NMR (300 MHz, CDCl3 ): 8 172.2, 135.1, 128.7, 128.0, 127.7, 111.8, 77.7, 76.4,
69.4, 60.6, 59.0, 44.2, 26.9, 25.5.
MeO-
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Hydroxyamide, 146
p-Methoxybenzylamine (0.172 mL, 1.315 mmoles) was dissolved in
benzene (2 mL) and cooled to 0°C under argon. Trimethylaluminum (2.0M
in hexane, 0.657 mL, 1.315 mmoles) was added dropwise, and the mixture
was stirred for 30 minutes at room temperature. The resulting solution was
added, via cannula, to a solution of the lactone, 130, (221.6 mg, 1.096 mmole)
in benzene (2 mL) at 0°C. The resulting mixture was stirred for 3 hours at
room temperature, after which it was cooled to 0°C and quenched with
saturated Rochelle's salt solution (2 mL). After stirring for 30 minutes at
room temperature, the products were extracted with ethyl acetate (3 X 5 mL),
and the combined extracts were washed with brine and dried over MgSO4.
The solvent was removed and the residue purified on silica gel (66% ethyl
acetate/hexane) to give the product (369.8 mg, 99%) as a colorless oil.
Physical Properties for 146
Rf = 0.25 (66% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 7.24(d, J = 6.8 Hz, 2H), 6.87(d, J = 6.8 Hz, 2H),
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6.86(m, 1H), 4.61(d, J = 7.9 Hz, 1H), 4.48(dd, J = 7.9, 2.6 Hz, 1H), 4.41(d, I = 5.8
Hz, 2H), 4.17(m, 1H), 3.80(s, 3H), 3.50(m, 2H), 3.39(s, 3H), 2.30(d, J = 7.1 Hz,
IH), 1.53(s, 3H), 1.38(s, 3H).
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MPM-Lactam, 147
The hydroxyamide, 146, (322.8 mg, 0.951 mmole) and triethylamine
(0.4 mL, 2.853 mmoles) were dissolved in CH2Cl2 (4 mL) and cooled to 0°C
under argon. Methanesulfonyl chloride (0.111 mL, 1.427 mmoles) was
added and the reaction was stirred at 0°C for 30 minutes. The solvent was
removed and the residue was diluted with THF (15 mL) and filtered
through Celite under argon. The resulting solution was cooled to -400C and
potassium tert-butoxide (0.6M in THF, 3.2 mL, 1.902 mmoles) was added.
After warming to room temperature over 1 hour, the reaction was
quenched with pH = 7 buffer. The products were extracted with ethyl acetate
(3 X 10 mL) and the combined extracts were washed with brine and dried
over MgSO4. The solvent was removed and the residue was purified on
silica gel (60% ethyl acetate/hexane) to yield the desired product (266.7 mg,
87%) as a colorless oil.
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Physical Properties for 147
Rf = 0.31 (30% acetone/hexane).
1 H NMR (300 MHz, CDC13): S 7.19(d, J = 8.7 Hz, 2H), 6.86(d, I = 8.7 Hz, 2H),
4.87(1/2 ABq, JAB = 15.0 Hz, 1H), 4.73(d, I = 5.4 Hz, 1H), 4.51(d, J = 5.4 Hz, 1H),
4.05(1/2 ABq, JAB = 15.0Hz, 1 H), 3.80(s, 3H), 3.54(dd, I = 2.6 Hz, 1H), 3.38(d, J
= 2.6 Hz, 2H), 3.24(s, 3H), 1.43(s, 3H), 1.36(s, 3H).
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Lactam, 148
The p-methoxybenzyl lactam, 147, (141 mg, 0.439 mmole) was
dissolved in acetonitrile/water (3/1, 7 mL) and cooled to 0°C. Ceric
ammonium nitrate (CAN, 962 mg, 1.751 mmoles) was added over 30
minutes. The reaction was stirred for an additional 6 hours at 0°C, after
which water was added and the products were extracted with ethyl acetate (3
X 10 mL). The combined extracts were washed with brine and dried over
MgSO4. The solvent was removed and the residue purified on silica gel
(33% ethyl acetate/hexane) to give the desired product, 148, (66.3 mg, 75%)
and the imide, 148a, (34.6 mg, 24%) as colorless oils.
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Physical Properties for 148
Rf = 0.22 (9% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl 3): 8 7.43(s, 1H), 4.59(ABq, JAB = 5.8Hz, AVAB = 12.1
Hz, 2H), 3.79(dd, J = 3.6 Hz, 1H), 3.44(qd, J = 9.8,3.6 Hz, 2H), 3.35(s, 3H), 1.47(s,
3H), 1.37(s, 3H).
Physical Properties for 148a
Rf = 0.80 (9% ethyl acetate/hexane).
1H NMR (250 MHz, C6D6 ): 6 7.83(d, ] = 8.8 Hz, 2H), 6.60(d, J = 8.8 Hz, 2H),
4.76(d, I = 5.4 Hz, I1H), 4.66(dd, I = 2.1 Hz, 1H), 4.25(d, I = 5.4 Hz, 1H), 3.64(dd, J
= 9.8, 2.5 Hz, 1H), 3.11(s, 3H), 2.92(dd, J = 9.8, 1.9 Hz, 1H), 2.78(s, 3H), 1.44(s,
3H), 1.17(s, 3H).
IR (CHC13) cm- 1: 2980 (m), 2930 (s, br), 2838 (m), 1755 (s, br), 1670 (s, br), 1600
(s), 1575 (m), 1500 (w), 1455 (m), 1380 (m), 1375 (m), 1365 (m), 1350 (m), 1313
(s), 1280-1300 (s, br), 1240-1260 (s, br), 1167 (s), 1150 (m), 1078-1110 (m, br), 1025
(m), 1010 (m), 960 (w).
MeO
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tBOC-Lactam, 149
The lactam, 148, (64.8 mg, 0.322 mmole), triethylamine (45 mL, 0.322
mmole), and DMAP (40 mg, 0.322 mmole) were dissolved in CH2C12 (3 mL)
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at room temperature under argon. A solution of (tBOC)20 (164 mg, 0.741
mmole) in CH2 C12 (2 mL) was added and the reaction was stirred at room
temperature for 2 hours. The solvent was the removed and the residue was
purified by on silica gel (25% ethyl acetate/hexane) to give the product (96.3
mg, 99%) as an oil which solidified on standing.
Physical Properties for 149
Rf = 0.23 (25% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13 ): 8 4.68(d, J = 5.3 Hz, 1H), 4.52(d, J = 5.3 Hz, 1H),
4.27(s, 1H), 3.67(dd, J = 9.8, 2.4 Hz, 1H), 3.58(d, J = 9.8 Hz, 1H), 3.31(s, 3H),
1.59(s, 9H), 1.45(s, 3H), 1.37(s, 3H).
MeO-
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tBOC-Aminoamide, 150
A solution of heptylamine (33.5 mL, 0.226 mmole) in benzene (1 mL)
was cooled to 0°C under argon and trimethylaluminum (2.0OM in hexane,
0.113 mL, 0.226 mmole) was added. After stirring for 1 hour at room
temperature, this solution was added, via cannula, to a solution of the
tBOC-lactam, 149, (56.7 mg, 0.188 mmole) in benzene (1 mL) at 0°C. The
resulting mixture was stirred for 3 hours at room temperature, after which it
was cooled to 0°C and carefully quenched with saturated Rochelle's salt
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solution. After stirring for 30 minutes at room temperature, the products
were extracted with ethyl acetate (3 X 5 mL) and the combined extracts were
washed with brine and dried over MgSO4. The solvent was removed and
the residue was purified on silica gel (25% ethyl acetate/hexane) to give the
desired product (63.2 mg, 81%) as a colorless oil.
Physical Properties for 150
Rf = 0.38 (40% ethyl acetate/hexane).
1 H NM; (300 MHz, CDC13 ): 8 6.62(t, J = 5.1 Hz, 1H), 4.94(d, ] = 8.4 Hz, 1H),
4.53(dd, J = 11.3, 6.6 Hz, 1H), 4.49(d, J = 6.6 Hz, 1H), 4.00(m, 1H), 3.63(dd, J =
9.7, 5.1 Hz, 1H), 3.50(dd, = 9.7, 4.4 Hz, 1H), 3.35(s, 3H), 3.16-3.48(m, 2H),
1.53(s, 3H), 1.43(s, 9H), 1.37(s, 3H), 1.27-1.53(m, 10H), 0.88(t, I = 6.9 Hz, 3H).
1H NMR (300 MHz, C6 D6 ): 6.49(t, J = 5.1 Hz, 1H), 5.37(d, J = 8.7 Hz, 1H),
4.59(dd, J = 6.8 Hz, 1H), 4.51(d, J = 6.8 Hz, 1H), 4.46(m, 1H), 3.72(dd, J = 9.6, 5.5
Hz, 1H), 3.66(dd, J = 9.6, 4.6 Hz, 1H), 3.13-3.22(m, 2H), 3.12(s, 3H), 1.49(s, 9H),
1.34(s, 3H), 1.09(s, 3H), 1.09-1.35(m, 10H), 0.88(t, = 6.9 Hz, 3H).
1. TBSOTf
'NHC 7H 15 2. TBAF MeOMeO NHC7H,5
'i::UU- 
150 151
Aminoamide, 151
The tBOC-aminoamide, 150, (14.6 mg, 0.035 mmole) and 2,6-lutidine
(8.2 mL, 0.105 mmole) were dissolved in CH2Cl2 (1 mL) at room temperature
under argon. tBuMe2SiOTf (12.1 iL, 0.053 mmole) was added and the
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reaction was stirred for 15 minutes. The reaction was quenched with
saturated NH4CI solution (2 mL) and the products were extracted ether (3 X 2
mL). The combined extracts were washed with brine and dried over MgSO4.
The solvent was removed and the residue was dissolved in THF (1 mL).
Tetrabutylammonium fluoride (1M in THF, 39 gL, 0.039 mmole) was added
and the reaction was stirred for 30 minutes at room temperature under
argon. After quenching with saturated NH4CI solution (3 mL), the reaction
was washed with chloroform (3 X 3 mL) and the combined organic extracts
were washed with brine and dried over MgSO4. The solvent was removed
and the residue was purified on silica gel (ethyl acetate then 10%
methanol/chloroform) to give the product (10.1 mg, 91%) as a 5: 1 mixture
of aminoamide, 151, and lactam, 148, as determined by 300-MHz 1H NMR.
Physical Properties for 151
Rf = 0.13 (2% methanol chloroform).
1H NMR (300 MHz, C6D6 ): 6.53(m, 1H), 4.58(d, J = 7.2 Hz, 1H), 4.33(dd, J =
9.4, 7.2 Hz, 1H), 3.72(dd, J = 8.9, 2.8 Hz, 1H), 3.56(dd, J = 8.9, 7.0 Hz, 1H),
3.38(m, 1H), 3.23(m, 1H), 3.11(s, 3H), 3.01(m, 1H), 2.61(s, 2H), 1.37(s, 3H),
1.14(s, 3H), 1.11-1.25(m, 10H), 0.87(t, J = 7.0 Hz, 3H).
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Methyl Lactam, 155
MeNH2-HCI (140.8 mg, 2.163 mmoles) was suspended in benzene (2
mL) and cooled to 0°C under argon. Trimethylaluminum (2.0M in hexane,
1.04 mL, 2.163 mmoles) was added, dropwise, over a period of 10 minutes.
After stirring for 30 minutes at room temperature, the resulting solution
was added, via cannula, to a solution of lactone, 130, (208.2 mg, 1.030
mmole) in benzene (4 mL) at room temperature under argon. The resulting
mixture was stirred for 3 hours, after which it was cooled to 0°C and
carefully quenched with saturated Rochelle's salt solution. After stirring for
1 hour, the products were extracted with ethyl acetate (4 X 5 mL) and the
combined extracts were washed with brine and dried over MgSO4. The
solvent was removed to give the hydroxyamide, 154, (238.1 mg, 99% yield) as
a white solid which was immediately dissolved in CH2Cl2 (3 mL).
Triethylamine (0.430 mL, 3.090 mmoles) was added and the mixture was
cooled to 0°C under argon. Methanesulfonyl chloride (0.12 mL, 1.545
mmoles) was then added and the reaction was stirred at 0°C for 30 minutes.
The solvent was then removed and the residue was diluted with THF (22
mL) and filtered through Celite under argon. The resulting solution was
cooled to -400C and potassium tert-butoxide (1.41M in THF, 3 mL, 4.120
mmoles) was added. After warming to room temperature over 1 hour, the
reaction was quenched with pH = 7 buffer (30 mL). The products were
184
LIA I~~~~~~
extracted with ethyl acetate (3 X 15 mL) and the combined extracts were
washed with brine and dried over MgSO4. The solvent was removed and
the product was purified on silica gel (80% ethyl acetate/hexane) to give the
methyl lactam (184.3 mg, 84%) as a colorless oil.
Physical Properties for 154
Rf = 0.14 (ethyl acetate).
1H NMR (300 MHz, CDCl3): 6.82(s, 1H), 4.57(d, J = 7.8 Hz, 1H), 4.45(dd, J =
7.8, 2.6 Hz, H), 4.11(ddd, J = 6.7, 6.0, 2.6 Hz, 1H), 3.50(ABX, JAB = 9.7 Hz, JAX =
6.7 Hz, JBX = 5.8 Hz, AVAB = 14.8 Hz, 2H), 3.83(s, 3H), 2.85(d, I = 4.7 Hz, 3H),
2.33(d, I = 6.9 Hz, 1H), 1.58(s, 3H), 1.39(s, 3H).
Physical Properties for 155
Rf = 0.32 (ethyl acetate).
1H NMR (300 MHz, CDCl3 ): 4.63(d, I = 5.8 Hz, 1H), 4.53(d, I = 5.8 Hz, 1H),
3.61(t, J = 2.7 Hz, 1H), 3.52(ABX, JAB = 10 Hz, JAX = 3.2 Hz, JBX = 2.7 Hz, AVAB
= 15 Hz, 2H), 3.33(s, 3H), 2.87(s, 3H), 1.42(s, 3H), 1.37(s, 3H).
13C NMR (300 MHz, CDCl 3): 8 171.48, 111.60, 77.31, 76.10, 69.42, 63.52, 59.17,
27.78, 26.87, 25.54.
EI Mass Spec: m/e 200 [M - 15] +, 170, 142, 85, 69, 45.
Exact Mass: [M - CH3]+ = 200.09228 (calculated)
[M - CH3] + = 200.0921 (measured).
IR (CHCl 3) cm- 1: 2995, 2937, 1700, 1450, 1400, 1375, 1120, 1070.
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Dibenzyl Lactam, 157
The methyl lactam, 155, (74.8 mg, 0.348 mmole) was dissolved in THF
(2 mL) and concentrated HCI (1.5 mL) was added. The reaction was stirred at
room temperature for 2 hours, after which it was concentrated to dryness.
The residue was azeotropically dried with benzene (3 X 5 mL) and kept
under vacuum for 24 hours. The residue was then dissolved in DMF (1 mL)
and Ag20 (367 mg, 5 equiv by wt) was added. Benzyl bromide (0.29 mL, 2.436
mmoles) was added to the resulting suspension and the reaction was stirred
at room temperature under argon for 20 hours. The reaction was then
filtered through Celite and the solids were washed with CHCl3. The
combined organics were diluted with ether/hexane (4/1, 5 mL) and
saturated NH4 Cl solution (5 mL) was added. The products were extracted
with ether/hexane (4/1, 3 X 5 mL) and the combined organics were washed
with brine and dried over MgSO4. The solvent was removed and the
residue was purified on silica gel (80% ethyl acetate/hexane) to give the
desired product (102.8 mg, 83%) as an oil.
Physical Properties for 157
Rf = 0.40 (ethyl acetate).
1H NMR (300 MHz, CDC13): 7.44(d, J = 6.8 Hz, 2H), 7.30(d, J = 7.1Hz, 2H),
7.06-7.19(m, 6H), 5.04(ABq, JAB = 11.9 Hz, AVAB = 85.2 Hz, 2H), 4.48(ABq, JAB
186
= 11.7 Hz, AVAB = 79.8 Hz, 2H), 4.07(d, I = 5.5 Hz, 1H), 3.80(dd, J = 5.5, 3.6 Hz, I1
H), 3.37(q, J = 3.6 Hz, 1H), 2.86(d, J = 3.6 Hz, 2H), 2.82(s, 3H), 2.57(s, 3H).
1H NMR (300 MHz, C6 D6 ): 8 7.40-7.44(m, 2H), 7.27-7.36(m, 8H), 4.89(ABq, JAB
= 11.9 Hz, AVAB = 55.3 Hz, 2H), 4.60(ABq, JAB = 11.9 Hz, AVAB = 48.7 Hz, 2H),
4.11(d, J = 5.8 Hz, 1H), 3.97(dd, = 5.8, 2.9 Hz, 1H), 3.59(q, I = 3.1 Hz, 1H),
3.48(dd, J = 10.3, 3.3 Hz, 1H), 3.29(dd, ] = 10.3, 2.8 Hz, 1H), 3.27(s, 3H), 2.86(s,
3H).
13C NMR (300 MHz, CDC13): 171.17, 137.86, 137.71, 128.25, 128.16, 127.97,
127.82, 127.70, 127.53, 74.97, 74.51, 72.26, 72.03, 69.71, 63.33, 59.01, 27.56.
FAB Mass Spec: m/e 356 [M + 1]+, 326, 278, 264, 248, 181.
Exact Mass: [M + 1]+ = 356.18618 (calculated)
[M + 1]+ = 356.1864 (measured).
IR (neat) cm-l: 3060, 3025, 2900, 1700, 1450, 1400, 1350, 1260, 1190, 1100, 1155,
730, 690.
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Bis-TBS Lactam, 158
The methyl lactam, 155, (447.1 mg, 2.077 mmole) was dissolved in
THF (5 mL) and concentrated HCl (5 mL) was added. The reaction was
stirred at room temperature for 3 hours, after which the solvent was
removed and the residue was azeotropically dried with benzene (5 X 5 mL)
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and kept under vacuum for 24 hours. The residue was dissolved in CH 2C12
(7 mL) and imidazole (710 mg, 10.385 mmoles) was added followed by tert-
butyldimethylchlorosilane (940 mg, 6.231 mmoles). After 24 hours, the
mixture was quenched with pH = 7 buffer (10 mL). The products were
extracted with ethyl acetate (3 X 10 mL) and the combined extracts were
washed with brine and dried over MgSO4. The solvent was removed and
the product purified on silica gel (15% ethyl acetate/hexane) to give the
product (797.7 mg, 95% yield) an oil.
Physical Properties for 158
Rf = 0.40 (33% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl3): 4.23(d, J = 5.1 Hz, 1H), 4.14(dd, J = 5.1, 1.9 Hz,
1H), 3.47(d, J = 1.1 Hz, 1H), 3.46(s, 1H), 3.35(m, 1H), 3.34(s, 3H), 2.84(s, 3H),
0.93(s, 9H), 0.88(s, 9H), 0.18(s, 3H), 0.14(s, 3H), 0.091(s, 3H), 0.086(s, 3H).
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CBZ-Aminoester, 159
The dibenzyl lactam, 157, (38.9 mg, 0.199 mmole) was dissolved in
CH2C12 (1 mL) and 2,6-di-tert-butylpyridine (49 gL, 0.398 mmole) was added
followed by Et3OBF4 (1M in CH2C12, 0.40 mL, 0.398 mmole). The reaction
was stirred at room temperature under argon for 6 hours, after which the
solvent was removed and the residue was dissolved in ether (1.5 mL). CBZ-
C1 (46 4L, 0.597 mmole) was added followed by saturated NaHCO 3 solution
188
(1.5 mL). The mixture was stirred for 1 hour, after which ethyl acetate (5
mL) and brine (5 mL) were added. The products were extracted with ethyl
acetate (3 X 5 mL) and the combined organics were washed with brine and
dried over MgSO4. The solvent was removed and the residue was purified
on silica gel (15% ethyl acetate/hexane) to give the desired product (43.8 mg,
75%) and the starting lactam (9.9 mg, 25%) as oils.
Physical Properties for 159
Rf = 0.62 (40% ethyl acetate/hexane).
1 H NMR (250 MHz, CDC13 ): 8 7.27-7.37 (m, 15H), 5.09 (s, 2H), (4.01, 4.28,
isomers, m, 4H), (4.33, 4.79, isomers, m, 5H), (3.50, 3.82, isomers, m, 2H),
(3.21, 3.27, isomers, s, s, 3H), (2.82, 2.85, isomers, s, s, 3H), (1.18, 1.24, isomers,
t, t, = 7.1 Hz, J = 7.2 Hz, 3H),.
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tBOC-Aminoester, 160
The dibenzyl lactam, 157, (37.7 mg, 0.106 mmole) and 2,6-di-tert-
butylpyridine (48 L, 0.212 mmole) were dissolved in CH2Cl2 (1 mL) and
Et3OBF4 (1M in CH2C12, 0.21 mL, 0.212 mmole) was added. The mixture was
stirred at room temperature under argon for 24 hours. The solvent was
removed, and the residue was dissolved in ether (2 mL). (tBOC)20 (47.1 mg,
0.212 mmole) was added followed by saturated NaHCO3 solution (1 mL).
The mixture was stirred for 1.5 hours, after which ethyl acetate (5 mL) and
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brine (5 mL) were added. The products were extracted with ethyl acetate (3 X
5 mL) and the combined extracts were washed with brine and dried over
MgSO4. The solvent was removed and the residue was purified on silica gel
(15% ethyl acetate/hexane) to give the product, 160, (38.5 mg, 72%) and the
lactam, 157, (7.3 mg, 19%) as oils.
Physical Properties for 160
Rf = 0.64 (50% ethyl acetate/hexane).
1 H NMR (250 MHz, CDCl 3 ): 8 7.27-7.39 (comp m, 10H), (4.71, 4.81, isomers,
m, 2H), (4.40, 4.52, isomers, m, 2H), (4.01, 4.25, isomers, m, 5H), (3.56, 3.84,
isomers, m, 2H), 3.28 (s, 3H), 2.77 (s, 3H), (1.40, 1.43, isomers, s, s, 9H), (1.23,
1.31, isomers, m, 3H).
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Dimethylaminoester, 161
The dibenzyl lactam, 157, (30 mg, 0.084 mmole) and 2,6-di-tert-
butylpyridine (38 tL, 0.168 mmole) were dissolved in CH2C12 (1 mL), and
Et3OBF4 (1M in CH2C12, 0.17 mL, 0.168 mmole) was added. The reaction was
stirred at room temperature under argon for 16 hours, after which the
solvent was removed. Aqueous formaldehyde (37%, 28 JIL, 0.336 mmole)
was added followed by saturated NaHCO3 solution (0.8 mL) and methanol (1
mL).
ZnCl2 (37 mg, 0.252 mmole) was dissolved in MeOH (1 mL) added, via
190
cannula, to a solution of NaCNBH3 (33.6 mg, 0.504 mmole) in MeOH (1 mL).
The mixture was stirred at room temperature under argon for 5 minutes,
after which it was added, via cannula, to the above reaction. The resulting
mixture was stirred for 4 hours and quenched with 0.IN KOH (1 mL). The
products were extracted with ethyl acetate (3 X 5 mL) and the combined
extracts were washed with brine and dried over MgSO4. The solvent was
removed and the product was purified on silica gel (25% ethyl
acetate/hexane) to give the dimethylaminoester, 161, (27.6 mg, 79%) and the
dibenzyl lactam, 157, (3.4 mg, 11%) as oils.
Physical Properties for 161
Rf = 0.38 (33% ethyl acetate/hexane).
1H NMR (250 MHz, C6 D6): 7.41(d, = 6.6 Hz, 2H), 7.33(d, I = 7.1 Hz, 2H),
7.06-7.21(m, 6H), 4.91(1/2 ABq, JAB = 12.1 Hz, 1H), 4.73(1/2 ABq, JAB = 11.4
Hz, 1H), 4.56(d, I = 1.7 Hz, 1 H), 4.46(1/2 ABq, JAB = 12.1 Hz, 1H), 4.42(1/2
ABq, JAB = 11.4 Hz, 1H), 4.11(dd, J = 10.1, 1.7 Hz, 1H), 4.05(q, J = 7.1 Hz, 2H),
3.67(dd, J = 9.8, 2.4 Hz, 1H), 3.54(dd, I = 9.8, 7.1 Hz, 1H), 3.41(ddd, I = 9.8, 7.1, 2.4
Hz, 1H), 3.05(s, 3H), 2.36(s, 6H), 1.02(t, J = 7.1 Hz, 3H).
13C NMR (300 MHz, CDC13): 8 170.04, 139.32, 138.98, 128.45, 128.38, 128.07,
128.03, 127.54, 80.72, 78.94, 73.03, 73.00, 69.78, 62.31, 60.16, 58.38, 42.15, 14.36.
FAB Mass Spec: m/e 416 [M + 1]+, 370, 308, 102.
Exact Mass: [M + 1]+ = 416.24370 (calculated)
[M + 1]+ = 416.2440 (measured).
IR (neat) cm-1: 3090, 3065, 3035, 2980, 2935, 2875, 2835, 1750, 1745, 1498, 1455,
1390, 1368, 1346, 1280, 1190, 1110, 1025, 760, 690.
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Dimethylaminoester, 162
The bis-TBS lactam, 158, (73.7 mg, 0.183 mmole) and 2,6-di-tert-
butylpyridine (0.125 mL, 0.549 mmole) were dissolved in CH2C12 (2 mL), and
Et30BF4 (1M in CH2C12, 0.55 mL, 0.549 mmole) was added. The mixture was
stirred at room temperature under argon for 24 hours, after which the
solvent was removed. Aqueous formaldehyde (37%, 60 piL, 0.732 mmole)
was added followed by saturated NaHCO3 solution (1 mL), and methanol (1
mL).
ZnC12 (81.8 mg, 0.549 mmole) was dissolved in MeOH (1 mL) and
added via cannula to a solution of NaCNBH3 (77.4 mg, 1.098 mmoles) in
MeOH (.5 mL). The mixture was stirred at room temperature under argon
for 5 minutes, after which the mixture was added, via cannula, to the above
reaction. The resulting mixture was stirred for 4 hours and quenched with
0.1N KOH (5 mL). The products were extracted with ethyl acetate (3 X 5 mL)
and the combined extracts were washed with brine and dried over MgSO4.
The solvent was removed and the product was purified on silica gel (2%
ethyl acetate/hexane) to give the dimethylaminoester, 162, (58.1 mg, 69%)
and the bis-TBS lactam, 158, (18.6 mg, 25%) as oils.
Physical Properties for 162
Rf = 0.73 (20% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13): 4.30(d, J = 1.5 Hz, 1H), 4.07(q, J = 7.3 Hz, 2H),
4.02(dd, J = 10.1, 1.5 Hz, 1H), 3.53(m, 2H), 3.29(s, 3H), 3.11(ddd, J = 10.1, 8.2, 4.0
192
Hz, 1H), 2.24(s, 6H), 1.27(t, J = 7.3 Hz, 3H), 0.94(s, 9H), 0.89(s, 9H), 0.11(s, 3H),
0.10(s, 3H), 0.07(s, 3H), 0.06(s, 3H).
1H NMR (300 MHz, C6 D6 ): 8 4.66(d, I = 1.5 Hz, 1H), 4.32(dd, I = 10.1, 1.5 Hz,
1H), 4.00(m, 2H), 3.58(d, J = 5.1 Hz, 2H), 3.36(m, 1H), 3.09(s, 3H),'2.39(s, 6H),
1.08(s, 18H), 1.02(t, J = 3.4 Hz, 3H), 0.25(s, 6H), 0.15(s, 3H), 0.13(s, 3H).
13C NMR (300 MHz, CDC13): 8 171.2, 77.2, 75.6, 74.6, 70.7, 61.4, 60.0, 58.4, 41.8,
26.0, 25.8, 18.4,18.0, 14.2, -3.9, -4.8, -5.0, -5.3.
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3.6 NMR Spectra
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Chapter 4:
The Absolute Stereochemistry of
Calyculin A and the
Synthesis of Fragment C
227
4.1 Introduction
Figure 4.1
HO
ie
Up to this point, our preparation of fragment C of calyculin A was
proceeding as expected. We had worked out strategies for the preparation of
fragments C1 and C2, and were beginning to study the final coupling to
fragment C. Unfortunately, while this work was in progress, two
independent publications 8, 13 6 appeared which demonstrated that natural
calyculin A, 163, bears the absolute stereochemistry shown in Figure 4.1.
This structure is enantiomeric to that drawn in the original report, although
the authors indicated that the absolute configuration was not determined. 4
Figure 4.2
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The relative stereochemistry had been determined utilizing NMR
and x-ray crystallographic techniques, 4 and we had no reason to approach
the synthesis of calyculin A with stereochemistry other than that depicted in
Fusetani's original publications. However, in late 1991 Fusetani and
coworkers reported the degradation of a mixture of calyculins followed by
the subsequent isolation of the C33-C37 fragment, 164 (Figure 4.2).136 This
fragment produced a positive Cotton effect at 207 nm in the CD spectrum
indicating the S configuration at C34.136 At the same time, Hamada and
coworkers reported the synthesis of the C33-C37 fragment of calyculin
bearing the (34R, 35R, 36R) configuration, 165 (Figure 4.2), and demonstrated
that its optical rotation was opposite to that of the same fragment isolated
from the degradation of natural calyculin.1 8 Both of these results
conclusively demonstrated that the absolute stereochemistry of the
calyculins was opposite to that depicted in previous publications.
In light of these results and in spite of the fact that we were close to
completing the synthesis of the enantiomer of calyculin A, we chose to go
back and prepare the fragments with the correct stereochemistry. In fact, all
of the methodology we had developed could be applied to the synthesis of
natural calyculin with the exception of one point in the preparation of
fragment C2. Although D-gulononlactone, 131, was a convenient starting
material for the enantiomer, L-gulonolactone was not commercially
available in any affordable quantities. This chapter will discuss the synthesis
of fragments C1 and C2 en route to the preparation of natural calyculin A.
4.2 The Lactone, 167
When considering that lactone, 130, derived from D-gulonolactone,
131, is a derivative of L-lyxonolactone, we might consider arriving at the
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lactone, 167, from D-lyxose, 166 (Scheme 4.1). Unfortunately, the cost of D-
lyxose, 166, precludes consideration of this strategy. Fortunately, it has been
well documented that aldoses can be oxidatively degraded by one carbon
unit to aldonic acid salts. On acidification, these salts can be converted to
lactones. 13 7,13 8 Thus, D-galactose, 168, was oxidized to potassium-D-
lyxonate, 169, on warming in aqueous KOH saturated with 02. Heating to
reflux a suspension of potassium-D-lyxonate, 169, in isopropanol saturated
with HCI gave D-lyxonolactone, 170 (65% yield, two steps, Scheme 4.2).138
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At this stage, completion of the preparation of lactone 167 centered
around the selective formation of the 2,3-acetonide, 171, followed by
methylation of the primary alcohol. It has been reported that D-
lyxonolactone, 170, can be converted to a 3: 1 mixture of the 2,3-acetonide,
171, and the 3,5-acetonide, 172, on treatment with acetone in the presence of
anhydrous copper sulfate (Scheme 4.3).139,140 We felt, however, that it was
more efficient to initially protect the primary alcohol, form the acetonide,
and then deprotect the primary alcohol (Scheme 4.4). The main advantage
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to this three step procedure was the elimination of a need to separate the 2,3-
acetonide, 171, from its 3,5-isomer, 172.
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In our development of the three step sequence shown in Scheme 4.4,
we found that we could selectively protect the primary alcohol as its tert-
butyldimethylsilyl ether, 175, in 95% yield (Scheme 4.5). Unfortunately,
when we attempted to form the acetonide, 176, utilizing 2,2-
dimethoxypropane and catalytic camphorsulfonic acid, we observed
formation of the desired acetonide, 176, in only 29% yield, accompanied by
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177 (30% yield) and 178 (6.5% yield). These products presumably arose from
initial scrambling of the silyl group.
Scheme 4.7
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Although our initial results were discouraging, we chose to examine
this strategy with a variety of protecting groups. When attempting this
strategy with the trityl ether, 179, we found that our conditions for acetonide
formation cleanly cleaved the trityl group (Scheme 4.6). However, as shown
in Scheme 4.7, when we converted D-lyxonolactone, 170, to the tert-
butyldiphenylsilyl ether, 180 (99% yield), we found that formation of the
acetonide, 181, could be accomplished in 96% yield as described above.
Removal of the silyl group on treatment with HF/pyridine/THF 141
produced the alcohol, 171, in 81% yield. Finally, conversion of the alcohol,
171, to the methyl ether, 167, was achieved in 83% yield using methyl iodide
and silver oxide.12 2 With this material in hand, we could proceed with the
preparation of the desired enantiomers of fragments C1 and C2.
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4.3 Fragments C and C2
With the lactone, 167, in hand, we could now proceed to the
preparation of fragments C1, 190, and C2, 194. The final syntheses of these
fragments will be discussed in this section.
4.3.1 Fragment C1, 190
Using the same methodology as described in Chapter 2, with the
exception of the opposite Sharpless epoxidation, fragment C1 was prepared
as summarized below (Scheme 4.8).
The alcohol, 70, was converted to the epoxide, 182, in 88% yield
utilizing the Sharpless asymmetric epoxidation.77 The epoxide, 182, was
then converted to the diol, 183, on treatment with trimethylaluminum
(91% yield),7 8, 79 and the diol was converted to the acid, 184, by sequential
treatment with NaIO4 and KMnO479 ,80 (95% yield, 2 steps). The amide, 185,
was then formed by converting the acid, 184, to the acid chloride with oxalyl
chloride followed by condensation with ammonia (100% yield, 2 steps).
The oxazole, 186, was prepared by condensing the amide, 185, with
ethyl bromopyruvate followed by dehydration with trifluoroacetic
anhydride. The alcohol, 187, was then formed on reduction of the ester with
LAH (96% yield), and subsequently converted to its MPM ether, 188, on
treatment with MPM-Br and KH (95% yield).
Final elaboration of the oxazole, 188, to fragment C1, 190, was
accomplished by initial cleavage of the silyl ether with
tetrabutylammonium fluoride (100% yield). The alcohol, 189, was then
converted to the azide, 190, on treatment with methane sulfonylchloride
followed by sodium azide (98% yield, 2 steps) to complete the synthesis of
fragment C1.
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4.3.2 Fragment C2, 194
Using the same methodology as in Chapter 3, fragment C2 was
prepared from the lactone, 167, as summarized below (Scheme 4.9).
The lactone, 167, was opened to the hydroxyamide, 191, (99% yield)
utilizing chemistry developed in the Weinreb group. 129 Cyclization of the
235
hydroxyamide, 191, to the lactam, 192, was accomplished in 84% on initial
conversion to the mesylate followed by treatment with base.
Scheme 4.9
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At this stage, the acetonide, 192, was hydrolyzed under acidic
conditions, and the resulting diol was reprotected as the corresponding
dibenzyl ether, 193. Completion of fragment C2, 194, was accomplished by
converting the lactam, 193, to its imidate on treatment with the Meerwein
reagent. 134 Basic hydrolysis of this imidate in the presence of formaldehyde
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then trapped the resulting amino ester as its iminium salt. This iminium
salt was then reduced to the amine, 194, utilizing the zinc chloride
modification of the NaCNBH3 reduction. 1 35 With these results, we had
completed the synthesis of fragment C2 and were now ready to complete
fragment C.
4.4 Fragment C
Scheme 4.10
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When considering the coupling of fragment C1 and C2, we chose to
utilize the corresponding enantiomers as models for the natural system.
Our approach was to involve the exploration of two strategies. The first of
these was the direct coupling of the amine, 66, with either the dibenzyl
amino ester, 161, or the bis-tert-butyldimethylsilyl amino ester, 162, to form
the appropriate amide, 195 or 196 (Scheme 4.10). The second strategy
involved the hydrolysis of either the dibenzyl amino ester, 161, or the bis-
tert-butyldimethylsilyl amino ester, 162, followed by use of DCC methodolgy
in the coupling of either amino acid 197 or 198 with the amine, 66, to form
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the respective amides, 195 or 196 (Scheme 4.11). This section will discuss
these strategies and the problems we encountered in their exploration.
Scheme 4.11
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4.4.1 Direct Coupling
We began our study of the direct coupling of fragments C1 and C2
with the bis-tert-butyldimethylsilyl protected amino ester, 162. With p-
methoxy benzylamine as a model for 66, we found that the best yield we
could obtain in the formation of the amide, 199 (Scheme 4.12), was 10%
even after heating the reaction to reflux for two days. However, we found
that if we first removed the terf-butyldimethylsilyl groups to form the diol,
200, we could increase the yield of the amide, 201, to 55% over the same two
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day period. With these disappointing results, we decided to explore the
possibility of first hydrolyzing the amino ester to the amino acid and then
utilizing DCC methodology in the coupling of fragments C1 and C2.
Scheme 4.12
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4.4.2 DCC Methodology
Our approach using DCC methodology involved initial hydrolysis of
the amino ester to an amino acid, and then effecting the coupling of the two
fragments. In this study, we began with the bis-tert-butyldimethylsilyl
amino ester, 162. Unfortunately, as shown in Scheme 4.13 and Table 4.1, the
hydrolysis of amino ester 162 to amino acid 198 was not as straightforward as
we had anticipated, and the best isolated yield remained at 55%. These
results are not meant to imply that the hydrolysis would not proceed beyond
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50%. The hydrolysis did, in fact, go to completion. The problem arose on
isolation of the amino acid when one of the two protecting groups was
cleaved. This led us to believe that the silyl protected amino ester was
unsuitable and we should explore the dibenzyl protected derivative, 161.
Scheme 4.13
TBSO 0 TBSO 0
MeO A OREt .Hydrolysis MeO OH
Me2 N OTBS Me2 N OTBS
162 198
Table 4.1
Hydrolysis of bis-TBS Protected Amino Ester
Hydrolysis Conditions Yield
2 equiv. LiOH
THF/MeOH/H20 2/2/1 50%
.2 days, 40-50 0C
8 equiv. tBuOK
2 equiv. H20 55%
Et20, 16 hours, RT
2 equiv. LiOH
THF/H 20 3/1 Very Slow
2 equiv. LiOH
tBuOH/H 20 Very Slow
As shown in Scheme 4.14, hydrolysis of the amino ester, 161,
provided the corresponding amino acid, 197, in 97% yield and requiring no
further purification. Furthermore, employing benzylamine as a model for
fragment C1, we were able to effect coupling with 197 to give the amide, 202,
in >90% yield on treatment with DCC/DMAP. Applying these conditions to
fragments C1 and C2, we obtained a 69% yield of fragment C, 195 (Scheme
4.15) thus completing my contribution to the synthesis of calyculin A.
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Scheme 4.15
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With the strategy to fragment C developed, the final preparation of
the natural enantiomer is being completed by Dr. Lian-Yong Chen. In this
capacity, and with knowledge of the instability of the amine, 66, conversion
of the azide, 190, to the amine, 204, followed by an in situ coupling with the
amino acid, 203, is being pursued.
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Scheme 4.16
BnO O BnO O
MeO OEt LOH MeO OH
Me 2N OBn Me2 N OBn194 203
Scheme 4.17
190 CH2OMPM
PPhWH2 0
r ..- 0 1
"2N -T% tJZN~
204 CH2OMPM
DCC/HOBT
IPM
As shown in Scheme 4.16, the ester, 194, was hydrolyzed to the acid,
203, on treatment with aqueous lithium hydroxide (97% yield). At this
stage, the acid is to be treated with the crude amine, 204, in the presence of
DCC and HOBT142,143,144 to give the natural enantiomer of fragment C of
calyculin A, 205, in its final form. With the positive results we had obtained
for the unnatural enantiomer of fragment C, no problems are anticipated
with this strategy and those remaining on the project should soon be able to
complete the syntheis of this intriguing natural product.
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4.5 Experimental Section
H(
OH KOH
02
OH
C2K+I 
HO H
HO H
LIro
1~1 "Ji"
CH 2OH_
HCI 
-OH
HO OH
168 169 170
D-Lyxonolactone, 170
KOH (28.0g, 0.499 mole) was dissolved in MeOH (250 mL) and H20 (60
mL) and warmed to 350C. 02 was bubbled into the solution through 2
stainless steel HPLC solvent filters and a solution of D-galactose (30.0g, 0.167
mole) in H20 (60 mL) was added over 9 hours with mechanical stirring. 02
was bubbled into the mixture for an additional 2 hours, after which air was
bubbled in through the same apparatus for 2 days. The resulting mixture
was then poured into MeOH (500 mL) and the suspension was stirred at
room temperature for 1 day. The solids were filtered off and suspended in
isopropanol (150 mL). HCl was bubbled into the suspension for 40 minutes,
after which the reaction was heated to reflux. The resulting solution was
immediately filtered, cooled, and concentrated to dryness. Recrystallization
of the residue from isopropanol provided D-lyxonolactone (16.0 g, 65%) as a
white crystalline solid.
Physical Properties for 170
1H NMR (300 MHz, D 2 0): 4.59(d, J = 4.73 Hz, 1H), 4.47(ddd, J = 4.41, 4.56,
9.46 Hz, 1H), 4.42(dd, = 2.93, 4.89 Hz, 1H), 3.79(dd, J = 4.56, 12.55 Hz, 1H),
3.74(dd, J = 7.01,12.55 Hz, 1H).
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_- . .
'BuPh2SiSitBuPh
HO OH
170 180
Silyl ether, 180
D-Lyxonolactone, 170, (2.001 g, 13.523 mmoles) and imidazole (1.933 g,
28.398 mmoles) were dissolved in DMF (20 mL) and tBuPh2 SiCl (3.69 mL,
14.20 mmoles) was added. The reaction was stirred at room temperature
under argon for 15 hours, after which it was poured onto H20 (100 mL). The
resulting mixture was washed with CH2C12 (4 X 20 mL) and the combined
extracts were dried over MgSO4. Concentration of the resulting solution
provided the pure silyl ether (5.168 g, 99%) as a colorless solid.
Physical Properties for 180
Rf = 0.26 (50% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13): 7.65(m, 4H), 7.42(m, 6H), 4.52(m, 1H), 4.41(m,
2H), 4.06(d, I = 5.22 Hz, 2H), 3.22(broad s, 1H), 3.00(broad s, 1H), 1.04(s, 9H).
O Me2 C(OMe)2
""'
_/2tD 4E~'IE1, '"iv;>lj.uri2 0 0I
Ph2
HO OH
180 181
Acetonide, 181
The silyl ether, 180, (0.112 g, 0.289 mmole) was dissolved in CH2C12 (1
mL) and camphorsulfonic acid (6.7 mg, 0.029 mmole) was added followed by
2,2-dimethoxypropane (0.356 mL, 2.891 mmoles). The reaction was stirred at
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room temperature under argon for 2.5 hours, after which it was washed
with saturated NaHCO3 solution (1 mL). The aqueous layer was washed
with CH2 C12 (1 mL) and the combined organics were dried over MgSO4 and
concentrated to dryness. Purification of the residue on silica gel (15% ethyl
acetate/hexane) gave the acetonide (0.118 g, 96%) as a colorless viscous oil.
Physical Properties for 181
Rf = 0.46 (25% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13 ): 8 7.67(m, 4H), 7.39(m, 6H), 4.77(d, J = 5.38 Hz,
1H), 4.75(d, J = 5.21 Hz, 1H), 4.55(dt, J = 3.10, 6.52 Hz, 1H), 3.98(s, 1H), 3.95(d, J
= 0.98, 1H), 1.35(s, 6H), 1.03(s, 9H).
O 0
OSitBuPh2 HF_ -OH
X X
181 171
Alcohol, 171
The acetonide, 181, (0.836 g, 1.962 mmole) was dissolved in THF (8.40
mL) and a solution of (HF/py)/py/THF (1/2.9/10, 8.40 mL) was added. The
reaction was stirred at room temperature under argon for 2 hours, after
which it was filtered through silica gel (ethyl acetate). The resulting
solution was concentrated to dryness and the residue was washed with
hexane. The resulting solids were dried under vacuum to provide the pure
alcohol (0.299 g, 81%) as a colorless solid.
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Physical Properties for 171
Rf = 0.63 (ethyl acetate).
[aiD = +90 c = 1.0 (acetone).
m. p. = 97-980C.
1H NMR (250 MHz, CDC13): 4.88(m, 2H), 4.59(m, 1H), 4.00(m, 2H), 2.00(dd,
1H), 1.49(s, 3H), 1.40(s, 3H).
13C NMR (300 MHz, CDC13): 68 173.44, 114.54, 79.18, 76.22, 76.15, 60.90, 26.67,
25.76.
EI Mass Spec: m/e 173 [M - 15]+, 149, 129, 83, 59, 43.
Exact Mass: [M - CH3]+ = 173.0450 (calculated)
[M - CH3]+ = 173.0452 (measured).
IR (CHCl3 ) cm-1 : 3600, 1795, 1375, 1175, 1110.
O
Mel, Ag2 0
X X
171 167
Methyl Ether, 167
The alcohol, 171, (0.010 g, 0.531 mmole) was dissolved in methyl
iodide (2 mL) and Ag2O (0.399 g) was added followed by anhydrous CaSO4
(0.147 g). The resulting suspension was stirred at room temperature under
argon for 7.5 hours, after which it was filtered through Celite and
concentrated to dryness. The residue was purified on on recrystallization
from hexane to give the desired product (0.089 g, 83%).
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Physical Properties for 167
Rf = 0.47 (50% ethyl acetate/hexane).
[a]D = +80 c = 0.5 (acetone).
m. p. = 83-85°C.
1H NMR (300 MHz, CDC13 ): 4.84(s, 2H), 4.63(m, 1H), 3.77(m, 2H), 3.46(s,
3H), 1.49(s, 3H), 1.41(s, 3H).
13C NMR (300 MHz, CDC13): 8 173.34, 114.30, 77.98, 76.02, 75.95, 70.16, 59.45,
26.73, 25.89.
El Mass Spec: m/e 187 [M - 15]+, 143, 85, 71, 45.
Exact Mass: [M - CH3]+ = 187.06065 (calculated)
[M - CH3]+ = 187.0607 (measured).
IR (CDC1 3) cm-1 : 1795, 1455, 1375, 1085, 870.
CH ~o~H (-)-DET, . .
tBuPhSiO H20 H TBHP, tBuPh2S iOCHH
7 0 Ti(O'Pr)4 182
Epoxide, 182
4A molecular sieves (22 g) was suspended in CH2C12 (190 mL) and
cooled to -300 C under argon. (-)-DET (0.651 mL, 3.805 mmoles), and
Ti(OiPr)4 (0.944 mL, 3.171 mmoles) were added and the mixture was stirred
for 5 minutes. TBHP (6.4M solution, 9.91 mL, 63.42 mmoles) was added
dropwise and the resulting mixture was stirred at -300C for 30 minutes. A
solution of the allylic alcohol, 70, (11.29 g, 31.71 mmole) in CH2C12 (50 mL)
was added dropwise and the resulting mixture was stirred at -30°C for 20
hours, after which it was warmed to 0°C. Water (20 mL) was then added
followed by a 30% aqueous solution of NaOH-NaCl (3.8 mL). The resulting
suspension was stirred at room temperature for 1 hour and the organic layer
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was separated. The aqueous layer was extracted three times with CH2C12 ,
and the combined extracts were washed with brine and dried over MgSO4.
The solvent was removed and the residue was purified on silica gel (15%
ethyl acetate/hexane) to furnish the epoxide (9.93g, 88%) as a colorless oil.
Physical Properties for 182
Rf = 0.30 (33% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 7.62-7.69 (m, 4H), 7.34-7.45(m, 6H), 3.90(ddd, J
= 12.4, 5.4, 2.4 Hz, IH), 3.80 (m, 2 H), 3.60(ddd, J = 12.4, 6.9, 4.3 Hz, 1H), 3.13(td,
J = 5.8, 2.5 Hz, 1H), 2.97(ddd, J = 4.4, 2.5, 2.5 Hz, 1H), 1.92(dd, J = 6.8, 6.3 Hz,
1H), 1.81(dd,J = 11.8, 6.2 Hz, 2H), 1.04(s, 9H).
13C NMR (300 MHz, CDC13): 8135.56, 133.61, 129.72, 127.73, 61.69, 60.78, 58.61,
53.73, 34.82, 26.86, 19.19.
FAB Mass Spec: m/e 357 [M + 1]+, 269, 199, 135.
Exact Mass: [M + 1]+ = 357.188599 (calculated)
[M + 1]+ = 357.1887 (measured).
IR (CHCl 3 ) cm-l: 3680 (w), 3600 (m), 3010 (s), 2960 (s), 2917 (s), 2860 (s), 2397
(m), 2325 (m), 2315 (m), 1715-1750 (w, br), 1690 (w), 1605 (w), 1595 (w), 1514 (s),
1505 (s), 1480 (m), 1425 (s), 1380-1390 (m, br), 1180-1240 (s, br), 1075-1120 (s, br),
995 (m), 970 (s), 920 (s) .
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Diol, 183
A solution of the epoxide, 182, (9.81 g, 27.51 mmol) in pentane (200
mL) was cooled to 0°C and trimethylaluminum (2.0M in hexane, 41.3 mL,
82.53 mmoles) was added dropwise over 15 minutes. After 2 hours at 0°C,
the reaction was carefully quenched with 10% HCl. The resulting mixture
was stirred at room temperature for 15 minutes. The products were
extracted three times with ethyl acetate and the combined extracts were
washed with saturated NaHCO3 solution and brine. After drying over
MgSO4, the solvent was removed and the product was purified on silica gel
(20% ethyl acetate/hexane) to give the diol, 183, (9.30g 91%) as a colorless oil.
The products comprised a diastereomeric mixture of 40: 1, as determined by
300-MHz 1H NMR of the corresponding bis-MTPA ster and a > 40: 1
mixture of 1,2 and 1,3 diols, as determined by GLC analysis.
Physical Properties for 183
Rf = 0.20 (40% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl3 ): 6 7.68-7.71(m, 4H), 7.44(m, 6H), 3.6(s, 1H), 3.52-
3.82(m, 5H), 2.41(s, 1H), 1.57-1.85(m, 3H), 1.07(s, 9H), 0.90(d, J = 6.9 Hz, 3H).
13 C NMR (300 MHz, CDCl3): 8 135.59, 133.19, 129.83, 127.79, 76.10, 64.97, 62.27,
35.79, 34.06,26.84,19.11, 16.54.
FAB Mass Spec: m/e 373 [M + 1]+, 297, 199, 135, 117, 99.
Exact Mass: [M + 1]+ = 373.219899 (calculated)
[M + 1]+ = 373.2196 (measured).
IR (CHCl3) an- 1 : 3560, 3350, 2900, 1450, 1410, 1375, 1075.
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KMnO4 .'
tBuPh2SiO- C O2H
184
Acid, 184
The diol, 183, (2.01 g, 5.395 mmoles) was dissolved in tBuOH (30 mL)
and pH = 5 buffer (30 mL). NaIO4 (1.73 g, 8.093 mmoles) was added and the
mixture was stirred at room temperature for 40 minutes. KMnO4 (1.OM
aqueous solution, 14 mL) was then added and the reaction was stirred for an
additional 10 minutes, after which the reaction was titrated with saturated
Na2SO3 until disappearance of the purple color was observed. The resulting
brown precipitate was dissolved on titration with 10% HCl. The products
were then extracted three times with ethyl acetate and the combined extracts
were washed with brine and dried over MgSO4. The solvent was removed
and the residue was purified on silica gel (10% ethyl acetate/hexane) to yield
the acid (1.84 g, 95%) as a colorless solid. Upon reduction of the acid
(Me2S.BH3, ether) and formation of the corresponding MTPA ester, the
enantiomeric purity of the acid was found to be 40: 1.
Physical Properties for 184
Rf = 0.29 (33% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl 3): 7.65-7.68(m, 4H), 7.37-7.46(m, 6H), 3.71(m, 2H),
2.74(ddd, J = 13.8, 7.1, 7.1 Hz, 1H), 2.02(m, 1H), 1.65(ddd, I = 13.8, 7.8, 6.0 Hz,
1H), 1.19(d, J = 7.1 Hz, 3H), 1.04(s, 9H).
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13C NMR (300 MHz, CDCl 3): 6 182.38, 135.54, 133.69, 129.58, 127.62, 61.56,
36.09, 35.87, 26.81, 19.14, 16.82.
FAB Mass Spec: m/e 357 [M + 1]+,339, 299, 221, 199, 135.
Exact Mass: [M + 1]+ = 357.188599 (calculated)
[M + 1]+ = 357.1889 (measured).
IR (CHCl3 ) cm-l: 3530 (w), 2900-3330 (m, br), 3030 (w), 2960 (s), 2935 (s), 2890
(s), 2860 (s), 1710 (s), 1590 (w), 1475 (m), 1430 (m), 1390 (m), 1375 (w), 1240-1305
(m, br), 1090-1230 (m, br), 995 (m), 900 (m).
(COC02
tBuPh2 SiO CO2H tBuPhSiO " COC
184
NH3
tBuPSiO CONH2
185
Amide, 185
Oxalyl chloride (0.31 mL, 3.54 mmoles) was added dropwise to a
solution of the acid, 184, (840 mg, 2.36 mmoles) in benzene (10 mL) at 0°C
under argon. The reaction was stirred for 1 hour at room temperature, after
which N,N-dimethylformamide (I drop) was added. After an additional 1
hour, the solution was diluted with THF (15 mL) and transferred, via
cannula, to a solution of NH3(l) (5 mL) in THF (10 mL) at -78C under argon.
The mixture was warmed to room temperature and the excess NH3 was
allowed to evaporate over 4 hours. After dilution with ethyl acetate,
saturated NH4 Cl solution was added and the products were extracted twice
with ethyl acetate. The combined extracts were washed with brine, dried
over MgSO4, and concentrated to dryness to yield the pure amide (840 mg,
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100%) as a colorless solid. The products comprised a > 20 : 1 mixture
enantiomers as determined by chiral HPLC. Furthermore, after 3
recrystallizations from hexane, the optical purity of the amide was increased
to >99: 1.
Physical Properties for 185
Rf = 0.25 (50% ethyl acetate/hexane).
[]D = +11.9 c = 2.01 (CHCl3 ).
1H NMR (300 MHz, CDC13 ): 7.64-7.67(m, 4H), 7.35-7.46(m, 6H), 5.49(s, 1H),
5.42(s, 1H), 3.71(m, 2H), 2.58(m, 1H), 1.87(ddd, J = 13.5, 8.2, 5.3 Hz, 1H),
1.64(ddd, J = 13.5, 6.5, 6.5 Hz, 1H), 1.14(d, J = 7.1 Hz, 3H), 1.06(s, 9H).
13C NMR (300 MHz, CDC13): 179.15, 135.50, 133.67, 129.70, 127.70, 61.66,
36.85, 36.67, 26.92, 19.21, 17.51.
EI Mass Spec m/e 340 [M - 15]+, 298, 220,198.
Exact Mass: [M - CH3]+ = 340.17328 (calculated)
[M - CH3 ]+ = 340.1732 (measured).
IR (CHC13 ) cm-1: 3540 (m), 3420 (m), 2980 (s), 2940 (s), 2890 (s), 2860 (s), 1685
(s, br), 1595 (s), 1475 (m), 1445 (w), 1395 (m), 1370 (w), 1280 (m, br), 1070-1125
(s, br), 995 (m), 975 (m), 895 (m).
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Oxazole, 186
The amide, 185, (500 mg, 1.406 mmoles) was dissolved in THF at
room temperature under argon. Epoxycyclopentene (0.80 mL, 10.00
mmoles) was added followed by ethyl bromopyruvate (0.882 mL, 7.030
mmoles). The resulting solution was stirred at room temperature for 5
hours, after which epoxycyclopentene (0.33 mL, 4.12 mmoles) was added.
Stirring was continued for an additional 5 hours after which a further
portion of epoxycyclopentene (0.33 mL, 4.12 mmoles) was added. After 5
more hours, a final addition of epoxycyclopentene (0.33 mL, 4.12 mmoles)
was made. The reaction was stirred for 8 hours, after which it was cooled to
0°C. Pyridine (0.910 mL, 11.249 mmoles) was added followed by TFAA (0.794
mL, 5.624 mmoles) and the resulting solution was stirred at 0°C for 10
minutes. The reaction was quenched with pH = 7 buffer and washed three
times with ethyl acetate. The combined extracts were washed twice with
saturated CuSO4 solution, saturated NaHCO3 solution, and brine. After
drying over MgSO4, the solvent was removed and the residue was purified
on silica gel (6% ethyl acetate/hexane) to give the oxazole (0.400 g, 63%) and
the nitrile (0.166 g 35%) as colorless oils.
Physical Properties for 186
Rf = 0.46 (20% ethyl acetate/hexane).
[a]D = +9.9 c = 2.23 (CHC13).
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1H NMR (300 MHz, CDC13): 6 8.09(s, 1H), 7.60-7.66(m, 4H), 7.32-7.44(m, 6H),
4.38(q, J = 6.9 Hz, 2H), 3.67(m, 2H), 3.34(m, 1H), 2.15(m, 1H), 1.83(m, H),
1.37(t, I = 6.9 Hz, 3H), 1.33(d, I = 6.9 Hz, 3H), 1.03(s, 9H).
13C NMR (300 MHz, CDC13): 6 169.19, 161.41, 143.30, 135.51, 133.74, 133.67,
129.55,127.60, 61.27, 60.96, 37.31, 30.45, 26.82, 19.14, 18.29, 14.29.
EI Mass Spec: m/e 436 [M - 15]+, 394, 288, 179.
Exact Mass: [M - CH3 ]+ = 436.19441 (calculated)
[M - CH 3] + = 436.1941 (measured).
IR (neat) cm-1: 3160, 3060, 2930, 1780, 1740, 1580, 1470, 1425, 1370, 1310.
tBuPh2 SiO LAH, tBuPhSiO % "
186 C0 2Et 187 CH20H
Alcohol, 187
LiAlH 4 (81.1 mg, 2.106 mmoles) was suspended in ether (10 mL) and
cooled to 0°C under argon. The oxazole, 186, (460.9 mg, 1.053 mmoles) was
dissolved in ether (25 mL) and added via cannula to the LiAlH4. The
mixture was stirred at 0°C for 20 minutes, after which it was quenched with
Na2SO4-10H20. The resulting mixture was stirred at room temperature for 1
hour, after which it was filtered through a Celite pad. Concentration of the
filtrate produced the pure alcohol (412.3 mg, 96%) as a colorless oil.
Physical Properties for 187
Rf = 0.30 (60% ethyl acetate/hexane).
[a]D = +14.0 c = 1.87 (CHC13).
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1H NMR (300 MHz, CDCl 3): 7.61-7.67(m, 4H), 7.45(s, 1H), 7.33-7.45(m, 6H),
4.55(d, = 5.5 Hz, 2H), 3.69(m, 2H), 3.25(sext, I = 6.9 Hz, 1H), 2.11(m, 2H),
1.81(m, 1H), 1.30(d, J = 6.9 Hz, 3H), 1.03(s, 9H).
13C NMR (300 MHz, CDC13): 8 168.91, 139.75, 135.52, 134.30, 133.76, 129.54,
127.59,61.36,56.84,37.49,30.33,26.83, 19.16,18.32.
EI Mass Spec: m/e 409 M +, 394, 352, 274, 199, 136.
Exact Mass: M+ = 409.20732 (calculated)
M+ = 409.2069 (measured).
IR (neat) cm-1: 3350,3060, 2920, 1560, 1470, 1425, 1100.
tBuPh 2 SiO/ M PM-Br tBuPh SiO
187 CH2OH 188 CH2OMPM
MPM Ether, 188
KH (35%, 230 mg, 2.064 mmoles) was suspended in THF (10 mL) and
18-Crown-6 (cat. amount) was added. The mixture was cooled to 0°C under
argon, and a solution of the oxazole, 187, (600.7 mg, 1.474 mmol) in THF (20
mL) was added. After 15 minutes at 0°C, p-methoxybenzyl bromide (0.31
mL, 2.064 mmoles) was added. The reaction was stirred at room
temperature for 4 hours, cooled to 0°C, and carefully quenched with water.
The products were extracted three times with ethyl acetate, and the
combined extracts were washed with brine and dried over MgSO4. The
solvent was removed residue was purified on silica gel (10% ethyl
acetate/hexane) to give the desired product (744 mg, 95%) as a colorless oil
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Physical Properties for 188
Rf = 0.24 (15% ethyl acetate/hexane).
[a]D = +8.9 c = 2.06 (CHCl3 ).
1 H NMR (300 MHz, CDC13 ): 7.60-7.66(m, 4H), 7.45(t, J = 0.98 Hz, 1H), 7.30-
7.43(m, 6H), 7.27(dm, = 8.8 Hz, 2H), 6.87(dm, J = 8.8 Hz, 2H), 4.53(s, 2H),
4.39(d, J = 0.98 Hz, 2H), 3.80(s, 3H), 3.69(d, J = 6.3 Hz, 2H), 3.24(m, 1H), 2.12(m,
1H), 1.80(m, 1H), 1.30(d, I = 7.0 Hz, 3H), 1.02(s, 9H).
13C NMR (300 MHz, CDC13): 168.59, 159.24, 137.41, 135.47, 133.72, 133.65,
129.96, 129.50, 127.53, 113.76, 72.29, 63.71, 61.28, 55.19, 37.39, 30.23, 26.78, 19.12,
18.31.
El Mass Spec: m/e 514 M - 15]+, 472, 393, 259, 121.
Exact Mass: [M - CH3]+ = 514.24136 (calculated)
[M - CH3]+ = 514.2409 (measured).
IR (neat) cm-: 3060, 2910, 2850, 1610, 1565, 1510, 1460, 1425, 1245, 1170, 1100,
815, 730, 690.
TBAF HO
'H,OMPM 1 8 9 CH,OMPM
Alcohol, 189
The MPM ether, 188, (744 mg, 1.404 mmoles) was dissolved in THF (8
mL) at room temperature under argon. Tetrabutylammonium fluoride
(1.OM in THF, 2.8 mL, 2.808 mmoles) was added and the reaction was stirred
for 6 hours. The solvent was removed and the product was purified on
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silica gel (75% ethyl acetate/hexane) to give the alcohol (418.9 mg, 100%) as a
colorless oil.
Physical Properties for 189
Rf = 0.24 (80% ethyl acetate/hexane).
la]D = +17.1 c = 2.03 (CHC 3 ).
1H NMR (300 MHz, CDC13): 8 7.50(t, J = 0.95 Hz, 1H), 7.29(dm, J = 8.7 Hz, 2H),
6.88(dm, I = 8.7 Hz, 2H), 4.52(s, 2H), 4.40(d, I = 0.95 Hz, 2H), 3.80(s, 3H), 3.68(t, J
= 5.9 Hz, 2H), 3.19(m, 1H), 2.74(s, 1H), 1.84-2.08(m, 2H), 1.36(d, J = 7.1 Hz, 3H).
13C NMR (300 MHz, CDC13 ): 8 168.49, 159.30, 137.26, 135.81, 129.88, 129.51,
113.81, 72.38, 63.55, 60.25, 55.24, 37.54, 31.09, 18.46.
FAB Mass Spec: m/e 292 [M + 1]+, 155, 121.
Exact Mass: [M + 1]+ = 292.15488 (calculated)
[M + 1]+ = 292.1547 (measured).
IR (neat) cm-l: 3400, 2940, 1613, 1570, 1510, 1460, 1300, 1245, 1170, 1075, 813.
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HO'N
HO1 MsC PM
189 CH20MPM
NaN3 Na
190 CH20OMPM
Azide, 190
The alcohol, 189, (136.2 mg, 0.467 mmole) was dissolved in CH2C12
(1.6 mL), cooled to 0°C under argon, and triethylamine (0.19 mL, 1.401
mmole) was added. Methanesulfonyl chloride (54.4 L, 0.700 mmole) was
then added and the reaction was stirred at 0°C for 30 minutes. The solvent
was removed under reduced pressure and the residue was dissolved in DMF
(4.7 mL). NaN3 was added and the reaction was stirred at room temperature
under argon for 30 hours. The reaction was quenched with H20 (10 mL) and
washed with ethyl acetate (3 X 10 mL). The combined organics were washed
with brine (5 mL) and dried over Na2SO4. Concentration of the organics
and purification of the residue on silica gel (25% ethyl acetate/hexane) gave
the azide (128.1 mg, 87%) as a colorless oil.
Physical Properties for 190
Rf = 0.50 (50% ethyl acetate/hexane).
[I]D = +30.1 c = 1.90 (CHC1 3).
1H NMR (300 MHz, CDC13): 8 7.51(t, ] = 0.94 Hz, 1H), 7.29(dm, J = 8.3 Hz, 2H),
6.88(dm, J = 8.3 Hz, 2H), 4.55(s, 2H), 4.41(d, J = 0.94 Hz, 2H), 3.80(s, 3H), 3.33(td,
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J = 7.0, 2.9 Hz, 2H), 3.11(m, 1H), 2.10(ddd, J = 13.4, 8.1, 6.7 Hz, 1H), 1.86(ddd, J =
13.4, 7.4, 5.9 Hz, 1H), 1.36(d, I = 7.5 Hz, 3H).
13C NMR (300 MHz, CDC13 ): 6 166.97, 159.04, 137.51, 135.61, 129.69, 129.24,
113.53, 72.07, 63.44, 54.92, 48.87, 33.66, 30.85, 18.12.
FAB Mass Spec: m/e 317 [M +1]+, 274, 180.
Exact Mass: [M + 1 + = 317.16137 (calculated)
[M + 1]+ = 317.1610 (measured).
IR (neat) cm-l: 2940, 2040, 1610, 1570, 1510,1455, 1360, 1300, 1245, 1170, 1075,
1030, 810.
1. MeAICINHMe
2. Ms-CI
3. tBuOK
O~
167 192
Methyl Lactam, 192
MeNH 2-HCl (140.8 mg, 2.163 mmoles) was suspended in benzene (2
mL) and cooled to 0°C under argon. Trimethylaluminum (2.0M in hexane,
1.04 mL, 2.163 mmoles) was added, dropwise, over a period of 10 minutes.
After stirring for 30 minutes at room temperature, the resulting solution
was added, via cannula, to a solution of the lactone, 167, (208.2 mg, 1.030
mmoles) in benzene (4 mL) at room temperature under argon. The
resulting mixture was stirred for 3 hours, after which it was cooled to 0°C
and carefully quenched with saturated Rochelle's salt solution. After
stirring for 1 hour, the products were extracted with ethyl acetate (4 X 5 mL)
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and the combined extracts were washed with brine and dried over MgSO4.
The solvent was removed to give the hydroxyamide, 191, (238.1 mg, 99%) as
a white solid which was immediately dissolved in CH2C12 (3 mL).
Triethylamine (0.430 mL, 3.090 mmoles) was added and the mixture was
cooled to 0°C under argon. Methanesulfonyl chloride (0.12 mL, 1.545
mmoles) was then added and the reaction was stirred at 0°C for 30 minutes.
The solvent was removed and the residue was diluted with THF (22 mL)
and filtered through Celite under argon. The resulting solution was cooled
to -400C and potassium tert-butoxide (1.41M in THF, 3 mL, 4.120 mmoles)
was added. After warming to room temperature over 1 hour, the reaction
was quenched with pH = 7 buffer (30 mL). The products were extracted with
ethyl acetate (3 X 15 mL) and the combined extracts were washed with brine
and dried over MgS04. The solvent was removed and the product was
purified on silica gel (80% ethyl acetate/hexane) to give the methyl lactam
(184.3 mg, 84%) as a colorless oil.
Physical Properties for 191
Rf = 0.14 (ethyl acetate).
1H NMR (300 MHz, CDC13): 6 6.82(s, H), 4.57(d, J = 7.8 Hz, 1H), 4.45(dd, J =
7.8, 2.6 Hz, 1H), 4.11(ddd, J = 6.7, 6.0, 2.6 Hz, 1H), 3.50(ABX, JAB = 9.7 Hz, JAX =
6.7 Hz, JBx = 5.8 Hz, AVAB = 14.8 Hz, 2H), 3.83(s, 3H), 2.85(d, J = 4.7 Hz, 3H),
2.33(d, J = 6.9 Hz, 1H), 1.58(s, 3H), 1.39(s, 3H).
Physical Properties for 192
Rf = 0.32 (ethyl acetate).
[oID = +30.5 c = 2.37 (CHC1 3).
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1H NMR (300 MHz, CDC13): 4.63(d, J = 5.8 Hz, 1H), 4.53(d, J = 5.8 Hz, 1H),
3.61 (t, I = 2.7 Hz, 1H), 3.52(ABX, JAB = 10 Hz, JAX = 3.2 Hz, JBX = 2.7 Hz, AVAB
= 15 Hz, 2H), 3.33(s, 3H), 2.87(s, 3H), 1.42(s, 3H), 1.37(s, 3H).
13C NMR (300 MHz, CDC13): 171.48, 111.60, 77.31, 76.10, 69.42, 63.52, 59.17,
27.78, 26.87, 25.54.
EI Mass Spec: m/e 200 [M - 15]+, 170, 142, 85, 69, 45.
Exact Mass: [M - CH3]+ = 200.09228 (calculated)
[M - CH3 ]+ = 200.0921 (measured).
IR (CHCl3) cm-l: 2995, 2937, 1700, 1450, 1400, 1375, 1120, 1070.
Me
O
·OMe Me
I OMe
1. HCI
2. BnBr, Ag2 0 
F-]X BnO OBn
192 193
Dibenzyl Ether, 193
The methyl lactam, 192, (74.8 mg, 0.348 mmole) was dissolved in THF
(2 mL) and concentrated HCI (1.5 mL) was added. The reaction was stirred at
room temperature for 2 hours, after which it was concentrated to dryness.
The residue was azeotropically dried with benzene (3 X 5 mL) and kept
under vacuum for 24 hours. The residue was then dissolved in DMF (1 mL)
and Ag2O (367 mg, 5 equiv by wt) added. Benzyl bromide (0.29 mL, 2.436
mmoles) was added to the resulting suspension and the reaction was stirred
at room temperature under argon for 20 hours. The reaction was then
filtered through Celite and the solids were washed with CHCl3. The
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combined organics were diluted with ether/hexane (4/1, 5 mL) and
saturated NJH4CI solution (5 mL) was added. The products were extracted
with ether/hexane (4/1, 3 X 5 mL) and the combined organics were washed
with brine and dried over MgSO4. The solvent was removed and the
residue was purified on silica gel (80% ethyl acetate/hexane) to give the
desired product (102.8 mg, 83%) as an oil.
Physical Properties for 193
Rf = 0.40 (ethyl acetate).
[C]D =-113.9 c - 1.92 (CHC13).
1 H NMR (300 MHz, CDCl 3): 8 7.44(d, J = 6.8 Hz, 2H), 7.30(d, J = 7.1Hz, 2H),
7.06-7.19(m, 6H), 5.04(ABq, JAB = 11.9 Hz, AVAB = 85.2 Hz, 2H), 4.48(ABq, JAB
= 11.7 Hz, AVAB = 79.8 Hz, 2H), 4.07(d, J = 5.5 Hz, 1H), 3.80(dd, J = 5.5, 3.6 Hz,
1H), 3.37(q, J = 3.6 Hz, 1H), 2.86(d, J = 3.6 Hz, 2H), 2.82(s, 3H), 2.57(s, 3H).
1H NMR (300 MHz, C6 D6 ): 7.40-7.44(m, 2H), 7.27-7.36(m, 8H), 4.89(ABq, JAB
= 11.9 Hz, AVAB = 55.3 Hz, 2H), 4.60(ABq, JAB = 11.9 Hz, AVAB = 48.7 Hz, 2H),
4.11(d, J = 5.8 Hz, 1H), 3.97(dd, J = 5.8, 2.9 Hz, 1H), 3.59(q, J = 3.1 Hz, 1H),
3.48(dd, J = 10.3, 3.3 Hz, 1H), 3.29(dd, J = 10.3, 2.8 Hz, 1H), 3.27(s, 3H), 2.86(s,
3H).
13C NMR (300 MHz, CDCI 3): 8 171.17, 137.86, 137.71, 128.25, 128.16, 127.97,
127.82, 127.70, 127.53, 74.97, 74.51, 72.26, 72.03, 69.71, 63.33, 59.01, 27.56.
FAB Mass Spec: m/e 356 [M + 1]+, 326, 278, 264, 248, 181.
Exact Mass: [M + 1]+ = 356.18618 (calculated)
[M + 1]+ = 356.1864 (measured).
IR (neat) cm- 1: 3060, 3025, 2900, 1700, 1450, 1400, 1350, 1260, 1190, 1100, 1155,
730, 690.
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Me Me BnO O
1. Et 3 OBF 4
2. H2 C=O, H2 0, NaHCO 3 - MeO OE
3. ZnCI2 , NaCNBH 3 Me2 N OBn
BnO OBn
193 194
Amino ester, 194
The dibenzyl ether, 193, (30 mg, 0.084 mmole) and 2,6-di-tert-
butylpyridine (38 L, 0.168 mmole) were dissolved in CH2Cl2 (1 mL) and
Et3OBF4 (1M in CH2Cl2, 0.17 mL, 0.168 mmole) was added. The reaction was
stirred at room temperature under argon for 16 hours, after which the
solvent was removed. Aqueous formaldehyde (37%, 28 LL, 0.336 mmole)
was added followed by saturated NaHCO3 (0.8 mL) and methanol (1 mL).
ZnC12 (37 mg, 0.252 mmole) was dissolved in MeOH (1 mL) and
added, via cannula, to solution of NaCNBH 3 (33.6 mg, 0.504 mmole) in
MeOH (1 mL). The mixture was stirred at room temperature under argon
for 5 minutes, after which it was added, via cannula, to the above reaction.
The resulting mixture was stirred for 4 hours and quenched with 0.1N KOH
(1 mL). The products were extracted with ethyl acetate (3 X 5 mL) and the
combined extracts were washed with brine and dried over MgSO4. The
solvent was removed and the product was purified on silica gel (25% ethyl
acetate/hexane) to give the amino ester, 194, (27.6 mg, 79%) and the dibenzyl
ether, 193, (3.4 mg, 11%) as oils.
Physical Properties for 194
Rf - 0.38 (33% ethyl acetate/hexane).
[aID = -59.7 c = 1.75 (acetone).
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1H NMR (250 MHz, C6D6 ): 6 7.41(d, J = 6.6 Hz, 2H), 7.33(d, I = 7.1 Hz, 2H),
7.06-7.21(m, 6H), 4.91(1/2 ABq, JAB = 12.1 I-Tz, 1H), 4.73(1/2 ABq, JAB = 11.4
Hz, 1H), 4.56(d, J = 1.7 Hz, 1H), 4.46(1/2 ABq, JAB = 12.1 Hz, 1H), 4.42(1/2 ABq,
JAB = 11.4 Hz, 1H), 4.11(dd, J = 10.1, 1.7 Hz, 1H), 4.05(q, J = 7.1 Hz, 2H), 3.67(dd,
J = 9.8, 2.4 Hz, 1H), 3.54(dd, J = 9.8, 7.1 Hz, 1H), 3.41(ddd, J = 9.8, 7.1, 2.4 Hz,
1H), 3.05(s, 3H), 2.36(s, 6H), 1.02(t, J = 7.1 Hz, 3H).
13C NMR (300 MHz, CDC13 ): 170.04, 139.32, 138.98, 128.45, 128.38, 128.07,
128.03, 127.54, 80.72, 78.94, 73.03, 73.00, 69.78, 62.31, 60.16, 58.38, 42.15, 14.36.
FAB Mass Spec: m/e 416 [M + 1]+, 370, 308, 102.
Exact Mass: [M + 1+ = 416.24370 (calculated)
[M + 1]+ = 416.2440 (measured).
IR (neat) cm-l: 3090, 3065, 3035, 2980, 2935, 2875, 2835, 1750, 1745, 1498, 1455,
1390, 1368, 1346, 1280, 1190, 1110, 1025, 760, 690.
BnO O BnO O
LiOH
MeO OEt O - MeO OH
Me 2N OBn Me2N OBn194 203
Acid, 203
The ester, 194, (135 mg, 0.325 mmole) was dissolved in THF/H 20 (3/1,
1 mL) and LiOH-H2 0 (30 mg, 0.714 mmole) was added. The reaction was
stirred for 3 days at room temperature, after which it was acidified to pH = 3
with IN HC1. The product was extracted with ethyl acetate (10 X 2 mL) and
the combined extracts were dried over MgSO4. Concentration under
reduced pressure provided the pure acid (122 mg, 97%) as a white foam.
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Physical Properties for 202
Rf = 0.29 (10% MeOH/CH2Cl 2 )
1H NMR (300 MHz, C6 D6): 8 7.45(d, J = 7.8 Hz, 2H), 7.28(d, J = 7.2 Hz, 2H),
5.05(d, J = 12 Hz, 1H), 4.68(m, 3H), 4.50(dd, J = 12, 10.8 Hz, 2H), 4.17(m, 1H),
4.08(d, = 12.6 Hz, 1H), 3.64(dd, I = 11.4, 8.4 Hz, 1H), 2.96(s, 3H), 2.40(s, 6H).
13 C NMR (300 MHz, C6D6 ): 8 173.74, 138.90, 138.62, 128.60, 128.52, 128.18,
127.90, 127.42, 78.85, 78.76, 72.50, 71.64, 67.81, 65.09, 58.29, 41.86.
FAB Mass Spec: m/e 388 [M + 1]+, 307, 154, 136.
Exact Mass: [M + 1]+ = 388.212399 (calculated)
[M + 1]+ = 388.2121 (measured).
IR (CHC13) cm-l: 2980, 3000-2400, 1740, 1604, 1460, 1200, 1110, 1020.
Rnt n
C/CMAP
MeO
Me2 N OBn197
Fragment C Enantiomer, 195
To a solution of the amine, 66, (27.5 mg, 0.095 mmole) in CH2C12 (1
mL) was added DMAP (9.0 mg, 0.074 mmole) and DCC (17.2 mg, 0.083
mmole), and the reaction was cooled to 0°C under argon. A solution of the
acid, 197, (22.0 mg, 0.057 mmole) in CH2C12 (0.5 mL) was added, via cannula,
and the reaction was stirred at 0°C for 30 minutes and 11 hours at room
temperature. The reaction was then diluted with ether (5 mL) and the
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precipitate was removed by filtration. The filtrate was concentrated under
reduced pressure and the residue was purified on silica gel (5%
methanol/CH2Cl2) to give the product (25.9 mg, 69%) as a colorless oil.
Physical Properties for 195
Rf = 0.20 (5% methanol/CH2Cl2).
1H NMR (500 MHz, C6 D6 ): 6 7.03-7.31(m, 13H), 6.76(m, J = 8.79 Hz, 2H),
6.74(broad m, 1H), 4.66(d, I = 11.24 Hz, 1H), 4.57(d, J = 11.73 Hz, 1H), 4.47(d, J =
11.73 Hz, 1H), 4.44(d, J = 1.47 Hz, 1H), 4.40(d, J = 11.73 Hz, 1H), 4.38(s, 2H),
4.35(s, 2H), 4.27(dd, I = 1.46, 10.26 Hz, 1H), 3.65(dd, J = 2.45, 10.26 Hz, 1H),
3.55(dd, J = 6.84,10.26 Hz, 1H), 3.41(ddd, J = 2.94, 2;44, 6.84 Hz, 1H), 3.36(septet,
J = 3.36 Hz, 1H), 3.27(s, 3H), 3.10(sextet, J = 5.87 Hz, 1H), 3.04(s, 3H), 2.85(d
sextets, J = 6.35, 7.82 Hz, 1H), 2.37(s, 6H), 1.84(d sextets, J = 5.5, 8.0 Hz, 1H),
1.61(sextet, J = 1.61 Hz, 1H), 1.12(d, 6.5 Hz, 3H).
13C NMR (500 MHz, C6 D6): 8 169.81, 167.83, 159.73, 139.38, 138.83, 138.56,
135.62, 130.79, 129.56, 114.06, 80.97, 80.51, 73.62, 73.31, 72.33, 69.55, 64.44, 62.74,
58.38, 54.74, 42.29, 37.10, 35.34, 31.75, 18.46.
FAB Mass Spec: m/e 660 [M + 1]+, 121, 102, 91.
Exact Mass: [M + 1]+ = 660.36488 (calculated)
[M + 1]+ = 660.3653 (measured).
IR (C6 D6 ) cm-l: 3430, 3030, 2930, 2860, 1675, 1510, 1245, 1080, 1030, 725, 687.
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4.6 NMR Spectra
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Chapter 5:
Isoxazolidines as Chiral Auxiliaries
in Asymmetric Synthesis and their
Potential Use in the Preparation of
Fragment C1 of Calyculin A
302
5.1 Introduction
As shown in Scheme 5.1, our original preparation of the amide
intermediate, 65, to fragment C1 involved initial silylation of the
homoallylic alcohol, 66, followed by ozonolysis and Horner-Emmons
olefination. 76 The resulting c,-unsaturated ester,69, was then reduced with
DIBAL, epoxidized,77 and the epoxide was opened with trimethylaluminum
to the diol, 72.78,79 The diol was then oxidatively cleaved to an aldehyde,79
and the aldehyde was oxidized to the acid.8 0 Finally, the acid was converted
to the acid chloride and subsequently condensed with ammonia to produce
the amide, 65. This sequence represents a ten-step synthesis of a fragment
bearing only five essential carbons and one stereogenic center. We did not
find this very efficient, and set out to develop an alternate strategy.
Scheme 5.1
HOv ,1. BuPh 2SiCI .BAhSit
2. 03, DMS BuP68 693. (EtO) 2POCH 2CO 2Et DIBAL1. DIBAL
2. Sharpless Epoxidation
3. Me3AI
1. NaO 4 CH
tBuPh2SiO CONH2 -3. (KMOC4 tuPh2Sl)220H
3. (COC) 2
65 4. NH3 72 HO
5.2 The Design of a Chiral Auxiliary
Chiral auxiliaries have found great utility in organic synthesis, and
the search more effective and versatile chiral auxiliaries has been a
formidable challenge to organic chemists over recent years.14 5 In our search
for a better preparation of amide 65, an intermediate in the synthesis of
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fragment C1, we became aware of prolinol, 206 (Figure 5.1), a chiral auxiliary
that had been studied by Evans in 1980.146
Figure 5.1
H
20H6
Scheme 5.2
0
1. 2 LDNO_ N
2. Etl
208
92
+ NX
209
8
0
I,. LDA
2. Etl
21 0OMe
O
211 OMe
22
As shown in Scheme 5.2, Evans demonstrated that alkylation of N-
propionyl prolinol, 207, on treatment with two equivalents of LDA followed
by ethyl iodide provides a 92: 8 ratio of diastereomers. What we found even
more interesting was that when the methyl ether, 210, was used,
diastereomeric induction occurred to the extent of 22: 78 in the opposite
direction. These results can possibly be explained as follows using the two
enolate structures, 213 and 214, shown in Figure 5.2. If, on treatment with
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base, the enolate of 207 forms the lithium bridged 5-7 fused bicyclic ring
system, 213, we would expect this relatively hindered system to be blocked
from the back side and allow approach of an electrophile from the front. If,
on the other hand, the methyl ether, 210, forms the enolate, 214, in which
the lithium does not coordinate to the ether oxygen, we would expect more
shielding from the front and a greater ease of approach by an electrophile
from the rear. The lower diastereoinduction can be accounted for by the
greater freedom of rotation around the nitrogen-carbonyl bond.
Figure 5.2
Li %Li-. 0
> -j
_ DJ~~~~
213 214
Figure 5.3
215
When considering the two structures in Figure 5.2, we postulated that
we might be able to improve upon Evans' results by adding an extra
coordination site to the proline ring. Thus, by replacing the methylene
group adjacent to the nitrogen with an oxygen, we felt that formation of the
5-5 cis-fused lithium-bridged enolate, 215 (Figure 5.3), would be favored.
Therefore, we decided to study the utility of isoxazolidines as chiral
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auxiliaries for asymmetric synthesis.
5.3 Reactions of Isoxazolidides
Scheme 5.3
0
HCVH2 0 .
R OH
0Me 2AINR'2
R NR, 2
OMe
DIBAL
R.,~ O
0
R'-MgBr
'"- R R'
When considering the development of any new methodology, it is
important to be aware of its potential versatility. Therefore, we went to the
literature to learn what transformations were possible with isoxazolidides,
and their related N-methyl-N-methoxyamides. Our search, summarized in
Scheme 5.3, showed that these species can easily be hydrolyzed to acids
under acidic conditions, converted to other amides utilizing Weinreb
conditions, 127,128,129 converted to aldehydes on treatment with
DIBAL,14 7, 14 8 and transformed into ketones using alkyllithium or Grignard
reagents. 147 ,148,14 9,150 Therefore, as indicated in the literature, these
compounds are quite versatile and present avenues into many functional
groups desired from a synthetic standpoint. With these promising data, we
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next needed to determine if isoxazolides could be alkylated a to the carbonyl
group.
5.4 Preparation and Alkylation of Isoxazolidides
Scheme 5.4
NaHCO3
HONH 2 -HCI HONH OCH 2CH3
Cl OCH2CH3216 217
Br Br
jNHHCI HCVH20
_NHHC I
219 218
Before we could study the alkylation of isoxazolidides, we needed to
obtain quantities of isoxazolidine hydrochloride, 219. The preparation,
described by King,151 is shown in Scheme 5.4 and proceeded as follows.
Ethylchloroformate, 216, was converted to the N-hydroxyurethane, 217, on
treatment with hydroxylamine hydrochloride and sodium bicarbonate. The
urethane was then converted to N-ethoxycarbonyl isoxazolidide, 218, on
treatment with 1,3-dibromopropane in the presence of potassium carbonate.
Finally, isoxazolidine hydrochloride, 219, was formed upon acid hydrolysis
of 218. With isoxazolidine hydrochloride in hand, we were now ready to
form isoxazolidides and study the alkylation of these species.
As shown in Scheme 5.5, isoxazolidine hydrochloride, 219, was
converted to its free base, 220, and subsequently acylated1 52 with hexanoic
acid, 221, to give a 95% yield of the isoxazolidide, 222. At this point, we now
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needed to develop conditions for the alkylation of 222.
Scheme 5.5
OH
221
O
1. Cl "'OCH 2CH(CH 3) 2
2. CNH
220
fK2CO3
< NH-HCI
219
Scheme 5.6
O2
222
1. Base
2. Electrophile
R
223: R = Me
224: R = CH 2=CH-CH 2
Table 5.1
Alkylation and Allylation of Isoxazolidide 222
Solvent Base Electrophile Product Yield (%)
THF LDA Mel 223 0
THF (TMS) 2 NLi Mel 223 98
THF (TMS)2NLi CH2=CH-CH2 Br 224 56
Et2 O (TMS) 2 NLi CH 2 =CH-CH2 Br 224 0
CH2=CH-CH2Br/
THF (TMS)2NLi HMPA 224 92
The results from our initial study of the alkylation and allylation of
isoxazolidide 222 (Scheme 5.6) are shown in Table 5.1 and are described as
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N222 
222 _
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follows. All reactions were run at -780C over a three hour reaction period.
Initially, we attempted deprotonation of 222 with LDA. Under these
conditions, we found no reaction. However, when we deprotonated 222
with lithium hexamethyldisilazide, we were able to affect methylation with
methyl iodide in near quantitative yield. In the case of allylation with allyl
bromide, the reaction was not as straightforward, and we were able to effect a
92% yield of the desired product only after adding one equivalent of HMPA
to the reaction mixture. In any event, with these observations, we felt that
further study into the application of this methodology to the synthesis of
fragment C1 was warranted.
5.5 The Application of Isoxazolidides to Fragment C1
With the methodology for the methylation of isoxazolidides
established, it was now time to determine if this methodology could be
applied to a racemic synthesis of the amide, 65. This strategy, shown in
Scheme 5.7, proceeded as follows. Butyrolactone, 225, was treated with the
Weinreb reagent12 7,128 ,12 9 derived from isoxazolidine hydrochloride, 219,
and the crude hydroxyisoxazolidide was treated with tert-
butyldiphenylchlorosilane to provide the silyl ether, 226, in 75% over two
steps. The silyl ether, 226, was then deprotonated with lithium
hexamethyldisilazide and methylated on treatment with methyl iodide to
yield the isoxazolidide, 227. Treatment of this isoxazolidide with the
Weinreb reagent 12 7,1 2 8,1 2 9 derived from trimethylaluminum and ammonia
provided a 60% yield of amide 65 in racemic form. This four-step sequence
provided us with a better overall yield than our previous ten-step synthesis
and we were now ready to explore the utility of chiral isoxazolidines in
asymmetric synthesis.
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Scheme 5.7
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5.6 Chiral Isoxazolidines
Scheme 5.8
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The ability of sugars to induce asymmetry in chemical reactions has
been known since as early as 1890 in the Kiliani-Fischer extension of hexoses
to higher carbohydrates. 153, 1 54,155 With this in mind, it is not surprising
that Vasella developed a synthesis of chiral isoxazolidines using mannose as
a chiral auxiliary. 156 The specific synthesis is shown in Scheme 5.8 and is
described as follows. 2,3:5,6-(O)-Diisopropylidine-d-mannofuranose, 228,157
was converted to its oxime, 229, in 65% yield on treatment with
hydroxylamine. The oxime, 229, was then treated with tert-butylglyoxalate
at 800C under 1000 psi of ethylene to provide a 98% yield of isoxazolidine
glycosides 230 and 231 in a ratio of 3: 1. The mechanism of this reaction
presumably involves initial condensation of the oxime with the glyoxalate
followed by a (3 + 2) dipolar cycloaddition. Successive recrystalizations
easilly separated the products to provide a 47% yield of diastereomerically
pure 230.
At this stage, Vasella chose to separate the isoxazolidine from the
sugar under acidic hydrolytic conditions to study its activity as an unnatural
aminoacid in various proteins. Our needs, however, directed us to further
derivatize the glycoside, 230, in order to develop a useful set of chiral
auxiliaries. Our extension of Vasella's synthesis is shown in Scheme 5.9 and
proceeded as follows. The tert-butyl ester, 230, was reduced to the primary
alcohol, 232, in quantitative yield on treatment with LiAlH4. The resulting
alcohol, 232, was converted to the methyl ether, 233 (98% yield), or the
benzyl ether, 234 (99% yield), on treatment with NaH followed by methyl
iodide or benzyl bromide, respectively. Alternatively, the tert-butyl ester,
230, was converted to the tertiary alcohol, 235, in 95% yield on treatment
with MeMgBr. Subsequently, the tertiary alcohol, 235, was converted to the
corresponding methyl ether, 236, in 68% yield on treatment with NaH
311
followed by methyl iodide. This series of reactions provided us with five
easily attainable isoxazolidine derivatives which, after hydrolysis from the
sugar, could be used in our studies on asymmetric induction. In the interest
of simplicity, we began with the ether derivatives, 233, 234, and 236.
Scheme 5.9
>< 1. N;2. M
230
MeMgBr
T
0.
1. Nat
2. Mel-
A C(Me)2 0H
235
A C(Me)2OMe
236
5.7 Asymmetric Alkylations
Although the tert-butyl ester isoxazolidine was easily isolated on
hydrolysis of the glycosidic bond,15 6 our derivatives underwent rapid
decomposition under these conditions. Therefore, it was not feasible, at this
time, to isolate the pure isoxazolidines, and we proceeded with acylation of
312
these compounds using their crude reaction isolates (42-55% from
glycosides, Scheme 5.10). Once we had isolated the isoxazolidides, we began
our study of their utility as chiral auxiliaries.
Scheme 5.10
HCI/H2 0/MeOH
HN
[2
R = CH2 OMe
R = CH2 OBn
R = CMe 2 OMe
0
22 OH
221
0
1. CI OCH2CH(CH 3 )2
HN
2. R d
240: R = CH2OMe
241: R = CH 2OBn
242: R = CMe 2OMe
The general alkylation reaction we studied involved the use of a
hexamethyldisilazide base for enolate formation followed by treatment with
methyl iodide (Scheme 5.11). The results of this study are shown in Table
5.2 and are described as follows. Our initial experiments involved the use of
lithium as the counterion. Under these conditions, we found that Et2O was
not as good a solvent as THF, and the addition of HMPA to the reaction was
not advantageous. Furthermore, changing the counterion did not help the
reaction and our best results were obtained at -950C and provided a 93% de.
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233 R =
234: R=
236: R =
237:
238:
239:
This result represents a significant improvement over the results Evans
obtained utilizing prolinol as a chiral auxiliary. 148 We were disappointed,
however, to find that larger side groups on the isoxazolidide provided lower
diastereomeric excesses. In all cases, the configuration was determined by
converting the methylated isoxazolidides to their corresponding methyl
ketones and comparing the measured optical rotations with literature
values.
Scheme 5.11
0
NIT ~ 1. (TMS)2NM 
2. Mel
R
240: R = CH2OMe
241: R = CH 2OBn
242: R = CMe 2 OMe
0
R
243: R = CH2OMe 246: R = CH 2OMe
244: R = CH2OBn 247: R = CH2OBn
245: R = CMe 2 OMe 248: R = CMe 2 OMe
The observation of lower diastereomeric induction with larger R
groups was not surprising when considering the possible enolate structure
shown in Figure 5.4. When considering this structure, it is easy to imagine
that a smaller R group would allow for easier formation of the tricoordinate
lithium cation and greater shielding of the front side of the enolate. On the
other hand, if a larger R group is used, it is not unreasonable that the greater
steric requirements would cause the side chain to not coordinate to the
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lithium. This would decrease the shielding of the front side of the enolate
and cause a lower degree of diastereomeric induction. As this appeared to be
the case, the best R group on the isoxazolidine ring was determined to be
CH 3 OCH2 and we were ready to apply this technology towards the
preparation of amide 65.
Table 5.2
Results for Isoxazolidine Induced Diastereoinduction
Isoxazolidide M Solvent Temp Yield (%) %de Configuration
240 Li THF -78 84 90 R
240 Li THF/HMPA -78 85 81 R
240 Li Et20/HMPA -78 66 83 R
240 Li THF -95 97 93 R
240 MgBr THF -78 N R --
240 Na THF -78 83 88 R
240 K THF -78 79 89 R
241 Li THF -78 85 69 R
242 Li THF -78 78 75 R
Figure 5.4
249
5.8 Potential Application of Chiral Isoxazolidines to Fragment C1
The strategy for applying the use of chiral isoxazolidines to the
synthesis of fragment C1 is shown in Scheme 5.12. This strategy has not yet
been carried out due to the problems we have encountered in isolating the
315
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pure isoxazolidines from the hydrolysis of the corresponding glycosides.
Additionally, due to our need for large quantities of fragments C1 and C2,
this project was temporarily discontinued. However, in view of the
potential generality of this technology, it is hoped that this problem will be
quickly solved and the value of these chiral auxiliaries fully demonstrated.
Scheme 5.12
MeCIAN '
. BuPh2SiCMe
2. tBuPh2SiCI
0O
IBuPh2SiO N .#
250 OMe
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5.9 Experimental Section
O
O 1. CI KOCH 2CH(CH3 )2 O
OH (NH N
221 2. \ H 222
Isoxazolidide, 222
Isoxazolidine hydrochloride, 219, (1.00 g, 9.17 mmoles) was suspended
in THF (20 mL) and water (0.80 mL) was added. The mixture was stirred for
5 minutes under argon, after which K2CO3 (2.50 g) was added. The resulting
mixture was stirred for 2 hours after which K2 CO3 (0.50 g) was added. After
stirring for an additional 30 minutes, the solids were allowed to settle.
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O
225
Hexanoic acid, 221, (1.15 mL. 9.17 mmoles) was dissolved in THF (40
mL) and N-methylmorpholine (1.00 mL, 9.17 mmoles) was added. The
solution was cooled to -200C under argon and isobutyl chloroformate (1.20
mL, 9.17 mmoles) was added. After stirring for 1 minute, the isoxazolidine
solution prepared above was added via cannula. The reaction was allowed
to stir at -200 C for 1 hour, after which it was warmed to room temperature
and concentrated to dryness. Ethyl acetate (75 mL) was added to the residue
and the mixture was washed with 5% citric acid solution (50 mL). The
aqueous phase was washed with ethyl acetate (75 mL) and the combined
organic phases were washed with 5% citric acid solution (50 mL) and
saturated NaHCO 3 solution (2 X 50 mL). The organic layer was then dried
over Na2SO4, filtered, and concentrated. Distillation of the residue (P = 1
mm Hg, T = 117-120C) gave the product (1.10 g, 70%) as a colorless liquid.
Physical Properties for 222
Rf = 0.07 (15% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13 ): 3.92(t, J = 6.76 Hz, 2H), 3.69(dd, J = 7.3 Hz, 2H),
2.40(dd, I = 7.37 Hz, 2H), 2.28(quintet, J = 6.93 Hz, 2H), 1.62(m, 2H), 1.30(m,
4H), 0.88(t, J = 6.90 Hz, 3H).
O O
N;1 1 (TMS) 2NU 0
2. Mel 
222 223
Methyl Isoxazolidide, 223
(TMS)2NH (147gLL, 0.698 mmole) was dissolved in THF (4 mL) and
cooled to -780C under argon. n-BuLi (2.46M in hexane, 260 gIL, 0.640 mmole)
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was added and the mixture was stirred at -78°C for 30 minutes. Isoxazolidide
222 (100 IL, 0.581 mmole) was added and the mixture was stirred at -78C for
1 hour, after which methyl iodide (200 L) was added. The reaction was
maintained at -78°C for 1 hour, after which it was allowed to warm to -20°C
over 2 hours. After an additional hour at -200C, the reaction was quenched
with saturated NH4CI solution (1 mL) and washed with ethyl acetate (10
mL). The ethyl acetate was dried over MgSO4, and concentrated to dryness.
Purification on silica gel (50% ethyl acetate/hexane) yielded the desired
product as a colorless oil (105 mg, 98%).
Physical Properties for 223
Rf = 0.49 (15% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl3): 3.92(dt, J = 2.06, 6.76 Hz, 2H), 3.69(m, 2H),
2.85(m, 1H), 2.27(quintet, J = 7.06 Hz, 2H), 1.63(m, 1H), 1.38(m, 1H), 1.26(m,
4H), 1.07(d, J = 6.86 Hz, 3H), 0.85(t, J = 6.86 Hz, 3H).
0 0
,s 1. (TMS) 2NLi
2. CH2=CHCH 2B 
222 224
2-Allyl Hexanoic Isoxazolidide, 224
(TMS)2NH (147 gL, 0.698 mmole) was dissolved in THF (4 mL) and
cooled to -780C under argon. n-BuLi (2.46M in hexane, 260 gL, 0.640 mmole)
was added and the mixture was stirred at -78°C for 30 minutes. Isoxazolidide
222 (100 gIL, 0.581 mmole) was added and the mixture was stirred at -78°C for
1 hour, after which HMPA (100 jiL, 0.581 mmole) was added followed by
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allyl bromide (277 grL, 3.197 mmoles). The reaction was warmed from -78 to
-20°C over 1.5 hours, after which it was quenched with saturated NH4CI
solution (1 mL) and washed with ethyl acetate (10 mL). The ethyl acetate
was washed with water (2 X 2 mL), dried over MgSO4, and concentrated to
dryness. Purification on silica gel (50% ethyl acetate/hexane) yielded the
desired product (113 mg, 92%) as a colorless oil.
Physical Properties for 224
Rf = 0.30 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 5.74(m, 1H), 5.00(dd, J = 17.13, 21.80 Hz, 2H),
3.93(dt, J = 1.82, 6.93 Hz, 2H), 3.72(m, 2H), 2.95(broad m, 1H), 2.31(m, 3H),
2.19(m, 1H), 1.62(m, 1H), 1.43(m, 1H), 1.27(m, 4H), 0.86(t, J = 6.86 Hz, 3H).
00 0j . ( NAICIMe t Ph2S i NO )
2. BuPh 2SiCI 
225 226
tert-Butyldiphenylsilyloxy Isoxazolidide, 226
Isoxazolidine hydrochloride, 219, (0.880 g, 8.077 mmoles) was
suspended in C6 H 6 (17.6 mL) and cooled to 0°C under argon.
Trimethylaluminum (2M in hexanes, 4.04 mL, 8.08 mmoles) was added and
the reaction was stirred at room temperature for 1.5 hours. Butyrolactone,
225, (0.310 mL, 4.039 mmoles) was added and the reaction was stirred at
room temperature for 2 hours, after which it was cooled to 0°C. After
quenching with saturated Rochelle's salt solution (2 mL), the mixture was
washed with ethyl acetate (3 X 5 mL). The combined organic phases were
dried over MgSO4, filtered, and concentrated to dryness. The residue was
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dissolved in CH2C12 (10 mL) and imidazole (0.495 g, 7.271 mmoles) was
added. tBuPh2SiCl (0.945 mL, 3.635 mmoles) was added and the reaction was
stirred at room temperature under argon for 1 hour. The resulting mixture
was washed with water (10 mL), dried over MgSO4, and concentrated to
dryness. The residue was purified on silica gel (50% ethyl acetate/hexane) to
give the desired product (1.212 g, 76%) as a colorless oil.
Physical Properties for 226
Rf = 0.40 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 7.63(m, 4H), 7.37(m, 6H), 3.89(t, J = 6.68 Hz,
2H), 3.69(t, = 6.20 Hz, 2H), 3.67(t, I = 7.50 Hz, 2H), 2.53(t, J = 7.50 Hz, 2H),
2.26(m, J = 7.66 Hz, 2H), 1.87(m, ] = 7.82 Hz, 2H), 1.02(s, 9H).
O O
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226 227
Methyl tert-Butyldiphenylsilyloxy Isoxazolidide, 227
(TMS)2NH (0.2945 mL, 1.396 mmoles) was dissolved in THF (3.75 mL)
and cooled to -780C under argon. n-BuLi (2.40M in hexane, 0.582 mL, 1.396
mmoles) was added and the reaction was stirred for 30 minutes. The tert-
butyldiphenylsilyloxy isoxazolidide, 225, (0.504 mL, 1.269 mmoles) was
dissolved in THF (0.75 mL) and added, via cannula, to the (TMS)2NLi. The
reaction was stirred at -780C for 1 hour, after which MeI (0.435 mL, 6.980
mmoles) was added. Stirring was continued for an additional 1.5 hours,
after which the reaction was allowed to warm to -20°C over 2 hours. The
reaction was then quenched with saturated NH4Cl solution (5 mL), washed
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with ethyl acetate (2 X 10 mL), dried over MgSO4, and concentrated to
dryness. Purification of the residue on silica gel (50% ethyl acetate/hexane)
provided the desired product (0.500g, 96%) as a colorless oil.
Physical Properties for 227
Rf = 0.43 (50% ethyl acetate/hexane)
1H NMR (300 MHz, CDC13): 6 7.65(m, 4H), 7.36(m, 6H), 3.90(m, J = 6.45 Hz,
2H), 3.68(m, = 6.39 Hz, 4H), 3.16(m, 1H), 2.25(m, J = 2.50 Hz, 7.06 Hz, 2H),
1.98(m, J = 6.39 Hz, 1H), 1.58(m, J = 6.93 Hz, 1H), 1.10(d, = 6.93 Hz, 3H), 1.03(s,
9H).
O O
'BuPh2SiO Me2 AI tBUPh 2 SiO NH2
227 65
Racemic Amide, 65
Trimethylaluminum (2M in hexane, 0.14 mL, 0.285 mmole) was
added to a solution of NH3 (0.32M in CH2C12, 1.20 mL, 0.381 mmole) and
stirred at room temperature under argon for 15 minutes. The methyl tert-
butyldiphenylsilyloxy isoxazolidide, 227, (39.1 mg, 0.095 mmole) was
dissolved in C6H6 (1.50 mL) and added, via cannula, to the Me2AlNH2
solution. The reaction was stirred at 55°C for 6 hours, after which it was
cooled to 0°C and quenched with saturated Rochelle's salt solution (2 mL).
The mixture was stirred at room temperature for 20 minutes, after which it
was washed with ethyl acetate (3 X 5 mL). The combined organic phases
were dried over MgSO4 and concentrated. Purification on silica gel (50%
ethyl acetate/hexane) gave the amide (20.3 rmg, 60%) as a colorless solid.
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Physical Properties for 65
Rf = 0.25 (50% ethyl acetatehexane).
1H NMR (300 MHz, CDC13): 8 7.64-7.67(m, 4H), 7.35-7.46(m, 6H), 5.49(s, 1H),
5.42(s, 1H), 3.71(m, 2H), 2.58(m, 1H), 1.87(ddd, J = 13.5, 8.2, 5.3 Hz, IH),
1.64(ddd, I = 13.5, 6.5, 6.5 Hz, 1H), 1.14(d, J = 7.1 Hz, 3H), 1.06(s, 9H).
El Mass Spec: m/e 340 [M - 151+, 298, 220, 198.
Exact Mass: [M - CH3 + = 340.17328 (calculated)
[M - CH3]+ = 340.1732 (measured).
IR (CHC13) cm- 1: 3540 (m), 3420 (m), 2980 (s), 2940 (s), 2890 (s), 2860 (s), 1685
(s, br), 1595 (s), 1475 (m), 1445 (w), 1395 (m), 1370 (w), 1280 (m, br), 1070-1125
(s, br), 995 (m), 975 (m), 895 (m).
0
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230 232
Hydroxymethylisoxazolidine Mannoside, 232
The isoxazolidine mannoside, 230, (5.00 g, 12.05 mmoles) was
dissolved in THF (10 mL) under argon and added, via cannula, to a
suspension of LiAlH4 (915 mg, 24.10 mmoles) in THF (40 mL) at 0°C. The
reaction was stirred for 30 minutes at 0°C under argon, after which it was
quenched with Na2SO4.10H 20. The mixture was stirred at room
temperature for 1 hour, filtered, and concentrated to dryness yielding the
desired product (4.11 g, 99%) as a colorless solid requiring no purification.
322
>< V0.
Physical Properties for 232
Rf = 0.14 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 4.98(d, J = 5.87 Hz, 1H), 4.83(dd, J = 3.91, 6.26
Hz, 1H), 4.45(s, 1H), 4.38(dd, I = 6.13, 11.74 Hz, 1H), 4.14(dd, I = 3.74, 6.78 Hz,
1H), 3.84-3.62(m, 4H), 3.42-3.62(m, 3H), 2.35(m, 1H), 2.17(dd, I = 5.05, 7.37 Hz,
1H), 1.99(m, 1H), 1.47(s, 3H), 1.42(s, 3H), 1.36(s, 3H), 1.34(s, 3H).
><U
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Methoxymethylisoxazolidine Mannoside, 233
NaH (80%, 208 mg, 6.96 mmoles) was suspended in THF (20 mL) and
cooled to 0°C under argon. A solution of the hydroxymethylisoxazolidine
mannoside, 232, (2.00 g, 5.80 mmoles) in THF (10 mL) was added, via
cannula, and the resulting mixture was stirred at 0°C for 30 minutes.
Methyl iodide (0.38 mL, 6.38 mmoles) was added and the reaction was
allowed to warm to room temperature over 5 hours. After quenching with
pH = 7 buffer (30 mL), the product was extracted with ethyl acetate (2 X 30
mL). The ethyl acetate layer was dried over MgSO4, filtered, and
concentrated. The residue was purified on silica gel (50% ethyl
acetate/hexane) to yield the desired product (2.06 g, 99%) as a thick syrup.
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Physical Properties for 233
Rf = 0.49 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 4.97(d, I = 6.15 Hz, 1H), 4.82(dd, I = 3.65, 6.15
Hz, 1H), 4.41(s, 1H), 4.37(m, 1H), 4.18(dd, I = 3.65, 7.43 Hz, 1H), 4.07(ddd, J =
4.46, 5.58, 8.45 Hz, 2H), 3.93(m, 2H), 3.65(m, 1H), 3.38(dd, I = 6.45, 9.43 Hz, 1H),
3.36(s, 3H), 3.25(dd, I = 6.02, 9.43 Hz, 1H), 2.33(m, 1H), 2.03(m, 1H), 1.47(s, 3H),
1.43(s, 3H), 1.37(s, 3H), 1.33(s, 3H).
1. NaH 
2. BnBr-
232 234
Benzyloxymethyisoxazolidine Mannoside, 234
NaH (80%, 0.104 g, 3.471 mmoles) was suspended in THF (15 mL) and
cooled to 0°C under argon. The hydroxymethylisoxazolidine mannoside,
232, (1.001 g, 2.893 mmoles) was dissolved in THF (5 mL) and added, via
cannula, to the NaH. The mixture was stirred at 0°C for 30 minutes, after
which benzyl bromide (0.378 mL, 3.182 mmoles) was added. The reaction
was stirred at room temperature for 22 hours, after which it was quenched
with pH = 7 buffer (30 mL) and washed with ethyl acetate (3 X 20 mL). The
combined organics were dried over MgSO4 and concentrated to dryness.
The residue was purified on silica gel (25% ethyl acetate/hexane) to give the
desired product (1.255 g, 99%) as a colorless oil.
324
Physical Properties for 234
Rf = 0.71 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 7.31(m, 5H), 4.95(d, J = 6.03 Hz, 1H), 4.80(dd, J =
3.75, 6.20 Hz, 1H), 4.53(AB, I = 12.06 Hz, 2H), 4.41(s, 1H), 4.35(m, 1H), 4.16(dd, J
= 3.59, 7.50 Hz, 1H), 4.06(dd, I = 6.20, 8.64 Hz, 1H), 4.00(dd, I = 4.73, 8.48 Hz,
1H), 3.90(m, 2H), 3.68(m, 1H), 3.46(dd, I = 6.68, 9.45 Hz, 1H), 3.30(dd, J = 6.85,
9.29 Hz, 1H), 2.32(m, 1H), 2.04(m, IH), 1.46(s, 3H), 1.38(s, 3H), 1.35(s, 3H),
1.32(s, 3H).
20H
230 235
Dimethylhydroxymethylisoxazolidine Mannoside, 235
The isoxazolidine mannoside, 230, (5.00 g, 12.05 mmoles) was
dissolved in ether (100 mL) and cooled to 0°C under argon. MeMgBr (3M in
ether, 12.05 mL, 36.15 mmoles) was added, dropwise, and the solution was
stirred at 0°C for 1 hour. The reaction was then quenched with pH = 7 buffer
(100 mL) and water (100 rnL) was added. The resulting mixture was washed
with ethyl acetate (2 X 100 mL). The ethyl acetate was dried over MgSO4,
filtered, and concentrated to dryness yielding the desired product (4.27 g,
95%) as a thick syrup requiring no further purification.
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Physical Properties for 235
Rf = 0.31 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13 ): 8 5.00(d, J = 6.12 Hz, 1H), 4.83(dd, I = 3.67, 6.10
Hz, 1H), 4.38(m, 2H), 4.14(dd, J = 3.46, 7.55 Hz, 1H), 4.08(dd, J = 6.16, 8.62 Hz,
1H), 3.93-4.01(m, 3H), 3.35(dd, I = 4.83, 7.30 Hz, 1H), 2.30(m, 2H), 2.03(s, 1H),
1.47(s, 3H), 1.41(s, 3H), 1.36(s, 3H), 1.34(s, 3H), 1.22(s, 3H), 1.16(s, 3H).
1. NaH,
2. Mel
X C(Me) 2 0H 2OMe
235 236
Dimethylmethoxymethylisoxazolidine Mannoside, 236
NaH (80%, 161 mg, 5.37 mmoles) was suspended in TEF (10 mL) at
room temperature under argon. A solution of the
dimethylmethoxymethylisoxazolidine mannoside, 235, (1.67 g, 4.48 mmoles)
in THF (10 mL) was added, via cannula, and the resulting mixture was
stirred at room temperature for 45 minutes. Methyl iodide (0.28 mL, 4.48
mmoles) was added and the reaction was stirred at room temperature for 2
days. After quenching with pH = 7 buffer (25 mL), the product was extracted
with ethyl acetate (2 X 25 mL). The ethyl acetate layers were dried over
MgSO4, filtered, and concentrated. The residue was purified on silica gel
(15% ethyl acetate/hexane) to yield the desired product (1.18 g, 68%) as a
thick syrup and recovered starting material (0.30 g, 18%).
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Physical Properties for 236
Rf = 0.74 (50% ethyl acetate/hexane).
IH NMR (300 MHz, CDCl3 ): 8 5.00(d, I = 6.03 Hz, 1H), 4.81(dd, 1 = 3.49, 6.03
Hz, 1H), 4.37(m, 1H), 4.33(s, 1H), 4.15(dd, J = 3.59, 7.50 Hz, 1H), 4.05(ABX, I =
6.19, 8.80, 4.56 Hz, 2H), 3.96(m, 1H), 3.90(m, 1H), 3.47(dd, I = 3.26, 8.97 Hz, IH),
3.20(s, 3H), 2.47(m, 1H), 2.35(m, 1H), 1.47(s, 3H), 1.42(s, 3H), 1.36(s, 3H), 1.33(s,
3H), 1.19(s, 3H), 1.07(s, 3H).
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5-(S)-Methoxymethylisoxazolidide, 240
The methoxymethylisoxazolidine mannoside, 233, (1.016 g, 2.831
mmoles) was dissolved in MeOH (15 mL) and concentrated HCl (1.5 mL)
was added. The reaction was stirred at room temperature for 6 hours, after
which it was quenched with saturated NaHCO3 solution (30 mL). NaOH (1
pellet) was dissolved in the mixture and the resulting solution was washed
with ethyl acetate (3 X 30 mL). The combined ethyl acetate layers were dried
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over MgSO4, concentrated to dryness, and dissolved in THF (5 mL).
Hexanoic acid, 221, (355 gL, 2.83 mmoles) was dissolved in THF (10 mL) and
N-methylmorpholine (311 L, 2.83 mmoles) was added. The mixture was
cooled to -200C under argon and isobutyl chloroformate (367 IgL, 2.83
mmoles) was added. After 1 minute, the isoxazolidine solution was added,
via cannula, and the reaction was stirred at -200C for 1 hour. The reaction
was then warmed to room temperature, concentrated, and combined with
ethyl acetate (15 mL). The ethyl acetate was washed with 5% citric acid
solution (2 X 10 mL) and saturated NaHCO3 solution (2 X 10 mL), after
which it was dried over MgSO4, concentrated to dryness, and purified on
silica gel (50% ethyl acetate/hexane) to yield the desired product (0.256 g,
42%) as a colorless liquid.
Physical Properties for 240
Rf = 0.47 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 8 4.50(m, 1H), 4.11(dt, J = 3.59, 7.91 Hz, 1H),
3.70(dt, J = 7.17, 7.99 Hz, H), 3.55(dd, ] = 4.89, 9.62 Hz, 1H), 3.39(dd, J = 6.36,
9.46 Hz, 1H), 3.37(s, 3H), 2.45(m, 1H), 2.35(m, 2H), 2.23(m, 1H), 1.60(m, 2H),
1.30(m, 4H), 0.87(m, 3H).
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5-(S)-Benzyloxymethylisoxazolidide, 241
The benzyloxymethylisoxazolidine mannoside, 234, (1.180 g, 2.713
mmoles) was dissolved in MeOH (16 mL) and 10% HCl was added. The
reaction was stirred at room temperature for 6 hours, after which it was
quenched with saturated NaHCO3 solution (30 mL). NaOH (1 pellet) was
added and the reaction was washed with ethyl acetate (3 X 30 mL). The
combined organics were dried over MgSO4, concentrated to dryness and the
residue was dissolved in THF (5 mL). Hexanoic acid, 221, (0.340 mL, 2.713
mmoles) was dissolved in THF (15 mL). N-methylmorpholine (0.298 mL,
2.713 mmoles) was added and the mixture was cooled to -20C under argon.
Isobutylchloroformate (0.352 mL, 2.713 mmoles) was added and the reaction
was stirred for 1 minute. The isoxazolidine solution was added, via
cannula, and the reaction was stirred at -2°0C for 1 hour, after which it was
warmed to room temperature and concentrated to dryness. After adding
ethyl acetate (20 mL), the mixture was washed with 5% citric acid solution (2
X 10 mL) and saturated NaHCO3 solution (2 X 10 mL). The combined
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organic phases were dried over MgSO4 and concentrated to dryness.
Purification of the residue on silica gel (25% ethyl acetate/hexane) provided
the desired product (0.579 g, 73% yield) as a colorless oil.
Physical Properties for 241
Rf = 0.58 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDCl 3): 8 7.31(m, 5H), 4.54(m, 3H), 4.10(dt, J = 3.75, 7.82
Hz, 1H), 3.72(m, 1H), 3.66(dd, J = 4.89, 9.62 Hz, 1H), 3.45(dd, J = 6.85, 9.62 Hz,
1H), 2.34(m, 4H), 1.61(m, 2H), 1.31(m, 4H), 0.87(m, 3H).
0
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5-(S)-Dimethylmethoxymethyl Isoxazolidide, 242
The dimethylmethoxymethylisoxazolidine mannoside, 236, (1.184 g,
3.059 mmoles) was dissolved in MeOH (18 mL) and concentrated HCl (1.8
mL) was added. The reaction was stirred at room temperature for 6 hours
after which, it was quenched with saturated NaHCO3 solution (30 mL).
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NaOH (1 pellet) was dissolved in the mixture and the resulting solution was
extracted with ethyl acetate (3 X 30 mL). The ethyl acetate was dried over
MgSO4, concentrated, and dissolved in THF (5 mL). Hexanoic acid, 221, (383
gL, 3.06 mmoles) was dissolved in THF (10 mL) and N-methylmorpholine
(336 [tL, 3.06 mmoles) was added. After cooling to -200C under argon,
isobutyl chloroformate (397 IgL, 3.06 mmoles) was added. After 1 minute,
the isoxazolidine solution was added, via cannula, and the reaction was
stirred at -200C for 1 hour. The reaction was then warmed to room
temperature, concentrated, and combined with ethyl acetate (15 mL). The
ethyl acetate was washed with 5% citric acid solution (2 X 10 mL) and
saturated NaHCO3 solution (2 X 10 mL), after which it was dried over
MgSO4, concentrated to dryness, and purified on silica gel (50% ethyl
acetate/hexane) to yield the desired product (0.412 g, 55%) as a colorless
liquid.
Physical Properties for 242
Rf = 0.68 (50% ethyl acetate/hexane).
1 H NMR (300 MHz, CDC13 ): 4.41(dd, J = 5.70, 9.29 Hz, 1H), 4.12(dt, J = 1.96,
8.08 Hz, 1H), 3.55(dt, J = 7.82, 10.27 Hz, 1H), 3.24(s, 3H), 2.56(m, 1H), 2.41(m,
1H), 2.35(m, 1H), 2.21(m, 1H), 1.62(m, 2H), 1.32(m, 4H), 1.20(s, 3H), 1.15(s, 3H),
0.89(m, 3H).
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5-(S)-Methoxymethyl-2'-(R)-Methylhexanoyl Isoxazolidide, 243
(TMS)2NH (33.7 AL, 0.160 mmole) was dissolved in THF (0.5 mL) and
cooled to -78°C under argon. n-BuLi (2.40M in hexane, 67 gL, 0.160 mmole)
was added and the mixture was stirred at -78°C for 30 minutes. Hexanoic
isoxazolidide 240 (29.8 AiL, 0.145 mmole) was added and the mixture was
stirred at -780C for 1 hour, after which it was cooled to -950C. Methyl iodide
(50 jiL, 0.803 mmole) was added and the reaction was stirred at -950C for 3
hours, after which it was allowed to warm to -780C over 1 hour. The
reaction was quenched with saturated NH4Cl solution (1 mL), warmed to
room temperature, and extracted with ethyl acetate (3 mL). The ethyl acetate
layer was dried over MgSO4, and concentrated to dryness. Purification of the
residue on silica gel (50% ethyl acetate/hexane) yielded the desired product
(34.2 mg, 97%, 93% de) as a colorless liquid.
Physical Properties for 243
Rf = 0.51 (50% ethyl acetate/hexane).
1H NMR (300 MHz, CDC13): 4.51(m, 1H), 4.13(dt, J = 3.65, 7.91 Hz, 1H),
3.72(m, 1H), 3.59(dd, J = 4.56, 9.63 Hz, 1H), 3.42(dd, J = 6.58, 9.63 Hz, 1H), 3.39(s,
3H), 2.88(m, 1H), 2.40(m, 1H), 2.27(m, 1H), 1.62(m, 1H), 1.34(m, 5H), 1.14(d, J =
6.89 Hz, 3H), 0.88(m, 3H).
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5-(S)-Benzyloxymethyl-2'-(R)-Methylhexanoyl Isoxazolidide, 244
(TMS)2NH (33.7 gL, 0.160 mmole) was dissolved in THF (0.5 mL) and
cooled to -78°C under argon. n-BuLi (2.40M in hexane, 67 gIL, 0.160 mmole)
was added and the mixture was stirred at -78°C for 30 minutes. Hexanoic
isoxazolidide 241 (30 gL, 0.145 mmole) was dissolved in THF (0.25 mL) and
added, via cannula, to the (TMS)2NLi. The mixture was stirred at -78C for 1
hour, after which methyl iodide (50 L, 0.803 mmole) was added. The
reaction was stirred at -78°C for 3 hours, after which it was quenched with
saturated NH4CI solution (1 mL) and washed with ethyl acetate (3 mL). The
ethyl acetate layer was dried over MgSO4, and concentrated to dryness.
Purification on silica gel (50% ethyl acetate/hexane) yielded the desired
product (37.7 mg, 85%, 69% de) as a colorless liquid.
Physical Properties for 244
Rf = 0.70 (50% ethyl acetate/hexane)
1H NMR (300 MHz, CDC13): 8 7.31(m, 5H), 4.55(m, 3H), 4.11(dt, J = 3.75, 7.82
Hz, 1H), 3.71(dd, J = 7.17 Hz, 1H), 3.68(dd, I = 4.80, 9.62 Hz, 1H), 3.45(dd, J =
6.85, 9.62 Hz, 1H), 2.39(m, 2H), 2.37(m, 1H), 2.29(m, 1H), 1.61(m, 2H), 1.30(m,
4H), 0.87(m, 3H).
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5-(S)-Dimethylmethoxymethyl-2'-(R)-Methylhexanoyl Isoxazolidide, 245
(TMS)2NH (33.7 gL, 0.160 mmole) was dissolved in THF (0.5 mL) and
cooled to -78°C under argon. n-BuLi (2.40M in hexane, 67 pL, 0.160 mmole)
was added and the mixture was stirred at -78°C for 30 minutes. Hexanoic
isoxazolidide 242 (35.2 gL, 0.145 mmole) was added and the mixture was
stirred at -78°C for 1 hour. Methyl iodide (50 lL, 0.803 mmole) was added
and the reaction was stirred at -780C for 3 hours, after which it was quenched
with saturated NH4Cl solution (1 mL) and washed with ethyl acetate (3 mL).
The ethyl acetate layer was dried over MgSO4, filtered, and concentrated to
dryness. Purification on silica gel (50% ethyl acetate/hexane) yielded the
product (29.1 mg, 78%, 75% de) as a colorless liquid.
Physical Properties for 245
Rf = 0.81 (50% ethyl acetate/hexane)
1H NMR (300 MHz, CDC13): 4.45(dd, J = 5.47, 9.43 Hz, 1H), 4.13(dt, J = 2.44,
8.22 Hz, 1H), 3.57(dt, J = 7.67, 9.96 Hz, 1H), 3.25(s, 3H), 2.94(m, 1H), 2.44(m,
1H), 2.23(m, 1H), 1.64(m, 1H), 1.29(m, 5H), 1.20(s, 3H), 1.17(d, J = 6.92 Hz, 3H),
1.14(s, 3H), 0.88(t, J = 6.76 Hz, 3H).
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Chapter 6:
Summary and Discussion
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6.1 Introduction
Chapter 1 discussed our early attempts at the preparation of fragment
A of calyculin A. Chapters 2 and 3 described the preparation of fragments
which would lead to the enantiomer of calyculin A, and chapter 4 illustrated
our preparation of the natural enantiomers of these fragments as well as
their coupling to form fragment C. Finally, Chapter 5 described progress
towards tne development of a new and potentially useful chiral auxiliary.
However, at no point in these chapters was there a comparison of our
research to work recently published by other groups. Therefore, this chapter
will present such arguments specifically pertaining to the preparation of the
oxazole in fragment C1, the preparation of fragment C2, and the usefulness
of isoxazolidines as chiral auxiliaries when compared to other proven
compounds.
6.2 The Oxazole
Scheme 6.1
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Our oxazole preparation, shown in Scheme 6.1, incorporates the
condensation of the amide, 185, with ethyl bromopyruvate, 80, followed by
dehydration of the corresponding 4-hydroxyoxazoline with trifluoroacetic
anhydride and pyridine (see chapter 2). As it turns out, of all the work on
calyculin that has been published to date,16, 17, 21,2 5 our synthesis is the only
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one exploiting this methodology. The remainder of this section will
describe work published by Armstrong,17 Smith,16 Hamada,21 and Evans.25
Scheme 6.2
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The only reported method for the preparation of the oxazole that
resembles ours is that of Armstrong.1 7 His strategy, shown in Scheme 6.2,
involves the condensation of an amide, 252, with 1,3-dichloroacetone, 253.
The other three groups16 ,2 1,2 5 all report similar strategies towards this
functional group and incorporate the dehydrogenation of an oxazoline, 255,
to an oxazole, 256 (Scheme 6.3). Although these two general strategies seem
quite different, they both involve the application of elevated temperatures
to oxazolines. The oxazoline from Armstrong's method is an intermediate
in the condensation of the amide with 1,3-dichloroacetone (see Scheme 2.5)
while those reported by the others are prepared and isolated. The problems
involving elevated temperatures on oxazolines are apparent from our
observation that the NiO2 procedure induces some epimerization. Further
support of this observation was found in literature claims that oxazolines,
when heated to 40°C for 16 hours, lose all stereochemical integrity.8 3 ,84
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With this in mind, it is surprising that Evans and Smith reported no study
of epimerization during this reaction. Hamada reported no observed
epimerization during the NiO2 reaction, but his group carried out this
transformation at room temperature. This result was particularly surprising
when considering our observed lack of reaction under these conditions.
There is one more method reported for the formation of the oxazole.
This is an alternate approach utilized by Evans2 5 for large scale preparations
and involves selenium chemistry (Scheme 6.4). Although Evans reports no
study of epimerization during this reaction, it is likely that the
stereochemical integrity of the a-center remains intact due to the greater
acidity of the proton oa to the ester.
Scheme 6.4
'BOCHN A 1. PhSeCI, (TMS) 2NK
257CHN 2. H202, Pyridine
CO2 Me
0
tBOCHN 
258 CO2Me
6.3 Fragment C2
Our preparation of fragment C2 incorporates the derivatization of D-
lyxonolactone, 170, a readily available chiral pool starting material bearing
two correct stereocenters and one requiring inversion, to the literature
compound 167122 (see Scheme 4.7). This strategy is comprised of four one-
pot reaction sequences from 167 (Scheme 6.5) in which no stereogenic
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centers need be created. Consequently, our preparation is highly
competitive with four published routes to analogous compounds. These
routes, the starting materials of which are shown in Figure 6.1, include
Smith's ten-step synthesis from 2,3-O-isopropylidine-D-erythronolactone,
259,16 Hamada's nine-step synthesis from 4-hydroxymethylbutyrolactam,
260,18 an eight-step synthesis from N-methylglycine, 261, by Evans,2 5 and
Koskinen's six-step synthesis from the serine-derived aldehyde, 262.19 All of
these strategies require the introduction of one or more stereogenic centers.
Scheme 6.5
MeAICINHMe
MeO
167 191
1. Ms-CI
2. KOtBu
Me
1. HCVH20
2. Bn-Br/Ag2 0
193 192
1. Et 3OBF 4
2. NaHCO3 , H 20,
H2 C=O
3. NaCNBH 3, ZnCI2
BnO O
MeO Et
Me2N OBn194
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Figure 6.1
O
'HO
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0
NH MeHNH 1,. OH
259 260 261 262
6.4 Isoxazolidine Chemistry
Although Chapter 5 dealt extensively with our study of isoxazolidines
as chiral auxiliaries in asymmetric synthesis, no comparison was made with
Evans' extremely successful oxazolidinone auxiliaries.1 58 The Evans
auxiliaries are convenient in that they are easily prepared by reduction of
aminoacids followed by treatment with diethyl carbonate (Scheme 6.6).159
Scheme 6.6
NH2 O
Ke OH -1. BH 3-Me 2 S
2. (EtO)2CO 
O
Although the formation of oxazolidinones is much easier than
formation of chiral isoxazolidines (see Schemes 5.8 and 5.9), our auxiliaries
potentially have advantages over Evans'. For example, the Evans
auxiliaries can only be acylated by reaction with acid chlorides or other
similarly reactive derivatives, but not esters. On the other hand,
isoxazolidines avoid this problem in that they are fully compatible with
Weinreb methodology.127,128,129 Other advantages include the ability to
directly cleave the auxiliary with alkyllithium, Grignard, or Weinreb
reagents. 147,148 ,149,150 These factors alone illustrate the complementarity of
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these two methodologies in spite of the slightly lower diastereomeric
inductions of isoxazolidines (93% vs >99%).
6.5 Conclusion
This thesis has extensively dealt with strategies, both successful and
not, directed toward the synthesis of fragments of calyculin A, as well as the
introduction of new methodology. Our strategies have distinct advantages
over other reported routes to analogous compounds and illustrate the
application of contemporary organic chemistry to the solution of relatively
complex synthetic problems. With these problems solved, the completion
of the total synthesis of calyculin A should not be far off.
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